
<html lang="en"     class="pb-page"  data-request-id="355f0caf-404b-4ec3-bfe9-7881c5d69d7f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.0c01763;issue:issue:10.1021/jmcmar.2021.64.issue-2;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis" /></meta><meta name="dc.Creator" content="Zhuang  Li" /></meta><meta name="dc.Creator" content="Jie  Tu" /></meta><meta name="dc.Creator" content="Guiyan  Han" /></meta><meta name="dc.Creator" content="Na  Liu" /></meta><meta name="dc.Creator" content="Chunquan  Sheng" /></meta><meta name="dc.Description" content="Due to the evolution and development of antifungal drug resistance, limited efficacy of existing drugs has led to high mortality in patients with serious fungal infections. To develop novel antifun..." /></meta><meta name="Description" content="Due to the evolution and development of antifungal drug resistance, limited efficacy of existing drugs has led to high mortality in patients with serious fungal infections. To develop novel antifun..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 27, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01763" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01763" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01763" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01763" /></link>
        
    
    

<title>Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01763" /></meta><meta property="og:title" content="Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0010.jpeg" /></meta><meta property="og:description" content="Due to the evolution and development of antifungal drug resistance, limited efficacy of existing drugs has led to high mortality in patients with serious fungal infections. To develop novel antifungal therapeutic strategies, herein a series of carboline fungal histone deacetylase (HDAC) inhibitors were designed and synthesized, which had potent synergistic effects with fluconazole against resistant Candida albicans infection. In particular, compound D12 showed excellent in vitro and in vivo synergistic antifungal efficacy with fluconazole to treat azole-resistant candidiasis. It cooperated with fluconazole in reducing the virulence of C. albicans by blocking morphological mutual transformation and inhibiting biofilm formation. Mechanism studies revealed that the reversion of drug resistance was due to downregulation of the expression of the azole target gene ERG11 and efflux gene CDR1. Taken together, fungal HDAC inhibitor D12 offered a promising lead compound for combinational treatment of azole-resistant candidiasis." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Due to the evolution and development of antifungal drug resistance, limited efficacy of existing drugs has led to high mortality in patients with serious fungal infections. To develop novel antifungal therapeutic strategies, herein a series of carboline fungal histone deacetylase (HDAC) inhibitors were designed and synthesized, which had potent synergistic effects with fluconazole against resistant Candida albicans infection. In particular, compound D12 showed excellent in vitro and in vivo synergistic antifungal efficacy with fluconazole to treat azole-resistant candidiasis. It cooperated with fluconazole in reducing the virulence of C. albicans by blocking morphological mutual transformation and inhibiting biofilm formation. Mechanism studies revealed that the reversion of drug resistance was due to downregulation of the expression of the azole target gene ERG11 and efflux gene CDR1. Taken together, fungal HDAC inhibitor D12 offered a promising lead compound for combinational treatment of azole-resistant candidiasis." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0010.jpeg" /></meta><meta name="twitter:title" content="Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01763"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01763">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01763&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01763&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01763&amp;href=/doi/10.1021/acs.jmedchem.0c01763" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 2</span><span class="cit-fg-pageRange">, 1116-1126</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/2" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01712" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01783" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhuang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhuang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhuang++Li">Zhuang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jie Tu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jie Tu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jie++Tu">Jie Tu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guiyan Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guiyan Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guiyan++Han">Guiyan Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Na Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Na Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#22101a171b111b151a166253530c414d4f"><span class="__cf_email__" data-cfemail="9dafa5a8a4aea4aaa5a9ddececb3fef2f0">[email protected]</span></a>. Phone/Fax: +86 21 81871230.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Na++Liu">Na Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3920-1008" title="Orcid link">http://orcid.org/0000-0002-3920-1008</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Chunquan Sheng</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunquan Sheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</div><div class="loa-info-affiliations-info">School of Medicine, Tongji University, Shanghai 200072, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#bbc8d3ded5dcd8cafbc8d6d6ce95dedfce95d8d5"><span class="__cf_email__" data-cfemail="4d3e2528232a2e3c0d3e20203863282938632e23">[email protected]</span></a>. Phone/Fax: +86 21 81871201.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunquan++Sheng">Chunquan Sheng</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9489-804X" title="Orcid link">http://orcid.org/0000-0001-9489-804X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01763&amp;href=/doi/10.1021%2Facs.jmedchem.0c01763" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 2</span><span class="cit-pageRange">, 1116–1126</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 27, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>7 October 2020</li><li><span class="item_label"><b>Published</b> online</span>27 December 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 January 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01763" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01763</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1116%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhuang%2BLi%252C%2BJie%2BTu%252C%2BGuiyan%2BHan%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D2%26contentID%3Dacs.jmedchem.0c01763%26title%3DNovel%2BCarboline%2BFungal%2BHistone%2BDeacetylase%2B%2528HDAC%2529%2BInhibitors%2Bfor%2BCombinational%2BTreatment%2Bof%2BAzole-Resistant%2BCandidiasis%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1126%26publicationDate%3DJanuary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01763"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1123</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01763" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Carboline Fungal Histone Deacetylase (HDAC) Inhibitors for Combinational Treatment of Azole-Resistant Candidiasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhuang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jie&quot;,&quot;last_name&quot;:&quot;Tu&quot;},{&quot;first_name&quot;:&quot;Guiyan&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Na&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Chunquan&quot;,&quot;last_name&quot;:&quot;Sheng&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;2&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;1116-1126&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01763&quot;},&quot;abstract&quot;:&quot;Due to the evolution and development of antifungal drug resistance, limited efficacy of existing drugs has led to high mortality in patients with serious fungal infections. To develop novel antifungal therapeutic strategies, herein a series of carboline fungal histone deacetylase (HDAC) inhibitors were designed and synthesized, which had potent synergistic effects with fluconazole against resistant Candida albicans infection. In particular, compound D12 showed excellent in vitro and in vivo synergistic antifungal efficacy with fluconazole to treat azole-resistant candidiasis. It cooperated with fluconazole in reducing the virulence of C. albicans by blocking morphological mutual transformation and inhibiting biofilm formation. Mechanism studies revealed that the reversion of drug resistance was due to downregulation of the expression of the azole target gene ERG11 and efflux gene CDR1. Taken together, fungal HDAC inhibitor D12 offered a promising lead compound for combinational treatment of azole-resistant ca&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01763&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01763" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01763&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01763" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01763&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01763" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01763&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01763&amp;href=/doi/10.1021/acs.jmedchem.0c01763" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01763" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01763" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01763%26sid%3Dliteratum%253Aachs%26pmid%3D33356256%26genre%3Darticle%26aulast%3DLi%26date%3D2021%26atitle%3DNovel%2BCarboline%2BFungal%2BHistone%2BDeacetylase%2B%2528HDAC%2529%2BInhibitors%2Bfor%2BCombinational%2BTreatment%2Bof%2BAzole-Resistant%2BCandidiasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D2%26spage%3D1116%26epage%3D1126%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292518" title="Biofilms">Biofilms</a>,</li><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292227" title="Drug resistance">Drug resistance</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290677" title="Toxicological synergy">Toxicological synergy</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/2" title="Go to Volume 64, Issue 2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/jmcmar.2021.64.issue-2/20210128/jmcmar.2021.64.issue-2.largecover.jpg" alt="Go to Volume 64, Issue 2"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Due to the evolution and development of antifungal drug resistance, limited efficacy of existing drugs has led to high mortality in patients with serious fungal infections. To develop novel antifungal therapeutic strategies, herein a series of carboline fungal histone deacetylase (HDAC) inhibitors were designed and synthesized, which had potent synergistic effects with fluconazole against resistant <i>Candida albicans</i> infection. In particular, compound <b>D12</b> showed excellent <i>in vitro</i> and <i>in vivo</i> synergistic antifungal efficacy with fluconazole to treat azole-resistant candidiasis. It cooperated with fluconazole in reducing the virulence of <i>C. albicans</i> by blocking morphological mutual transformation and inhibiting biofilm formation. Mechanism studies revealed that the reversion of drug resistance was due to downregulation of the expression of the azole target gene <i>ERG11</i> and efflux gene <i>CDR1</i>. Taken together, fungal HDAC inhibitor <b>D12</b> offered a promising lead compound for combinational treatment of azole-resistant candidiasis.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Invasive fungal infections (IFIs) have been increasingly realized as a lethal threat to immunocompromised and critical patients in clinic. It is estimated that the number of deaths caused by IFIs reaches 1.5 to 2 million per year.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> About 17% intensive care unit (ICU) patients suffer from candidiasis.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Due to the high survival ability in the bloodstream, <i>Candida albicans</i> is the most common fungal pathogen.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> Currently, only four types of antifungal drugs (azoles, polyenes, echinocandins, and flucytosine) are approved to treat fungal infections, whose therapeutic effects are limited by low potency and high toxicity.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> A single type of antifungal agent could easily lead to the rapid evolution and development of drug resistance, and in most cases, higher mortality is closely associated with the drug-resistant fungal infection.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> Therefore, there is an urgent need to develop novel antifungal agents or drug combinations with synergistic effects to expand current therapeutic strategies.</div><div class="NLM_p">Combinational drug therapy is one of the promising strategies that could enhance the efficacy of first-line drugs and block the emergence of drug resistance.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> Drug resistance of fungi involves transcriptional regulation, in which chromatin kinetics and histone modification play a major role.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Histone modification, regulated by HDACs, plays a vital role in stress-signaling responses, which is related to fungal adaptation to various environmental stresses including drug stress.<a onclick="showRef(event, 'ref4 ref11'); return false;" href="javascript:void(0);" class="ref ref4 ref11">(4,11)</a> Fungal HDACs participate in fungal infection and resistance through various ways, including limiting fungal development, reducing fungal virulence, and preventing its dissemination. It is reported that the combination of HDAC inhibitors and azole drugs has synergistic antifungal effects against azole-resistant <i>C. albicans</i>.<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12−15)</a> However, human HDAC inhibitors are mostly developed as antitumor agents, which hamper their direct use as synergistic antifungal agents. Thus, there is an urgent need to develop fungal HDAC inhibitors with improved selectivity and synergistic potency and reduced cytotoxicity.</div><div class="NLM_p">In our previous studies, we designed lanosterol 14α-demethylase (CYP51)-HDAC<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and Janus kinase 2 (JAK2)-HDAC6<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> dual inhibitors for the treatment of resistant candidiasis. In particular, the HDAC6/JAK2 dual inhibitors showed excellent synergistic effects with fluconazole (FLC) to treat resistant <i>C. albicans</i> infections. Inspired by the results, we further assayed the synergistic effects of tubastatin A (TBA), a selective HDAC6 inhibitor, with azole antifungal agents. The results revealed that TBA synergized with FLC, voriconazole (VRC), and itraconazole (ITC) against resistant <i>C. albicans</i> isolates (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">Table S1</a> in the Supporting Information). Thus, HDAC6 inhibitor TBA offered a lead compound for discovering novel synergistic antifungal agents. To further improve the antifungal activity and clarify the structure–activity relationships (SARs), herein a series of carboline compounds were designed and synthesized on the basis of our previously identified carboline antifungal scaffold<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Most compounds were able to potentiate the antifungal activity of FLC against FLC-resistant <i>C. albicans</i> cells. In particular, the combination of compound <b>D12</b> and FLC effectively blocked the morphological changes and biofilm formation of <i>C. albicans</i> and showed potent <i>in vivo</i> efficacy in a model of resistant candidiasis.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of carboline compounds as novel fungal HDAC inhibitors. The fraction inhibitory concentration index (FICI) is defined as the sum of the ratios that divide the MIC value of each drug used in combination by the value of the drug used alone. Synergism and antagonism were defined by FICIs of ≤0.5 and >4, respectively. An FICI > 0.5 but <4 is considered irrelevant. The subfigure at the bottom right is the antifungal activity in the form of a heat map measured by the checkerboard microdilution assay. The relative growth of fungi (0–1.5) changes from green to black (the greener the color, the stronger the inhibition).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17103" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17103" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Design of Carboline HDAC Inhibitors</h3><div class="NLM_p last">The pharmacophores of typical HDAC inhibitors can be divided into three parts: a cap group, a linker (usually hydrophobic), and a zinc-binding group (ZBG). In particular, ZBG (hydroxamic acid or benzamide group) binds to the zinc ion and plays a crucial role in the inhibition of zinc-dependent HDACs.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Typically, TBA consists of a carboline cap group, a benzyl linker, and a hydroxamic acid ZBG group. On the basis of our previous work, the β-carboline ring was proven to be a potent antifungal scaffold,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which was selected as the cap group and the hydroxamic acid ZBG necessary for HDAC binding was retained. Considering the structural features of TBA and carboline lead compounds, the propoxy phenyl group was designed as the linker and various substitutions were introduced on the carboline scaffold (<b>D1–12</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The chemical synthesis of carboline compounds is described in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Intermediates <b>4a–m</b> were synthesized according to our previous methods by using various substituted indoles as starting materials.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A substitution reaction between intermediate <b>3</b> and intermediates <b>4a–m</b> was performed in the presence of NaH to give products <b>5a–m</b>. Target compounds (<b>D1–12</b>) were obtained via two steps including the removal of the <i>t</i>-butoxycarbonyl protective group in intermediates <b>5a–m</b> and the nucleophilic addition reaction with hydroxylamine.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Synthesis of Carboline Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><b>Reagents and conditions:</b> (a) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, yield 64%; (b) NaH, dimethylformamide (DMF), yield 24–85%; (c) trifluoroacetic acid (TFA), CH<sub>2</sub>Cl<sub>2</sub>; and (d) KOH, NH<sub>2</sub>OH·HCl, and CH<sub>3</sub>OH, yield 31–84%.</p></p></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Carboline Derivatives in Combination with FLC Inhibited Azole-Resistant <i>C. albicans</i></h3><div class="NLM_p">The antifungal activities of TBA and carboline derivatives used alone or in combination with FLC are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. The minimum concentration of 80% inhibition (MIC<sub>80</sub>) is defined as the lowest concentration of a drug alone or synergistically that inhibits fungal cell growth by 80%. Carboline derivatives generally were inactive in inhibiting the growth of FLC-resistant <i>C. albicans</i> (MIC<sub>80</sub> ≥ 64 μg/mL) when used alone. In contrast, they showed synergistic effects with FLC and the antifungal activities of compounds <b>D1</b>–<b>12</b> in combination with FLC were significantly enhanced. The MIC<sub>80</sub> values were reduced from >64 μg/mL to 0.25–8 μg/mL with the FICI values ranging from 0.035 to 0.13. Compounds <b>D1</b>–<b>12</b> were also tested for the synergistic effects with other azoles (VRC and ITC) against azole-resistant <i>C. albicans</i>, which also showed excellent synergistic activities (FICI <b>=</b> 0.035–0.13, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">Table S2</a> in the Supporting Information). Thus, carboline compounds could enhance the efficacy of azole drugs against azole-resistant <i>C. albicans</i> and reverse the development of antifungal drug resistance. Among them, compound <b>D12</b> showed the best synergistic effect and could be considered as a potential lead compound for the combinational treatment of candidiasis.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. <i>In Vitro</i> Antifungal Activity of Compounds Used Alone or in Combination with FLC against the <i>C. albicans</i> Strain (0304103) by the Checkerboard Microdilution Assay</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="3" align="center">compounds</th><th class="rowsep1 colsep0" colspan="2" align="center">FLC</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center">alone</th><th class="colsep0 rowsep0" align="center">synergetic</th><th class="colsep0 rowsep0" align="center">alone</th><th class="colsep0 rowsep0" align="center">synergetic</th><th class="colsep0 rowsep0" align="center" char=".">FICI<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D1</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.070</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D2</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D3</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.066</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D4</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">0.062</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D5</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.047</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D6</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D7</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.078</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D8</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D9</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.047</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D10</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.047</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D11</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D12</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>SAHA</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">025</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>TBA</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Synergism and antagonism were defined by FICIs of ≤0.5 and >4, respectively. An FICI > 0.5 but < 4 is considered irrelevant.</p></div></div></div><div class="NLM_p">Inspired by the synergistic antifungal effect of compound <b>D12</b> and FLC, a series of clinically isolated strains were selected to further verify whether <b>D12</b> also has a broad synergic activity against various types of <i>Candida</i> spp. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, compound <b>D12</b> showed excellent synergistic antifungal activity against all of these strains when used in combination with FLC (FICI range: 0.035–0.25). Compared with TBA, compound <b>D12</b> had a better synergistic effect against all of the tested strains. It is worth noting that TBA had no synergistic effect on <i>Candida krusei</i>, while compound <b>D12</b> had an FICI of 0.25 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">Figure S1</a> in the Supporting Information). The synergistic activities of compound <b>D12</b> in combination with VRC and ITC against other clinical strains such as <i>Candida auris</i>, <i>Candida glabrata</i> (<i>Cornus glabrata</i>), <i>Candida tropicalis</i>, and <i>Cryptococcus neoformans</i> were further tested. The results revealed that compound <b>D12</b> had synergistic effects with azoles against most <i>Candida</i> species, whereas the synergism was lost against <i>C. neoformans</i> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">Table S3</a> in the Supporting Information). Therefore, compound <b>D12</b> represents a lead compound for potential antifungal combination therapy, whose <i>in vitro</i> and <i>in vivo</i> antifungal activities and antiresistance mechanisms were further investigated.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>In Vitro</i> Synergistic Effect of Compound <b>D12</b> When Used in Combination with FLC against Various <i>C. albicans</i> Strains and <i>C. krusei</i> Strains</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="11" align="center">MIC<sub>80</sub> (μg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">alone</th><th class="rowsep1 colsep0" colspan="2" align="center">synergetic</th><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="2" align="center">alone</th><th class="rowsep1 colsep0" colspan="2" align="center">synergetic</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">strains<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">D12</th><th class="colsep0 rowsep0" align="center">FLC</th><th class="colsep0 rowsep0" align="center">D12</th><th class="colsep0 rowsep0" align="center">FLC</th><th class="colsep0 rowsep0" align="center" char=".">FICI</th><th class="colsep0 rowsep0" align="center">TBA</th><th class="colsep0 rowsep0" align="center">FLC</th><th class="colsep0 rowsep0" align="center">TBA</th><th class="colsep0 rowsep0" align="center">FLC</th><th class="colsep0 rowsep0" align="center" char=".">FICI</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9172</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9884</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">0.078</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10061</b></td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">0.062</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4108</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="char" char=".">0.035</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10153</b></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="left">>64</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last"><i>C. albicans</i> strains include 9172, 9884, 10061, and 4108. The <i>C. krusei</i> strain includes 10153.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound D12 Blocked the Emergence of Fungal Resistance Combined with FLC and the Synergism Mainly Depended on Compound D12 Rather than FLC</h3><div class="NLM_p">To validate the synergistic effect of compound <b>D12</b> more intuitively, its ability to block the emergence of azole resistance was tested. It was observed that drug resistance appeared in a high concentration of FLC (32 μg/mL) or a medium concentration of compound <b>D12</b> (8 μg/mL). But no colony occurred on the medium containing both FLC and compound <b>D12</b> at the same concentration (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). In <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, it could be observed that compound <b>D12</b> could enhance the antifungal effects of FLC in a dose-dependent manner by comparing the size of the inhibition ring. Thus, the combination of compound <b>D12</b> and FLC blocked the emergence of FLC resistance and enhanced the efficacy of FLC. However, it still remains unclear what the relationship between FLC and compound <b>D12</b> is, and which is more important in suppressing the emergence of fungal resistance. Therefore, the relationship between the synergism and the concentration of the two drugs was investigated. Single use of compound <b>D12</b> (32 μg/mL) or FLC (64 μg/mL) led to no or weak antifungal activity. In contrast, the growth of fungi was inhibited markedly when the two drugs were used in combination (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). In addition, after fixing FLC to a specific concentration (4, 16, or 64 μg/mL), the inhibitory effect was dependent on the concentration of compound <b>D12</b>. In contrast, changing the concentration of FLC with a specific value of compound <b>D12</b> (8, 16, or 32 μg/mL) had no significant impact on the antifungal activity. These results indicated that compound <b>D12</b> not only enhanced the activity of FLC, but also played a major role in the synergistic effects. For further investigating the synergistic antifungal mechanism, the fungicidal effect of the combination was tested. The results showed that the combination of compound <b>D12</b> and FLC had a fungicidal effect at high concentrations (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>D12</b> cooperates with FLC to block the emergence of drug resistance and plays a major role in the synergistic process. (A) Compound <b>D12</b> blocks the emergence of FLC resistance in <i>C. albicans</i> (0304103). In total, 1 × 10<sup>4</sup> cells were plated on the Sabouraud Dextrose Agar (SDA) medium containing no drugs (Control), compound <b>D12</b> (8 μg/mL), FLC (32 μg/mL), or the combination. Plates were photographed 48 h after incubation at 35 °C. (B) FLC and compound <b>D12</b> are synergistic against <i>C. albicans</i>. Disks containing compound <b>D12</b> were plated on the plate containing FLC (32 μg/mL). The doses of compound <b>D12</b> on the disks were 32, 8, 2, and 0 μg from the top to the bottom. Experiments could be duplicated biologically. (C) Time growth curves of the <i>C. albicans</i> strain 0304103 under different concentrations of compounds. The initial concentration of <i>C. albicans</i> was 1.5 × 10<sup>6</sup> cells/mL. The number of cells was counted at a specific time point (0, 6, 12, 24, 48 h) and the concentration was calculated. (D) Time kill curves of <i>the C. albicans</i> strain 0304103 when compound <b>D12</b> (32 μg/mL) was used in combination with different concentrations of FLC. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>D12</b> Exhibited Selective Inhibitory Effect on Fungal HDACs</h3><div class="NLM_p">Due to limited knowledge of fungal HDACs, there lacks well-established assays for the evaluations of fungal HDAC inhibitors. Using our previously developed fungal whole cell HDAC enzymatic assay,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> the inhibitory activity of compound <b>D12</b> against fungal and human total HDACs was determined (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). As compared with TBA, compound <b>D12</b> generally showed improved inhibitory activity against fungal HDACs and decreased activity against human HDACs. Compound <b>D12</b> inhibited fungal HDACs stronger than TBA at the same concentration. In contrast, compound <b>D12</b> was less active in inhibiting human HDACs than TBA. Moreover, compound <b>D12</b> also exhibited weaker inhibitory activity against human-derived HDAC1 (IC<sub>50</sub> = 1034 nM) and HDAC6 (IC<sub>50</sub> = 549 nM) than TBA and SAHA (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As a result, the enhanced synergistic effect of compound <b>D12</b> might be associated with the increased selectivity of fungal HDACs over human HDACs. Furthermore, the cytotoxicity of compound <b>D12</b> alone and in combination with FLC on human normal cells was also tested. The result revealed that compound <b>D12</b> showed a relatively low toxicity to human umbilical vein endothelial cells (HUVEC, IC<sub>50</sub> = 9.64 μM) and human normal liver cells (L02, IC<sub>50</sub> = 11.46 μM, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">Table S4</a> in the Supporting Information). The combination of compound <b>D12</b> and FLC also revealed relatively low cytotoxicity (HUVEC, IC<sub>50</sub> = 12.2 μM, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">Table S5</a> in the Supporting Information).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibitory activity of compound <b>D12</b> and TBA against fungal (<i>C. albicans</i> 0304103) and human (HUVEC) total HDACs. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Human HDAC1/6 Enzyme Inhibition (IC<sub>50</sub>, nM)</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center" char="±">HDAC1</th><th class="colsep0 rowsep0" align="center" char="±">HDAC6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>D12</b></td><td class="colsep0 rowsep0" align="char" char="±">2226 ± 373.4</td><td class="colsep0 rowsep0" align="char" char="±">459 ± 56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>TBA</b></td><td class="colsep0 rowsep0" align="char" char="±">752 ± 70.6</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>SAHA</b></td><td class="colsep0 rowsep0" align="char" char="±">22.7 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">28 ± 5</td></tr></tbody></table></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> <b>Combination of Compound D12 and FLC Reversed Azole Resistance in</b><i>C. albicans</i><b>by Regulating the Azole Target Gene (<i>ERG11</i>) and Efflux gene (<i>CDR1</i>)</b></h3><div class="NLM_p">Previous research confirmed that azole resistance in <i>C. albicans</i> was correlated with the overexpression of <i>ERG11</i>, <i>CDR</i>, and <i>MDR1</i>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a><i>ERG11</i> is the target gene of azoles, and the efflux genes associated with azole resistance mainly include <i>CDR1, CDR2, MDR1</i>, and <i>FLU1</i>. To clarify the mechanism of the carboline derivative in reversing resistance, expression of several resistant genes treated with drugs alone or in combination was determined by the real-time reverse transcriptase polymerase chain reaction (RT-PCR). The overexpression (about 100-fold increase compared with the control) of <i>ERG11</i> could be detected after treated with FLC, which might be the main reason for the FLC resistance. Interestingly, the expression of <i>ERG11</i> was decreased to the basal levels after treated with the combination of FLC and compound <b>D12</b>. As for efflux pump genes, FLC upregulated the expression of <i>CDR1</i>, whereas the expression was downregulated to normal levels when FLC was used in combination with compound <b>D12</b>. FLC alone has no effect on the expression of <i>CDR2</i> and <i>MDR1</i>. On the contrary, compound <b>D12</b> alone upregulated the two genes. The upregulation of <i>CDR2</i> could be recovered to normal levels when compound <b>D12</b> was used in combination with FLC. However, the drug combination enhanced the <i>MDR1</i> levels by 8-fold. It is demonstrated that the combination of compound <b>D12</b> and FLC recovered azole sensibility in resistant <i>C. albicans</i> by regulating the azole target gene <i>ERG11</i> and efflux gene <i>CDR1</i> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Expression of resistant genes of <i>C. albicans</i>. (A) Difference of <i>ERG11</i> expressed in each group. (B) Difference of <i>MDR1</i> expressed in each group. (C) Difference of <i>CDR1</i> expressed in each group. (D) Difference of <i>CDR2</i> expressed in each group. <i>C. albicans</i> (0304103) solution with initial concentrations of 1 × 10<sup>6</sup> cells/mL was divided into four groups, and, respectively, treated with DMSO (control), FLC (32 μg/mL), <b>D12</b> (32 μg/mL), and FLC + <b>D12</b> (32 + 32 μg/mL). RT-PCR was used to detect differences in the gene expression. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Combination of Compound <b>D12</b> and FLC Blocks the Morphological Changes of <i>C. albicans</i></h3><div class="NLM_p">Pathogenic <i>C. albicans</i> has various morphological states, termed fungal polymorphism,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> including budded (yeasty) forms and hyphal forms.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The budded-to-hyphal transition process is crucial to fungi virulence<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and the conversion exists during the whole process of <i>C. albicans</i> tissue invasion.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Photomicrographs of cells treated with different drugs are shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. Morphological conversion from yeast to hypha was still observed after the treatment with FLC or compound <b>D12</b> alone. In the group treated with FLC and compound <b>D12</b> in combination, only yeast fungi were observed. Thus, compound <b>D12</b> successfully assisted FLC to block the morphological transition of fungi and reduce the invasion ability of <i>C. albicans</i>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hypha formation of <i>C. albicans</i> treated with <b>D12</b> and FLC alone or in combination. The initial concentration of <i>C. albicans</i> was 2 × 10<sup>6</sup> cells/mL. The Spider medium was used to induce the hyphae formation. The samples were observed and photographed after 3 h of incubation at 37 °C. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Combination of Compound <b>D12</b> and FLC Inhibits Fungal Biofilm Formation and Mature Biofilms</h3><div class="NLM_p">There is an intimate connection between fungal filamentation and biofilm formation because the hypha is an important part of mature fungal biofilm.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Biofilm formation is considered as a fungal survival mechanism related to drug resistance and immune escape.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> The synergism of compound <b>D12</b> and FLC on <i>C. albicans</i> biofilm formation and disruption of preformed biofilms was investigated. The results showed that FLC or compound <b>D12</b> used alone could not inhibit fungal biofilm formation. Compound <b>D12</b> and FLC used in combination blocked the formation of fungal biofilms significantly at 64 μg/mL of compound <b>D12</b>, while the synergistic inhibition effect was not influenced by the concentrations of FLC (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). The result is consistent with the time growth curves (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). The disruption of preformed biofilms by the combination was also investigated (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Compound <b>D12</b> could cooperate with FLC to destroy mature biofilms only at a high concentration (64 μg/mL).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of biofilm formation and disruption of mature biofilms treated with <b>D12</b> and FLC alone or in combination. (A) Inhibition of biofilm formation of <i>C. albicans</i> treated with <b>D12</b> and FLC alone or in combination. (B) Disruption of preformed biofilms of <i>C. albicans</i> treated with <b>D12</b> and FLC alone or in combination. The initial concentration of <i>C. albicans solution</i> was 2 × 10<sup>6</sup> cells/mL. The comparison between the two components was completed by the <i>t</i>-test. *** <i>P</i> < 0.001 compared to the control group. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound <b>D12</b> Enhanced the <i>In Vivo</i> Therapeutic Effect of FLC</h3><div class="NLM_p">The above results demonstrated the synergism of compound <b>D12</b> used in combination with FLC <i>in vitro</i>. Then, the <i>in vivo</i> antifungal potency of the drug combination was investigated. The mice models of candidiasis were established via tail vein injection of <i>C. albicans</i>. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, compound <b>D12</b> was inactive, and FLC had a weak therapeutic effect (<i>P</i> < 0.05). In the group of drug combination, the antifungal potency was significantly enhanced (<i>P</i> < 0.0001). The combinational use of compound <b>D12</b> (10 mg/kg) and FLC (1 mg/kg) effectively reduced the kidney fungal burden in the infected mice. The fungal invasions in tissues were further monitored through the tissue section of the kidney to clearly understand the status of the fungal infection in mice and the effect of drug treatment. In the control group, a large number of fungal clusters stained deeply with amaranth (rod-shaped and spherical) were observed in the renal pelvis (arrow 1) but not obvious in the renal parenchyma cortex and medulla. When compound <b>D12</b> or FLC was used alone, there were also small clusters of fungal infiltration in the renal pelvis (arrow 2 and 3). In contrast, the fungal clusters were cleared in the renal pelvis or medulla in the group treated with compound <b>D12</b> and FLC in combination. The rod-shaped fungi (hyphal forms) observed in the drug-free group and single-drug group verified the morphological changes of budded-to-hyphal transition (200 fold) in mammals (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Thus, the combination of compound <b>D12</b> and FLC could reduce the colonization and dissemination of fungi in tissue and attenuate the virulence of fungi to the host by inhibiting the transition of <i>C. albicans</i> to the hyphal state.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Combination of compound <b>D12</b> and FLC exhibits excellent therapeutic effects in mice candidiasis models. (A) Fungal burden in mice kidneys after treatment with different drugs. The infection model was established using 5 × 10<sup>5</sup> cells of <i>C. albicans</i> (0.04103) and the mice were divided into the control group, FLC group (1 mg/kg), <b>D12</b> group (10 mg/kg), and the combination group (FLC + <b>D12</b>, 1+10 mg/kg). The fungal burden of kidneys was determined after 5 days of treatment. The difference between the groups was compared by the <i>t</i>-test (* <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, **** <i>p</i> <0.0001). (B) Kidney tissue sections after drug treatment in mouse models of candidiasis. (-) means treated with the vehicle, and the treatments were consistent with the kidney fungal burden experiment. The tissue was observed and photographed with a biological microscope under 40× and 200× fields of view, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75858" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75858" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, novel carboline fungal HDAC inhibitors were designed, which provide a promising therapeutic strategy for combinational treatment of IFIs caused by azole-resistant <i>C. albicans</i>. In particular, compound <b>D12</b> had an excellent synergism with FLC against resistant <i>Candida</i> spp. The inhibition of hyphae and biofilm formation also demonstrated that the combination of compound <b>D12</b> and FLC could reduce fungal virulence. Compound <b>D12</b> reversed FLC resistance in <i>C. albicans</i> and enhanced efficacy of FLC probably because of downregulating the expression of the target gene <i>EGR11</i> and efflux gene <i>CDR1</i>. The <i>in vivo</i> antifungal potency was further validated in a mice candidiasis model, in which compound <b>D12</b> synergized with FLC to effectively clear the <i>C. albicans</i> burden in kidneys. Taken together, the fungal HDAC inhibitor <b>D12</b> represents a drug-like lead compound in the combinational treatment of candidiasis. Further research for fungal HDAC subtype selectivity, antifungal mechanisms, and lead optimization is proceeding.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Methods</h4><div class="NLM_p"><sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on Bruker AVANCE600 spectrometers (Bruker Company, Germany), using tetramethylsilane (TMS) as an internal standard and CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvents. Chemical shifts are given in ppm (δ). The mass spectra were recorded on an Esquire 3000 LC-MS mass spectrometer. Silica gel thin-layer chromatography was performed on precoated plates GF-254 (Qingdao Haiyang Chemical, China). All solvents and reagents were analytically pure, and no further purification was needed. All starting materials were commercially available. The purities of the compounds were determined by high-performance liquid chromatography (HPLC, Agilent 1260), and all final compounds exhibited purities greater than 95%.</div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Methyl 2-(4-(3-Bromopropoxy)phenyl)acetate (<b>3</b>)</h5><div class="NLM_p last">To a solution of methyl 2-(4-hydroxyphenyl)acetate (<b>2</b>, 5 g, 30.11 mmol) and K<sub>2</sub>CO<sub>3</sub> (8.31 g, 60.22 mmol) in MeOH (150 mL) was added 1,3-dibromopropane (<b>1</b>, 9.12 g, 45.16 mmol) dropwise with stirring at room temperature. The reaction mixture was refluxed at 80 °C for 4 h. The solid was removed by filtration after the reaction mixture was cooled to room temperature. Then, the filtrate was concentrated under reduced pressure, H<sub>2</sub>O (20 mL) was added, and the reaction mixture was extracted with EtOAc (40 mL × 3). The combined organic layer was washed with H<sub>2</sub>O (30 × 3) and saturated NaCl (30 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by column silica gel chromatography (hexane/EtOAc = 5/1) to give target compound <b>3</b> (5.5 g, 64.00%) as a colorless transparent liquid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.17 (d, <i>J</i> = 8.6 Hz, 1H), 6.89 (d, <i>J</i> = 8.6 Hz, 1H), 4.06 (t, <i>J</i> = 6.0 Hz, 1H), 3.66 (t, <i>J</i> = 6.6 Hz, 1H), 3.61–3.57 (m, 2H), 2.23 (p, <i>J</i> = 6.3 Hz, 1H).</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> <i>tert</i>-Butyl 8-Chloro-9-(3-(4-(2-methoxy-2-oxoethyl)phenoxy)propyl)-1,3,4,9-tetrahydro-2<i>H</i>-pyrido[3,4-<i>b</i>]indole-2-carboxylate (<b>5l</b>)</h5><div class="NLM_p last">To a solution of <i>tert</i>-butyl 8-chloro-1,3,4,9-tetrahydro-2<i>H</i>-pyrido[3,4-<i>b</i>]indole-2-carboxylate (<b>4l</b>, 0.24 g, 0.77 mmol) in dry DMF (3 mL), NaH (55 mg, 2.3 mmol) was added slowly at 0 °C. The reaction mixture was stirred at 0 °C for 5 min and then kept at room temperature for 30 min. Methyl 2-(4-(3-bromopropoxy)phenyl) acetate (<b>3</b>, 0.33 g, 1.15 mmol) was added into the mixture and stirred at room temperature for 1 h. The reaction mixture was added dropwise into H<sub>2</sub>O (10 mL) and extracted with EtOAc (20 mL × 3). The combined organic layer was washed with saturated NaCl (15 × 6), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was purified by column silica gel chromatography (hexane/EtOAc = 15/1) to give target compound <b>5l</b> (0.31 g, 85.30%) as a transparent oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>): δ 7.34 (d, <i>J</i> = 7.5 Hz, 1H), 7.20–7.14 (m, 2H), 7.11 (d, <i>J</i> = 7.6 Hz, 1H), 6.98 (t, <i>J</i> = 7.7 Hz, 1H), 6.84–6.80 (m, 2H), 4.64 (s, 2H), 4.55–4.51 (m, 2H), 3.90 (t, <i>J</i> = 5.7 Hz, 2H), 3.68 (s, 3H), 3.67–3.63 (m, 2H), 3.57–3.53 (m, 2H), 2.73 (s, 2H), 2.28–2.22 (m, 2H), 1.49 (s, 9H).</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> 2-(4-(3-(8-Chloro-1,2,3,4-tetrahydro-9<i>H</i>-pyrido[3,4-<i>b</i>]indol-9-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>D12</b>)</h5><div class="NLM_p">To a solution of <i>tert</i>-butyl 8-chloro-9-(3-(4-(2-methoxy-2-oxoethyl)phenoxy)propyl)-1,3,4,9-tetrahydro-2<i>H</i>-pyrido[3,4-<i>b</i>]indole-2-carboxylate (<b>5l</b>, 0.30 g, 0.59 mmol) in dry dichloromethane (DCM, 7 mL), TFA (3.5 mL) was added dropwise with stirring at 0 °C. The reaction mixture was allowed to stir for 30 min to remove the protection of <i>tert</i>-butoxycarbonyl. Saturated NaHCO<sub>3</sub> was added dropwise into the mixture with stirring violently for 30 min after the addition of EtOAc (20 mL). The mixture was extracted with EtOAc (20 × 2) and the combined organic layer was washed with saturated NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was used for the next reaction without further purification.</div><div class="NLM_p">A solution of KOH (2.80 g, 200 mmol) in MeOH (7 mL) was added dropwise into a solution of NH<sub>2</sub>OH<b>·</b>HCl (2.32 g, 33.5 mmol) in MeOH (12 mL) at 0 °C. Then, MgSO<sub>4</sub> (1 g, 8.31 mmol) was added into the reaction mixture and stirred at 0 °C for 30 min. The mixture was filtered to get a solution of NH<sub>2</sub>OH. Methyl 2-(4-(3-(1,2,3,4-tetrahydro-9<i>H</i>-pyrido[3,4-<i>b</i>] indol-9-yl)propoxy)phenyl)acetate obtained by the above reaction (0.27 g) was added into the solution of NH<sub>2</sub>OH (17 mL, freshly prepared). The reaction was stirred at 45 °C for 2 h. The solvent was removed under reduced pressure. H<sub>2</sub>O (3 mL) and 1N HCl were added into it to adjust the pH = 7–8. Then, the mixture was filtered and the residue was purified by HPLC to obtain target compound <b>D12</b> (0.12 g, 49%) as a white solid. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.57 (s, 1H), 7.35 (d, <i>J</i> = 7.4 Hz, 1H), 7.15 (d, <i>J</i> = 8.6 Hz, 2H), 7.07 (d, <i>J</i> = 7.4 Hz, 1H), 6.95 (t, <i>J</i> = 7.7 Hz, 1H), 6.82 (d, <i>J</i> = 8.6 Hz, 2H), 4.44 (t, <i>J</i> = 7.2 Hz, 2H), 3.92 (t, <i>J</i> = 5.9 Hz, 2H), 3.87 (s, 2H), 3.18 (s, 2H), 2.90 (t, <i>J</i> = 5.6 Hz, 2H), 2.56 (t, <i>J</i> = 5.4 Hz, 2H), 2.13–2.06 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.8 (s), 157.5 (s), 137.8 (s), 131.1 (s), 130.8 (s), 130.4 (s), 128.6 (s), 122.7 (s), 120.1 (s), 117.1 (s), 115.5 (s), 114.7 (s), 108.8 (s), 64.9 (s), 43.4 (s), 42.0 (s), 41.6 (s), 39.0 (s), 32.0 (s), 22.4 (s). ESI-MS (<i>m</i>/<i>z</i>): 414.52 [M + 1]. ESI-HRMS: calcd for C<sub>22</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>3</sub><i>m</i>/<i>z</i>: [M + H]<sup>+</sup> = 414.1579; found [M + H]<sup>+</sup> = 414.1588, HPLC purity: 99.47%.</div><div class="NLM_p last">The synthesis of compounds <b>5a–m</b> and <b>D1–D11</b> was similar to the methods of <b>5l</b> and <b>D12</b>, respectively.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> 2-(4-(3-(5-Chloro-1,2,3,4-tetrahydro-9<i>H</i>-pyrido[3,4-<i>b</i>]indol-9-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>D2</b>)</h5><div class="NLM_p last">A light yellow solid, 0.091 g, yield 54%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (s, 1H), 7.35 (dd, <i>J</i> = 7.7, 0.9 Hz, 1H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 6.99–6.93 (m, 2H), 6.87–6.82 (m, 2H), 4.18 (t, <i>J</i> = 6.9 Hz, 2H), 3.90–3.83 (m, 4H), 3.20 (s, 2H), 2.94–2.87 (m, 4H), 2.09–2.03 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 167.8 (s), 157.4 (s), 137.3 (s), 136.9 (s), 130.4 (s), 128.65 (s), 124.7 (s), 124.3 (s), 121.4 (s), 119.3 (s), 114.7 (s), 108.8 (s), 107.3 (s), 64.8 (s), 43.7 (s), 42.0 (s), 38.9 (s), 29.6 (s), 24.4 (s). MS (ESI positive) <i>m</i>/<i>z</i>: 414.57 [M + 1]. ESI-HRMS: calcd for C<sub>22</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>3</sub><i>m</i>/<i>z</i>: [M + H]<sup>+</sup> = 414.1579; found [M + H]<sup>+</sup> = 414.1585.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> 2-(4-(3-(6-Fluoro-1,2,3,4-tetrahydro-9<i>H</i>-pyrido[3,4-<i>b</i>]indol-9-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>D4</b>)</h5><div class="NLM_p last">A light yellow solid, 0.096 g, yield 84%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.61 (s, 1H), 7.41 (dd, <i>J</i> = 8.9, 4.4 Hz, 1H), 7.19 (dd, <i>J</i> = 9.8, 2.5 Hz, 1H), 7.16 (d, <i>J</i> = 8.6 Hz, 2H), 6.90 (td, <i>J</i> = 9.2, 2.5 Hz, 1H), 6.85 (d, <i>J</i> = 8.6 Hz, 2H), 4.20 (t, <i>J</i> = 6.9 Hz, 2H), 4.07 (s, 2H), 3.88 (t, <i>J</i> = 5.9 Hz, 2H), 3.20 (s, 2H), 3.10 (t, <i>J</i> = 5.7 Hz, 2H), 2.69 (t, <i>J</i> = 5.5 Hz, 2H), 2.12–2.02 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 167.8 (s), 157.4 (s), 157.4 (d, <i>J</i> = 213.8 Hz), 135.0 (s), 133.0 (s), 130.8 (s), 130.4 (s), 128.7 (s), 127.2 (d, <i>J</i> = 9.9 Hz), 114.8 (s), 110.7 (d, <i>J</i> = 9.7 Hz), 109.0 (d, <i>J</i> = 25.8 Hz), 107.2 (d, <i>J</i> = 4.0 Hz), 103.1 (d, <i>J</i> = 23.2 Hz), 64.8 (s), 42.9 (s), 41.3 (s), 40.5 (s), 38.9 (s), 29.8 (s), 21.1 (s). ESI-HRMS: calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>4</sub><i>m</i>/<i>z</i>: [M + H]<sup>+</sup> = 398.1874, [M – H]<sup>−</sup> = 396.1729; found [M + H]<sup>+</sup> = 398.1878 <i>m</i>/<i>z</i>, [M – H]<sup>−</sup> = 396.1751.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> 2-(4-(3-(6-Bromo-1,2,3,4-tetrahydro-9<i>H</i>-pyrido[3,4-<i>b</i>]indol-9-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>D6</b>)</h5><div class="NLM_p last">A light yellow solid, 0.18 g, yield 64%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.60 (s, 1H), 7.57 (d, <i>J</i> = 1.9 Hz, 1H), 7.38 (d, <i>J</i> = 8.7 Hz, 1H), 7.18–7.13 (m, 3H), 6.84 (d, <i>J</i> = 8.6 Hz, 2H), 4.18 (t, <i>J</i> = 6.9 Hz, 2H), 3.96 (s, 2H), 3.87 (t, <i>J</i> = 5.9 Hz, 2H), 3.20 (s, 2H), 2.99 (t, <i>J</i> = 5.6 Hz, 2H), 2.62 (t, <i>J</i> = 5.3 Hz, 2H), 2.10–2.03 (m, 2H). ESI-HRMS: calcd for C<sub>22</sub>H<sub>24</sub>BrN<sub>3</sub>O<sub>3</sub><i>m</i>/<i>z</i>: [M + H]<sup>+</sup> = 460.1053, [M – H]<sup>−</sup> = 458.0908; found [M + H]<sup>+</sup> = 460.1063, [M – H]<sup>−</sup> = 458.0938.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> 2-(4-(3-(7-Fluoro-1,2,3,4-tetrahydro-9<i>H</i>-pyrido[3,4-<i>b</i>]indol-9-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>D9</b>)</h5><div class="NLM_p last">A light yellow solid, 0.24 g, yield 66%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.63 (s, 1H), 7.40–7.36 (m, 1H), 7.27 (d, <i>J</i> = 8.9 Hz, 1H), 7.19–7.14 (m, 2H), 6.87–6.80 (m, 3H), 4.16 (t, <i>J</i> = 6.8 Hz, 2H), 3.97 (s, 2H), 3.88 (t, <i>J</i> = 5.8 Hz, 2H), 3.20 (s, 2H), 3.02 (t, <i>J</i> = 5.3 Hz, 2H), 2.69–2.61 (m, 2H), 2.09–2.03 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 167.8 (s), 159.1 (d, <i>J</i> = 233.9 Hz), 157.4 (s), 136.3 (d, <i>J</i> = 12.2 Hz), 133.8 (s), 130.8 (s), 130.4 (s), 128.7 (s), 123.8 (s), 118.9 (d, <i>J</i> = 10.3 Hz), 114.7 (s), 107.2 (d, <i>J</i> = 29.9 Hz), 96.5 (d, <i>J</i> = 26.4 Hz), 64.8 (s), 42.9 (s), 41.3 (s), 40.5 (s), 38.9 (s), 29.6 (s), 21.2 (s). ESI-HRMS: calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>3</sub>O<sub>3</sub><i>m</i>/<i>z</i>: [M + H]<sup>+</sup> = 398.1874, [M – H]<sup>−</sup> = 396.1729; found [M + H]<sup>+</sup> = 398.1888, [M – H]<sup>−</sup> = 396.1741.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> 2-(4-(3-(7-Chloro-1,2,3,4-tetrahydro-9<i>H</i>-pyrido[3,4-<i>b</i>]indol-9-yl)propoxy)phenyl)-<i>N</i>-hydroxyacetamide (<b>D10</b>)</h5><div class="NLM_p last">A light yellow solid, 0.17 g, yield 78%. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.59 (s, 1H), 7.50 (d, <i>J</i> = 1.7 Hz, 1H), 7.38 (d, <i>J</i> = 8.3 Hz, 1H), 7.16 (d, <i>J</i> = 8.5 Hz, 2H), 6.97 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 6.85 (d, <i>J</i> = 8.6 Hz, 2H), 4.17 (t, <i>J</i> = 6.9 Hz, 2H), 3.90–3.86 (m, 4H), 3.20 (s, 2H), 2.94 (t, <i>J</i> = 5.6 Hz, 2H), 2.59 (t, <i>J</i> = 5.4 Hz, 2H), 2.09–2.04 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO) δ 167.7 (s), 157.4 (s), 136.58 (s), 136.4 (s), 130.4 (s), 128.7 (s), 126.1 (s), 125.7 (s), 119.1 (s), 114.8 (s), 109.6 (s), 107.9 (s), 64.9 (s), 43.4 (s), 41.9 (s), 38.9 (s), 29.7 (s), 22.3 (s). MS (ESI positive) <i>m</i>/<i>z</i>: 414.39 [M + 1]. ESI-HRMS: calcd for C<sub>22</sub>H<sub>24</sub>ClN<sub>3</sub>O<sub>3</sub><i>m</i>/<i>z</i>: [M + H]<sup>+</sup> = 414.1579 <i>m</i>/<i>z</i>; found [M + H]<sup>+</sup> = 414.1579.</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Biology: Strains, Culture, and Agents</h3><div class="NLM_p last">All of the strains used in this study are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">S3</a> and derived from clinical isolates that were identified by standard mycological and molecular tests. The commonly used media are mainly as follows: the yeast extract peptone dextrose (YEPD) liquid medium (1% yeast extract, 2% peptone, and 2% dextrose), RPMI 1640 medium (buffered with 0.165 M MOPS, 0.2% NaHCO<sub>3</sub>, and 0.27% NaOH as the testing medium), and SDA medium (1% peptone, 4% glucose, and 2% agar). Strains were routinely resurrected in YEPD medium at 30 °C with continuous shaking. Compounds and FLC were diluted into 2 mg/mL solution using DMSO.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>In Vitro</i> Antifungal Activity Assay</h3><div class="NLM_p last"><i>In vitro</i> antifungal activity of the two compounds in synergy was measured by the checkerboard microdilution method in 96-well microtest plates. The assay was analyzed according to the methods described by the Clinical & Laboratory Standards Institute (CLSI, M27-A3) with a few modifications.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Briefly, exponentially grown <i>C. albicans</i> cells were harvested and resuspended in a fresh RPMI 1640 medium to a concentration of 10<sup>3</sup> cells/mL. The final concentrations for FLC and tested compounds ranged from 0.25 to 64 μg/mL and 2 to 64 μg/mL, respectively. Fungi were incubated at 35 °C for 48 h. The optical density at 630 nm (OD630) was determined using a microtiter plate reader while subtracting the background OD of each well. Synergy and antagonism were defined by FICIs of ≤0.5 and >4, respectively. An FICI > 0.5 but <4 was considered irrelevant.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Disk Diffusion Assay</h3><div class="NLM_p last">About 1 × 10<sup>4</sup> cells were plated on the SDA medium or on SDA medium containing FLC (32 μg/mL) or <b>D12</b> (8 μg/mL), or both of them. Plates were incubated at 35 °C for 48 h and photographed to intuitively reflect the drug resistance of <i>C. albicans</i> (0304103) and the synergism of compound <b>D12</b> and FLC. Disk diffusion testing of drugs in combination was performed as follows. SDA plates (90 mm diameter) containing FLC (32 μg/mL) were used in this study. The surface of the medium was coated with approximately 10<sup>5</sup><i>C. albicans</i> (0304103) cells by using a glass spreading rod. Disks containing different doses of compound <b>D12</b> (0, 2, 8, and 32 μg) were equidistantly placed onto the surface of the agar plate inoculated with fungi, and the plate was photographed 48 h after being incubated at 35 °C.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Growth Curve Assay</h3><div class="NLM_p last">Growth curve assay was performed according to a previous method with a few modifications.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> The exponentially grown <i>C. albicans</i> strain 0304103 was washed with PBS (phosphate buffer saline, 3 × 1 mL) and then resuspended in 5 mL of the RPMI 1640 medium to an initial concentration of 1.5 × 10<sup>6</sup> cells/mL and divided into different bottles. Samples added to different concentrations of compound <b>D12</b> and FLC were incubated in a shaking incubator (200 rpm) at 30 °C and counted at a specific time point (0, 6, 12, 24, and 48 h). Three independent experiments were performed.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Time Kill Curve Assay</h3><div class="NLM_p last">The sample preparation was the same as that in the growth curve assay. The initial fungal concentration was 1.5 × 10<sup>6</sup> cells/mL and the samples treated with drugs alone or in combination were incubated in a shaking incubator (200 rpm) at 30 °C. Samples were taken at a specific time point (0, 6, 12, 24, 36, and 48 h), diluted and coated on the SDA medium, and cultured at 35 °C for 48 h. The fungal colonies in the medium were counted and the number of viable fungi was calculated. Three independent experiments were performed.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>In Vitro</i> Biofilm Formation Assay</h3><div class="NLM_p last">The experimental procedure was performed according to our previous methods with a few modifications.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Suspensions of <i>C. albicans</i> (0304103) cells (1.0 × 10<sup>6</sup> CFU/mL in the RPMI 1640 medium) were added into a 96-well microtest plate (100 μL per well) and incubated at 37 °C for 90 min for adhesion. The adherent cells were washed with PBS (3 × 100 μL) after the upper culture medium was removed. A fresh RPMI 1640 medium with or without drugs was then added to adherent cells. The final concentrations for FLC and tested compounds ranged from 2 to 32 μg/mL and 0.12 to 64 μg/mL, respectively. Then, the plates were incubated at 37 °C for another 24 h. A semiquantitative measure of biofilm formation was calculated by using the method of the XTT reduction assay. The optical density at 490 nm (OD490) was determined using a microtiter plate reader and three independent experiments were performed.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Disruption Assay of Preformed Biofilms</h3><div class="NLM_p last">The experimental procedure was similar to the methods of the biofilm formation assay. Suspensions of <i>C. albicans</i> (0304103) cells (1.0 × 10<sup>6</sup> CFU/mL in the RPMI 1640 medium) were added into a 96-well microtest plate (100 μL per well) and incubated at 37 °C for 24 h to form a mature biofilm. The following operation was similar to the method of testing biofilm formation. Three independent experiments were performed.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>In Vitro</i> Hyphal Formation Assay</h3><div class="NLM_p last">The experimental procedure was performed according to reported methods with a few modifications.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Exponentially grown <i>C. albicans</i> cells resuspended in the Spider culture medium (10% Nutrient broth, 2% NaHCO<sub>3</sub>, 2% K<sub>2</sub>HPO<sub>4</sub>·2H<sub>2</sub>O,) to 2 × 10<sup>6</sup> cells/mL were transferred to 12-well plates while each well was added with 1 mL of the suspension. Drugs used alone or in combination were added, and cells treated with DMSO were used as the control group. Cells were observed and photographed with an inversed fluorescence microscope after 3 h of incubation at 37 °C.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Inhibition of Human HDAC1/6</h3><div class="NLM_p last">The assay was performed by quantitatively measuring the fluorescence intensity following an enzymatic reaction according to the reported method.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The dilution of compounds (5 μL) was added to a 40 μL of the reaction mixture (pH = 8.0) containing 25 mM Tris, 0.1 mM MgCl<sub>2</sub>, 0.1 mg/mL BSA, 137 mM NaCl, 2.7 mM KCl, and HDAC6 (15 ng per well), so that the concentration of compounds ranged from 100 mM to 10 nM (3-fold dilution). The mixture was preincubated at room temperature for 5 min. Finally, the enzyme substrate (10 μM) was added, and the enzymatic reactions were conducted at 37 °C for 30 minutes in a final volume of 50 μL. The reactions were terminated by adding the termination solution (50 μL) for 30 min at room temperature. The IC<sub>50</sub> values were calculated by measuring the fluorescence intensity at an excitation wavelength of 360 nm and an emission wavelength of 460 nm.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Inhibition of Fungal and Human Total HDACs</h3><div class="NLM_p last">The fungal protoplast was extracted by the rapid yeast genomic DNA isolation kit (Sangon Biotech). About 100 mg of wet weight <i>C. albicans</i> cells exponentially grown were harvested and resuspended in 3 mL of snailase reaction buffer. Mercaptoethanol (2.4 μL) and snailase (50 μL, dissolved in snailase storage buffer to a concentration of 120 mg/mL) were added into the reaction buffer, and the sample was then incubated at 37 °C for 3 h. The lysate was centrifuged and the supernatant-removed protoplast was resuspended in 20 mL of PBS. The suspension and compounds were added into the 96-well microtest plates (100 μL for per well). The final concentration of tested compounds ranged from 1 to 100 μM. HDAC substrate Boc-Lys(Ac)-AMC was added into the plates at a concentration of 33 μM after the plates were incubated at 35 °C for 12 h. Then, the plates were incubated at 37 °C for another 6 h, and the reaction was terminated by adding 100 μL of the termination solution (2 mg/mL trypsin, 1% Nonidet P-40, 50 mM Tris-HCl (pH = 8), 137mM NaCl, 2.7 mM KCl, 1 mM MgCl<sub>2</sub>) to each well and allowing the reaction to continue at 37 °C for 2 h. The reaction solution was transferred to a black 96-well plate, and the fluorescence intensity was measured at an excitation wavelength of 360 nm and an emission wavelength of 460 nm. The inhibition rate was calculated by the ratio of the fluorescence intensity of the compound group to that of the control group after subtracting the blank. Three independent experiments were performed. The human total HDAC Enzymatic assay was performed using HUVEC cells. Different from fungi, there was no need to prepare protoplasts, and about 15000 cells per well were seeded into 96-well transparent plates. After being incubated at 37 °C and 5% CO<sub>2</sub> atmosphere for 24 h, the compounds were added into the plates and the remaining operations were similar to the fungal HDAC enzymatic assay.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Quantification of the Gene Expression by Real-Time RT-PCR</h3><div class="NLM_p last">Real-Time RT-PCR was performed according to the previous work with a few modifications.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Primers were synthesized by Sangon Biotech (Shanghai) Co., Ltd. and listed in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">Table S6</a> in the Supporting Information. <i>C. albicans</i> cells treated with different drugs alone or in combination were incubated in the YEPD medium at 35 °C for 24 h. For extraction of the total RNA of collected fungi, the Column Fungal RNAout kit (Tiandz, Inc.) was used according to the instructions. Reverse transcription was performed by using the PrimeScript RT Master Mix kit (TaKaRa) through two steps (1. 37 °C for 15 min; 2. 85 °C for 5 s). The qRT–PCR was performed in the LightCycler Real-Time PCR system (Roche diagnostics, GmbH Mannheim, Germany), using SYBR Green I. Amplification of cDNA was carried out according to the established procedures: 95 °C for 30 s and then 40 cycles of 95 °C for 5 s, 60 °C for 34 s, 95 °C for 30 s, 60 °C for 60 s, and 95 °C for 15 s. Monitoring the fluorescence during cycling measures the threshold cycle. Fold changes in the gene expression was analyzed using the 2<sup>–ΔΔCt</sup> method, with <i>ACT1</i> as the internal control.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Murine Model of Candidiasis</h3><div class="NLM_p last">Female ICR (Institute of Cancer Research) mice (20–25 g each mouse) purchased from JOINN Laboratories (Certificate SCXK-2018-0006) were used in this experimentation. Four mice in each group and 5 × 10<sup>5</sup> cells <i>C. albicans</i> (0304103) were used to infect mice via lateral tail vein injection. Mice were then treated with the vehicle (1.5% glycerin and 0.5% Tween 80), 10 mg/kg compound <b>D12</b>, 1 mg/kg FLC, or the combination (<b>D12</b> + FLC) via intraperitoneal (IP) injections 24 h later. Treatments were administered continuously for 5 days after infection. The animal laboratory meets IACUC standards (Certificate SYXK-2017-0004). The kidneys were removed and homogenized. Diluent suspensions (1000-fold) were plated on the SDA medium containing chloramphenicol and incubated at 30 °C for at least 48 h to count the number of colonies and calculate the total fungal burden. The differences between groups were analyzed by analysis of variance (ANOVA).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Pathological Sections of Murine Kidneys</h3><div class="NLM_p last">Two mice in each group and the infection and treatment of mice were consistent with the methods used in the murine model of candidiasis as mentioned above. Groups of mice were sacrificed 5 days after treatment with drugs alone or in combination. Fixed with 4% paraformaldehyde, sampled conventionally, dehydrated, embedded with paraffin, sliced (4 μm thick), and stained with hematoxylin–eosin (HE), the renal tissues removed from mice were observed (NIKON Eclipse Ci) and photographed (40× and 200×).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01763" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45628" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45628" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01763?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01763</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings of the target compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_001.csv" class="ext-link">CSV</a>);</p></li><li><p class="inline">synergism of TBA in combination with different first-line azole drugs; synergism of compounds <b>D1–12</b> in combination with azoles (VRC and ITC) against <i>C. albicans</i> (0304103); synergism of compound <b>D12</b> in combination with azoles (VRC and ITC) against various clinically isolated <i>C. albicans</i>, <i>C. krusei</i>, <i>C. auris</i>, <i>C. glabrata</i>, <i>C. tropicalis</i>, and <i>C. neoformans</i>; cytotoxicity of compound <b>D12</b> and SAHA alone or in combination with FLC; sequence of primers; the relative growth of various clinically isolated strains (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) presented by the form of heat maps; protocols of the cytotoxicity assay; structural characterization; spectral data of target compounds; and HPLC spectra (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_001.csv">jm0c01763_si_001.csv (0.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf">jm0c01763_si_002.pdf (3.31 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01763" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Na Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3920-1008" title="Orcid link">http://orcid.org/0000-0002-3920-1008</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#eddfd5d8d4ded4dad5d9ad9c9cc38e8280"><span class="__cf_email__" data-cfemail="0c3e3439353f353b34384c7d7d226f6361">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunquan Sheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</span>; 
    <span class="hlFld-Affiliation affiliation">School
of Medicine, Tongji University, Shanghai 200072, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9489-804X" title="Orcid link">http://orcid.org/0000-0001-9489-804X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#c2b1aaa7aca5a1b382b1afafb7eca7a6b7eca1ac"><span class="__cf_email__" data-cfemail="d5a6bdb0bbb2b6a495a6b8b8a0fbb0b1a0fbb6bb">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhuang Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jie Tu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guiyan Han</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicinal Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d7e2637-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20572" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20572" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation of China (Grant 81973175 to N.L., Grant 81725020 to C.S.) and the Innovation Program of Shanghai Municipal Education Commission (Grant 2019-01-07-00-07-E00073 to C.S.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations List</td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term"><i>C. albicans</i></td><td class="NLM_def"><p class="first last"><i>Candida albicans</i></p></td></tr><tr><td class="NLM_term">IFIs</td><td class="NLM_def"><p class="first last">invasive fungal infections</p></td></tr><tr><td class="NLM_term">ICU</td><td class="NLM_def"><p class="first last">intensive care unit</p></td></tr><tr><td class="NLM_term">CYP51</td><td class="NLM_def"><p class="first last">lanosterol 14α-demethylase</p></td></tr><tr><td class="NLM_term">JAK2</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">FLC</td><td class="NLM_def"><p class="first last">fluconazole</p></td></tr><tr><td class="NLM_term">TBA</td><td class="NLM_def"><p class="first last">tubastatin A</p></td></tr><tr><td class="NLM_term">VRC</td><td class="NLM_def"><p class="first last">voriconazole</p></td></tr><tr><td class="NLM_term">ITC</td><td class="NLM_def"><p class="first last">itraconazole</p></td></tr><tr><td class="NLM_term">SARs</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">ZBG</td><td class="NLM_def"><p class="first last">zinc-binding group</p></td></tr><tr><td class="NLM_term">FICI</td><td class="NLM_def"><p class="first last">fractional inhibitory concentration index</p></td></tr><tr><td class="NLM_term">MIC<sub>80</sub></td><td class="NLM_def"><p class="first last">minimum concentration of 80% inhibition</p></td></tr><tr><td class="NLM_term"><i>C. krusei</i></td><td class="NLM_def"><p class="first last"><i>Candida krusei</i></p></td></tr><tr><td class="NLM_term"><i>Candida auris</i></td><td class="NLM_def"><p class="first last"><i>C. auris</i></p></td></tr><tr><td class="NLM_term"><i>Candida glabrata</i></td><td class="NLM_def"><p class="first last"><i>C. glabrata</i></p></td></tr><tr><td class="NLM_term"><i>Candida tropicalis</i></td><td class="NLM_def"><p class="first last"><i>C. tropicalis</i></p></td></tr><tr><td class="NLM_term"><i>Cryptococcus neoformans</i></td><td class="NLM_def"><p class="first last"><i>C. neoformans</i></p></td></tr><tr><td class="NLM_term">SDA</td><td class="NLM_def"><p class="first last">Sabouraud Dextrose Agar</p></td></tr><tr><td class="NLM_term">YEPD</td><td class="NLM_def"><p class="first last">Yeast extract Peptone Dextrose</p></td></tr><tr><td class="NLM_term">CLSI</td><td class="NLM_def"><p class="first last">Clinical & Laboratory Standards Institute</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffer saline</p></td></tr><tr><td class="NLM_term">ICR</td><td class="NLM_def"><p class="first last">Institute of Cancer Research</p></td></tr><tr><td class="NLM_term">OD</td><td class="NLM_def"><p class="first last">optical density</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">HE</td><td class="NLM_def"><p class="first last">hematoxylin–eosin</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denning, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromley, M. J.</span></span> <span> </span><span class="NLM_article-title">Infectious Disease. How to bolster the antifungal pipeline</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1416</span>, <span class="refDoi"> DOI: 10.1126/science.aaa6097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1126%2Fscience.aaa6097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=25814567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFyksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1414-1416&author=D.+W.+Denningauthor=M.+J.+Bromley&title=Infectious+Disease.+How+to+bolster+the+antifungal+pipeline&doi=10.1126%2Fscience.aaa6097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How to bolster the antifungal pipeline</span></div><div class="casAuthors">Denning, David W.; Bromley, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6229</span>),
    <span class="NLM_cas:pages">1414-1416</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYf6ts4qXAj7Vg90H21EOLACvtfcHk0lgllgxY7ouuRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFyksbY%253D&md5=ebd5ad0fc0f5e6225a4d9fff63149d6b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa6097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa6097%26sid%3Dliteratum%253Aachs%26aulast%3DDenning%26aufirst%3DD.%2BW.%26aulast%3DBromley%26aufirst%3DM.%2BJ.%26atitle%3DInfectious%2520Disease.%2520How%2520to%2520bolster%2520the%2520antifungal%2520pipeline%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1414%26epage%3D1416%26doi%3D10.1126%2Fscience.aaa6097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gullo, A.</span></span> <span> </span><span class="NLM_article-title">Invasive fungal infections: the challenge continues</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.2165/11315530-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.2165%2F11315530-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=19877737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BD1MjmslShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=65-73&author=A.+Gullo&title=Invasive+fungal+infections%3A+the+challenge+continues&doi=10.2165%2F11315530-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive fungal infections: the challenge continues</span></div><div class="casAuthors">Gullo Antonino</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Invasive fungal infections (IFIs) are being increasingly recognized as a major threat in critically ill adult and paediatric patients.  They can range widely in severity and can be life threatening in some patients.  Candida and Aspergillus species are the most common causes of IFIs, but other yeasts and filamentous fungi are emerging pathogens.  C. albicans, the most significant pathogenic species, is seen in almost all of the 17% of patients treated in the intensive care unit (ICU) who develop IFIs, and is associated with significant morbidity and mortality.  Non-albicans spp. are becoming more common, particularly in neutropenic patients and those on existing azole therapy.  Early diagnosis is challenging due to delays in, and low sensitivity of, confirmatory blood cultures, and difficulty in discriminating colonization from invasive candidiasis.  Once diagnosed, early initiation of appropriate antifungal therapy is essential for reducing morbidity and mortality.  Amphotericin B deoxycholate and azoles, once standard therapy, have been largely superseded in the ICU by broad-spectrum azoles, liposomal amphotericin B and the newer echinocandin agents with improved efficacy/tolerability profiles.  The echinocandins (caspofungin, micafungin and anidulafungin) exhibit fungicidal activity against Candida spp. and fungistatic activity against Aspergillus spp.  Echinocandins have demonstrated clinical efficacy, broad spectrum of activity and favourable pharmacological properties, and are, therefore, likely to replace fluconazole as the initial antifungal agent of choice among critically ill patients.  Current evidence supports echinocandin empirical therapy for candidaemia or invasive candidiasis in ICU patients with or without neutropenia, and as rescue therapy in patients with life-threatening IFIs caused by strains resistant to other antifungals.  Anidulafungin represents a new advance in the treatment of IFIs and is approved for treatment of candidaemia, intra-abdominal abscesses, peritonitis and oesophageal candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNrRccr0OgNkodMGTatQ7LfW6udTcc2eZo312auuvBzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjmslShtg%253D%253D&md5=bfa1f73bab6c2adae6a6bf265cf32310</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2165%2F11315530-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11315530-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DGullo%26aufirst%3DA.%26atitle%3DInvasive%2520fungal%2520infections%253A%2520the%2520challenge%2520continues%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D65%26epage%3D73%26doi%3D10.2165%2F11315530-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mylonakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. Y.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo activities of pterostilbene against <i>Candida albicans</i> biofilms</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2344</span>– <span class="NLM_lpage">2355</span>, <span class="refDoi"> DOI: 10.1128/AAC.01583-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FAAC.01583-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=24514088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=2344-2355&author=D.+D.+Liauthor=L.+X.+Zhaoauthor=E.+Mylonakisauthor=G.+H.+Huauthor=Y.+Zouauthor=T.+K.+Huangauthor=L.+Yanauthor=Y.+Wangauthor=Y.+Y.+Jiang&title=In+vitro+and+in+vivo+activities+of+pterostilbene+against+Candida+albicans+biofilms&doi=10.1128%2FAAC.01583-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo activities of pterostilbene against Candida albicans biofilms</span></div><div class="casAuthors">Li, De-Dong; Zhao, Lan-Xue; Mylonakis, Eleftherios; Hu, Gan-Hai; Zou, Yong; Huang, Tong-Kun; Yan, Lan; Wang, Yan; Jiang, Yuan-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2344-2355, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pterostilbene (PTE) is a stilbene-derived phytoalexin that originates from several natural plant sources.  In this study, we evaluated the activity of PTE against Candida albicans biofilms and explored the underlying mechanisms.  In 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) redn. assays, biofilm biomass measurement, confocal laser scanning microscopy, and SEM, we found that ≤16 μg/mL PTE had a significant effect against C. albicans biofilms in vitro, while it had no fungicidal effect on planktonic C. albicans cells, which suggested a unique antibiofilm effect of PTE.  Then we found that PTE could inhibit biofilm formation and destroy the maintenance of mature biofilms.  At 4 μg/mL, PTE decreased cellular surface hydrophobicity (CSH) and suppressed hyphal formation.  Gene expression microarrays and real-time reverse transcription-PCR showed that exposure of C. albicans to 16 μg/mL PTE altered the expression of genes that function in morphol. transition, ergosterol biosynthesis, oxidoreductase activity, and cell surface and protein unfolding processes (heat shock proteins).  Filamentation-related genes, esp. those regulated by the Ras/cAMP (cAMP) pathway, including ECE1, ALS3, HWP1, HGC1, and RAS1 itself, were downregulated upon PTE treatment, indicating that the antibiofilm effect of PTE was related to the Ras/cAMP pathway.  Then, we found that the addn. of exogenous cAMP reverted the PTE-induced filamentous growth defect.  Finally, with a rat central venous catheter infection model, we confirmed the in vivo activity of PTE against C. albicans biofilms.  Collectively, PTE had strong activities against C. albicans biofilms both in vitro and in vivo, and these activities were assocd. with the Ras/cAMP pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcxr9Baao5_rVg90H21EOLACvtfcHk0lgllgxY7ouuRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVSmtLk%253D&md5=b9e37b735cb17649b909b30cc4703713</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FAAC.01583-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01583-13%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%2BD.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DMylonakis%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DG.%2BH.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DT.%2BK.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%2BY.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520activities%2520of%2520pterostilbene%2520against%2520Candida%2520albicans%2520biofilms%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D2344%26epage%3D2355%26doi%3D10.1128%2FAAC.01583-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garnaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champleboux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maubon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govin, J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases and their inhibition in Candida species</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1238</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2016.01238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.3389%2Ffmicb.2016.01238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=27547205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1238&author=C.+Garnaudauthor=M.+Champlebouxauthor=D.+Maubonauthor=M.+Cornetauthor=J.+Govin&title=Histone+deacetylases+and+their+inhibition+in+Candida+species&doi=10.3389%2Ffmicb.2016.01238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylases and Their Inhibition in Candida Species</span></div><div class="casAuthors">Garnaud Cecile; Maubon Daniele; Cornet Muriel; Champleboux Morgane; Govin Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1238</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Fungi are generally benign members of the human mucosal flora or live as saprophytes in the environment.  However, they can become pathogenic, leading to invasive and life threatening infections in vulnerable patients.  These invasive fungal infections are regarded as a major public health problem on a similar scale to tuberculosis or malaria.  Current treatment for these infections is based on only four available drug classes.  This limited therapeutic arsenal and the emergence of drug-resistant strains are a matter of concern due to the growing number of patients to be treated, and new therapeutic strategies are urgently needed.  Adaptation of fungi to drug pressure involves transcriptional regulation, in which chromatin dynamics and histone modifications play a major role.  Histone deacetylases (HDACs) remove acetyl groups from histones and actively participate in controlling stress responses.  HDAC inhibition has been shown to limit fungal development, virulence, biofilm formation, and dissemination in the infected host, while also improving the efficacy of existing antifungal drugs toward Candida spp.  In this article, we review the functional roles of HDACs and the biological effects of HDAC inhibitors on Candida spp., highlighting the correlations between their pathogenic effects in vitro and in vivo.  We focus on how HDAC inhibitors could be used to treat invasive candidiasis while also reviewing recent developments in their clinical evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqH6RST9Bi-Ebxh97K6Vt6fW6udTcc2eagZ-f1l9o3_7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D&md5=73b9e6f664ac8652a3220c7757952ae6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2016.01238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2016.01238%26sid%3Dliteratum%253Aachs%26aulast%3DGarnaud%26aufirst%3DC.%26aulast%3DChampleboux%26aufirst%3DM.%26aulast%3DMaubon%26aufirst%3DD.%26aulast%3DCornet%26aufirst%3DM.%26aulast%3DGovin%26aufirst%3DJ.%26atitle%3DHistone%2520deacetylases%2520and%2520their%2520inhibition%2520in%2520Candida%2520species%26jtitle%3DFront.%2520Microbiol.%26date%3D2016%26volume%3D7%26spage%3D1238%26doi%3D10.3389%2Ffmicb.2016.01238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrosky-Zeichner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadevall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galgiani, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odds, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, J. H.</span></span> <span> </span><span class="NLM_article-title">An insight into the antifungal pipeline: selected new molecules and beyond</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">719</span>, <span class="refDoi"> DOI: 10.1038/nrd3074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1038%2Fnrd3074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=20725094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCmurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=719&author=L.+Ostrosky-Zeichnerauthor=A.+Casadevallauthor=J.+N.+Galgianiauthor=F.+C.+Oddsauthor=J.+H.+Rex&title=An+insight+into+the+antifungal+pipeline%3A+selected+new+molecules+and+beyond&doi=10.1038%2Fnrd3074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An insight into the antifungal pipeline: selected new molecules and beyond</span></div><div class="casAuthors">Ostrosky-Zeichner, Luis; Casadevall, Arturo; Galgiani, John N.; Odds, Frank C.; Rex, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">719-727</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Invasive fungal infections are increasing in incidence and are assocd. with substantial mortality.  Improved diagnostics and the availability of new antifungals have revolutionized the field of medical mycol. in the past decades.  This Review focuses on recent developments in the antifungal pipeline, concg. on promising candidates such as new azoles, polyenes and echinocandins, as well as agents such as nikkomycin Z and the sordarins.  Developments in vaccines and antibody-based immunotherapy are also discussed.  Few therapeutic products are currently in active development, and progression of therapeutic agents with fungus-specific mechanisms of action is of key importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-y4lzJruauLVg90H21EOLACvtfcHk0lhMDLNEH7A8MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCmurvK&md5=d7ccb58b653d567179e53437061df80e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3074%26sid%3Dliteratum%253Aachs%26aulast%3DOstrosky-Zeichner%26aufirst%3DL.%26aulast%3DCasadevall%26aufirst%3DA.%26aulast%3DGalgiani%26aufirst%3DJ.%2BN.%26aulast%3DOdds%26aufirst%3DF.%2BC.%26aulast%3DRex%26aufirst%3DJ.%2BH.%26atitle%3DAn%2520insight%2520into%2520the%2520antifungal%2520pipeline%253A%2520selected%2520new%2520molecules%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D719%26doi%3D10.1038%2Fnrd3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicola, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paes, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kioshima, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadio, A. K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocca, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felipe, M. S.</span></span> <span> </span><span class="NLM_article-title">Antifungal drugs: new insights in research & development</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.pharmthera.2018.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=30347212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2019&pages=21-38&author=A.+M.+Nicolaauthor=P.+Albuquerqueauthor=H.+C.+Paesauthor=L.+Fernandesauthor=F.+F.+Costaauthor=E.+S.+Kioshimaauthor=A.+K.+R.+Abadioauthor=A.+L.+Boccaauthor=M.+S.+Felipe&title=Antifungal+drugs%3A+new+insights+in+research+%26+development&doi=10.1016%2Fj.pharmthera.2018.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal drugs: New insights in research & development</span></div><div class="casAuthors">Nicola, Andre Moraes; Albuquerque, Patricia; Paes, Hugo Costa; Fernandes, Larissa; Costa, Fabricio F.; Kioshima, Erika Seki; Abadio, Ana Karina Rodrigues; Bocca, Anamelia Lorenzetti; Felipe, Maria Sueli</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The need for better antifungal therapy is commonly accepted in view of the high mortality rates assocd. with systemic infections, the low no. of available antifungal classes, their assocd. toxicity and the increasing no. of infections caused by strains with natural or acquired resistance.  The urgency to expand the range of therapeutic options for the treatment of fungal infections has led researchers in recent decades to seek alternative antifungal targets when compared to the conventional ones currently used.  Although new potential targets are reported, translating the discoveries from bench to bedside is a long process and most of these drugs fail to reach the patients.  In this review, we discuss the development of antifungal drugs focusing on the approach of drug repurposing and the search for novel drugs for classical targets, the most recently described gene targets for drug development, the possibilities of immunotherapy using antibodies, cytokines, therapeutic vaccines and antimicrobial peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOHI9vLKZwzbVg90H21EOLACvtfcHk0lhvbqFHxhtmFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzJ&md5=c4dc91ed5580dcd7b09e2b03b5680382</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DNicola%26aufirst%3DA.%2BM.%26aulast%3DAlbuquerque%26aufirst%3DP.%26aulast%3DPaes%26aufirst%3DH.%2BC.%26aulast%3DFernandes%26aufirst%3DL.%26aulast%3DCosta%26aufirst%3DF.%2BF.%26aulast%3DKioshima%26aufirst%3DE.%2BS.%26aulast%3DAbadio%26aufirst%3DA.%2BK.%2BR.%26aulast%3DBocca%26aufirst%3DA.%2BL.%26aulast%3DFelipe%26aufirst%3DM.%2BS.%26atitle%3DAntifungal%2520drugs%253A%2520new%2520insights%2520in%2520research%2520%2526%2520development%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D195%26spage%3D21%26epage%3D38%26doi%3D10.1016%2Fj.pharmthera.2018.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, R.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, B.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-Y.</span></span> <span> </span><span class="NLM_article-title">Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant <i>Candida albicans</i>: endogenous ROS augmentation</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5296</span>– <span class="NLM_lpage">5304</span>, <span class="refDoi"> DOI: 10.1021/pr9005074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr9005074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=5296-5304&author=Y.+Xuauthor=Y.+Wangauthor=L.+Yanauthor=R.-M.+Liangauthor=B.-D.+Daiauthor=R.-J.+Tangauthor=P.-H.+Gaoauthor=Y.-Y.+Jiang&title=Proteomic+analysis+reveals+a+synergistic+mechanism+of+fluconazole+and+berberine+against+fluconazole-resistant+Candida+albicans%3A+endogenous+ROS+augmentation&doi=10.1021%2Fpr9005074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: Endogenous ROS augmentation</span></div><div class="casAuthors">Xu, Yi; Wang, Yan; Yan, Lan; Liang, Rong-Mei; Dai, Bao-Di; Tang, Ren-Jie; Gao, Ping-Hui; Jiang, Yuan-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5296-5304</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A previous study showed that concomitant use of berberine (BBR) and fluconazole (FLC) provided a synergistic action against FLC-resistant Candida albicans (C. albicans) clin. strains in vitro.  To clarify the mechanism underlying this action, the authors performed a comparative proteomic study in untreated control cells and cells treated with FLC and/or BBR in 2 clin. strains of C. albicans resistant to FLC.  Their analyses identified 16 differentially expressed proteins, most of which were related to energy metab. (e.g., Gap1, Adh1, and Aco1).  Functional analyses revealed that FLC + BBR treatment increased mitochondrial membrane potential, decreased intracellular ATP level, inhibited ATP synthase activity, and increased generation of endogenous reactive oxygen species (ROS) in FLC-resistant strains.  In addn., checkerboard microdilution assay showed that addn. of antioxidant ascorbic acid or reduced glutathione reduced the synergistic antifungal activity of FLC + BBR significantly.  These results suggest that mitochondrial aerobic respiration shift and endogenous ROS augmentation contribute to the synergistic action of FLC + BBR against FLC-resistant C. albicans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe-555LzTQqLVg90H21EOLACvtfcHk0lhvbqFHxhtmFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqtb%252FE&md5=2240cc574a99bf927aa200b6dac3af7c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fpr9005074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr9005074%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DR.-M.%26aulast%3DDai%26aufirst%3DB.-D.%26aulast%3DTang%26aufirst%3DR.-J.%26aulast%3DGao%26aufirst%3DP.-H.%26aulast%3DJiang%26aufirst%3DY.-Y.%26atitle%3DProteomic%2520analysis%2520reveals%2520a%2520synergistic%2520mechanism%2520of%2520fluconazole%2520and%2520berberine%2520against%2520fluconazole-resistant%2520Candida%2520albicans%253A%2520endogenous%2520ROS%2520augmentation%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2009%26volume%3D8%26spage%3D5296%26epage%3D5304%26doi%3D10.1021%2Fpr9005074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Invasive candidiasis in intensive care units in China: a multicentre prospective observational study</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1093/jac/dkt083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1093%2Fjac%2Fdkt083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=23543609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFCitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=1660-1668&author=F.+Guoauthor=Y.+Yangauthor=Y.+Kangauthor=B.+Zangauthor=W.+Cuiauthor=B.+Qinauthor=Y.+Qinauthor=Q.+Fangauthor=T.+Qinauthor=D.+Jiang&title=Invasive+candidiasis+in+intensive+care+units+in+China%3A+a+multicentre+prospective+observational+study&doi=10.1093%2Fjac%2Fdkt083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive candidiasis in intensive care units in China: a multicentre prospective observational study</span></div><div class="casAuthors">Guo, Fengmei; Yang, Yi; Kang, Yan; Zang, Bin; Cui, Wei; Qin, Bingyu; Qin, Yingzhi; Fang, Qiang; Qin, Tiehe; Jiang, Dongpo; Li, Weiqin; Gu, Qin; Zhao, Hongsheng; Liu, Dawei; Guan, Xiangdong; Li, Jianguo; Ma, Xiaochun; Yu, Kaijiang; Chan, Dechang; Yan, Jing; Tang, Yaoqing; Liu, Wei; Li, Ruoyu; Qiu, Haibo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1660-1668</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives To describe the epidemiol., microbiol. and management of invasive Candida infection (ICI) in intensive care units (ICUs) in China.  Methods A multicentre, prospective, observational study in 67 hospital ICUs across China.  Patients were ≥18 years old with clin. signs of infection and at least one of the following diagnostic criteria: (i) histopathol., cytopathol. or microscopic confirmation of yeast cells from a normally sterile site; (ii) at least one peripheral blood culture pos. for Candida; and (iii) pos. Candida culture from a normally sterile site.  The China-SCAN study is registered with ClinicalTrials.gov (NCT T01253954).  Results ICI incidence was 0.32% (306 patients/96 060 ICU admissions) and median time between ICU admission and diagnosis was 10.0 days.  Candida albicans was the most prevalent single isolate (41.8% of patients), although non-albicans species accounted for the majority of infections.  Diagnostic confirmation was based solely on at least one pos. blood culture in 290 (94.8%) cases.  Treatment was initiated after diagnostic confirmation in 166/268 (61.9%) patients.  Triazoles (62.7%) and echinocandins (34.2%) were the most commonly used antifungal agents; first-line therapy was typically fluconazole (37.7%).  The median duration of antifungal therapy was 14 days.  The mortality rate was 36.6% (112/306); the median time between diagnosis and death was 14.5 days.  Mortality was higher in older individuals, those with solid tumors, those with recent invasive mech. ventilation and those with a higher sequential organ failure assessment score at diagnostic confirmation.  Susceptibility to first-line antifungals was assocd. with lower mortality than dose-dependent susceptibility or complete resistance (P = 0.008).  Conclusions More infections were caused by non-albicans than Candida albicans strains.  The majority of patients were treated only after diagnostic confirmation, rather than empirically.  First-line antifungal susceptibility was assocd. with lower mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcDrKNy2pe8rVg90H21EOLACvtfcHk0lg18Uwr4D-NCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFCitbs%253D&md5=ee8da03375b5824d56745dc48a7d4869</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt083%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DQin%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DD.%26atitle%3DInvasive%2520candidiasis%2520in%2520intensive%2520care%2520units%2520in%2520China%253A%2520a%2520multicentre%2520prospective%2520observational%2520study%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D1660%26epage%3D1668%26doi%3D10.1093%2Fjac%2Fdkt083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spitzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span> <span> </span><span class="NLM_article-title">Combinatorial strategies for combating invasive fungal infections</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1080/21505594.2016.1196300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1080%2F21505594.2016.1196300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=27268286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGls7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=169-185&author=M.+Spitzerauthor=N.+Robbinsauthor=G.+D.+Wright&title=Combinatorial+strategies+for+combating+invasive+fungal+infections&doi=10.1080%2F21505594.2016.1196300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial strategies for combating invasive fungal infections</span></div><div class="casAuthors">Spitzer, Michaela; Robbins, Nicole; Wright, Gerard D.</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-185</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Invasive fungal infections are an important cause of human mortality and morbidity, particularly for immunocompromised populations.  However, there remains a paucity of antifungal drug treatments available to combat these fungal pathogens.  Further, antifungal compds. are plagued with problems such as host toxicity, fungistatic activity, and the emergence of drug resistance in pathogen populations.  A promising therapeutic strategy to increase drug effectiveness and mitigate the emergence of drug resistance is through the use of combination drug therapy.  In this review we describe the current arsenal of antifungals in medicine and elaborate on the benefits of combination therapy to expand our current antifungal drug repertoire.  We examine those antifungal combinations that have shown potential against fungal pathogens and discuss strategies being employed to discover novel combination therapeutics, in particular combining antifungal agents with non-antifungal bioactive compds.  The findings summarized in this review highlight the promise of combinatorial strategies in combating invasive mycosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvt4bQOjaNnrVg90H21EOLACvtfcHk0lg18Uwr4D-NCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGls7nJ&md5=4318a442233ec8cb8a59d319e84b35b1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F21505594.2016.1196300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2016.1196300%26sid%3Dliteratum%253Aachs%26aulast%3DSpitzer%26aufirst%3DM.%26aulast%3DRobbins%26aufirst%3DN.%26aulast%3DWright%26aufirst%3DG.%2BD.%26atitle%3DCombinatorial%2520strategies%2520for%2520combating%2520invasive%2520fungal%2520infections%26jtitle%3DVirulence%26date%3D2017%26volume%3D8%26spage%3D169%26epage%3D185%26doi%3D10.1080%2F21505594.2016.1196300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, L. E.</span></span> <span> </span><span class="NLM_article-title">Using combination therapy to thwart drug resistance</span>. <i>Future Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1726</span>, <span class="refDoi"> DOI: 10.2217/fmb.15.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.2217%2Ffmb.15.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=26597425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyktbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1719-1726&author=J.+A.+Hillauthor=L.+E.+Cowen&title=Using+combination+therapy+to+thwart+drug+resistance&doi=10.2217%2Ffmb.15.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Using combination therapy to thwart drug resistance</span></div><div class="casAuthors">Hill, Jessica A.; Cowen, Leah E.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-1726</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug combination therapy is a promising strategy to extend the lifespan of our antimicrobials.  Drug combinations used in treatment must be carefully selected to minimize the evolution of resistance, either by carefully detg. drug pairs that hinder the acquisition of resistance mechanisms, or by screening for combinations that inhibit growth and show reduced vulnerability to resistance.  Modeling of interactions between drugs has provided intriguing insights into strategies for combination therapy deployment.  Ultimately, more rigorous clin. trials need to be performed to evaluate the lab. and modeling results and advance treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_0ohVLhTJbVg90H21EOLACvtfcHk0lg18Uwr4D-NCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyktbzI&md5=a6834b1376682c02b4b631e4619d21d3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2217%2Ffmb.15.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb.15.68%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DCowen%26aufirst%3DL.%2BE.%26atitle%3DUsing%2520combination%2520therapy%2520to%2520thwart%2520drug%2520resistance%26jtitle%3DFuture%2520Microbiol.%26date%3D2015%26volume%3D10%26spage%3D1719%26epage%3D1726%26doi%3D10.2217%2Ffmb.15.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlin, D. S.</span></span> <span> </span><span class="NLM_article-title">Coping with stress and the emergence of multidrug resistance in fungi</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e1004668</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1371%2Fjournal.ppat.1004668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=25790300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlSksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&author=E.+Shorauthor=D.+S.+Perlin&title=Coping+with+stress+and+the+emergence+of+multidrug+resistance+in+fungi&doi=10.1371%2Fjournal.ppat.1004668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coping with stress and the emergence of multidrug resistance in fungi</span></div><div class="casAuthors">Shor, Erika; Perlin, David S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1004668/1-e1004668/7</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A review.  Frequent and prolonged exposures of fungal cells to antifungal drugs activate fungal stress responses, which both support the short-term cellular adaptation to the drugs and promote genetic instability to facilitate the emergence of stable drug resistant mutants refractory to therapy, including multidrug-resistant strains.  We focus on drug resistance in Candida species because of its clin. significance, esp. with the development of emerging multidrug resistance, and because mechanisms of drug resistance and stress-assocd. genetic instability are best studied in Candida.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomq9_8wt-FP7Vg90H21EOLACvtfcHk0lgPKnxj7LHVdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlSksbk%253D&md5=13b2e0d6924a806b7796261606dd7580</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004668%26sid%3Dliteratum%253Aachs%26aulast%3DShor%26aufirst%3DE.%26aulast%3DPerlin%26aufirst%3DD.%2BS.%26atitle%3DCoping%2520with%2520stress%2520and%2520the%2520emergence%2520of%2520multidrug%2520resistance%2520in%2520fungi%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26doi%3D10.1371%2Fjournal.ppat.1004668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlind, T. D.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors enhance <i>Candida albicans</i> sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3532</span>– <span class="NLM_lpage">3539</span>, <span class="refDoi"> DOI: 10.1128/AAC.46.11.3532-3539.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FAAC.46.11.3532-3539.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=12384361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3532-3539&author=W.+L.+Smithauthor=T.+D.+Edlind&title=Histone+deacetylase+inhibitors+enhance+Candida+albicans+sensitivity+to+azoles+and+related+antifungals%3A+correlation+with+reduction+in+CDR+and+ERG+upregulation&doi=10.1128%2FAAC.46.11.3532-3539.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span></div><div class="casAuthors">Smith, W. Lamar; Edlind, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3532-3539</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone acetylation and deacetylation play important roles in eukaryotic gene regulation.  Several histone deacetylase (HDA) inhibitors have been characterized, including trichostatin A (TSA), apicidin, and sodium butyrate.  We tested their effects on Candida albicans in vitro growth, heat sensitivity, and germ tube formation; minimal effects were obsd.  However, there was a dramatic effect of TSA on C. albicans sensitivity to the azoles fluconazole, itraconazole, and miconazole.  Similar effects were obsd. with other HDA inhibitors and with the antifungals terbinafine and fenpropimorph, which target, as do azoles, enzymes in the ergosterol biosynthetic pathway.  In contrast, HDA inhibitors had minimal effect on the activities of amphotericin B, flucytosine, and echinocandin, which have unrelated targets.  Specifically, addn. of 3 μg of TSA/mL lowered the itraconazole MIC for five susceptible C. albicans isolates an av. of 2.7-fold at 24 h, but this increased to > 200-fold at 48 h.  Thus, the primary effect of TSA was a redn. in azole trailing.  TSA also enhanced itraconazole activity against Candida parapsilosis and Candida tropicalis but had no effect with four less related yeast species.  To examine the mol. basis for these effects, we studied expression of ERG genes (encoding azole and terbinafine targets) and CDR/MDR1 genes (encoding multidrug transporters) in C. albicans cells treated with fluconazole or terbinafine with or without TSA.  Both antifungals induced to various levels the expression of ERG1, ERG11, CDR1, and CDR2; addn. of TSA reduced this upregulation 50 to 100%.  This most likely explains the inhibition of azole and terbinafine trailing by TSA and, more generally, provides evidence that trailing is mediated by upregulation of target enzymes and multidrug transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4DpmS0neAOrVg90H21EOLACvtfcHk0lgPKnxj7LHVdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D&md5=8a372cf4fcb9077cf8b92c21b37792bf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.11.3532-3539.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.11.3532-3539.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BL.%26aulast%3DEdlind%26aufirst%3DT.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520enhance%2520Candida%2520albicans%2520sensitivity%2520to%2520azoles%2520and%2520related%2520antifungals%253A%2520correlation%2520with%2520reduction%2520in%2520CDR%2520and%2520ERG%2520upregulation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3532%26epage%3D3539%26doi%3D10.1128%2FAAC.46.11.3532-3539.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passariello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamara, A. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in <i>Candida albicans</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1225</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.bmcl.2006.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=17196388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1221-1225&author=A.+Maiauthor=D.+Rotiliauthor=S.+Massaauthor=G.+Broschauthor=G.+Simonettiauthor=C.+Passarielloauthor=A.+T.+Palamara&title=Discovery+of+uracil-based+histone+deacetylase+inhibitors+able+to+reduce+acquired+antifungal+resistance+and+trailing+growth+in+Candida+albicans&doi=10.1016%2Fj.bmcl.2006.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans</span></div><div class="casAuthors">Mai, Antonello; Rotili, Dante; Massa, Silvio; Brosch, Gerald; Simonetti, Giovanna; Passariello, Claudio; Palamara, Anna Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1221-1225</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among fungal pathogens such as Candida albicans, acquired drug resistance has not been assocd. with plasmids or other transferable elements, but it is thought to involve primarily mutations and genetic or epigenetic phenomena.  This the authors to test some histone deacetylase inhibitors (HDACi) from their library, in combination with fluconazole, against C. albicans strains in vitro.  Among the tested compds., the two chloro-contg. uracil-hydroxamates 1c and 1d showed a strong redn. of the MIC values on Candida strains that show the trailing growth effect.  In this assay, 1c,d were more potent than SAHA, a well-known HDAC inhibitor, in reducing the Candida growth.  Compds. 1c,d as well as SAHA were able to inhibit the fluconazole-induced resistance induction in Candida cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgG2dBVCiTN7Vg90H21EOLACvtfcHk0lgPKnxj7LHVdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D&md5=459aca01b82b284070f9bfe6229aca3b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DSimonetti%26aufirst%3DG.%26aulast%3DPassariello%26aufirst%3DC.%26aulast%3DPalamara%26aufirst%3DA.%2BT.%26atitle%3DDiscovery%2520of%2520uracil-based%2520histone%2520deacetylase%2520inhibitors%2520able%2520to%2520reduce%2520acquired%2520antifungal%2520resistance%2520and%2520trailing%2520growth%2520in%2520Candida%2520albicans%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1221%26epage%3D1225%26doi%3D10.1016%2Fj.bmcl.2006.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in <i>Candida albicans</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1993</span>– <span class="NLM_lpage">2003</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1093%2Fjac%2Fdkv070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=25825380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OltbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1993-2003&author=X.+Liauthor=Q.+Caiauthor=H.+Meiauthor=X.+Zhouauthor=Y.+Shenauthor=D.+Liauthor=W.+Liu&title=The+Rpd3%2FHda1+family+of+histone+deacetylases+regulates+azole+resistance+in+Candida+albicans&doi=10.1093%2Fjac%2Fdkv070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans</span></div><div class="casAuthors">Li, Xiaofang; Cai, Qing; Mei, Huan; Zhou, Xiaowei; Shen, Yongnian; Li, Dongmei; Liu, Weida</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1993-2003</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The histone deacetylase (HDAC) has recently been linked to the morphogenesis and virulence of yeast.  However, the effects of HDAC on antifungal susceptibility are not well understood.  We sought to characterize the action of histone deacetylation on azole resistance in Candida albicans and its possible mechanism of action.  Methods: A total of 40 C. albicans strains were studied.  Azole susceptibility with or without trichostatin A (TSA) was detd. according to the CLSI microdilution method.  The null mutants of HDA1 and RPD3 (genes targeted by TSA) were also investigated using drop-plate assays and a rapid acquisition of adaptation to the azole test.  Transcriptional levels of HDAC genes and efflux genes were quantified using RT-PCR for both the basal and fluconazole-induced conditions.  Results: The inhibition of HDACs by TSA (0.25 mg/L) markedly reduced the trailing growth and the growth of most C. albicans strains.  Trailing growth for C. albicans strains was decreased from 2-fold to 256-fold at 48 h.  The deletion of HDA1 or RPD3 increased the susceptibility to azoles compared with the WT strain.  The expression of HDA1 and RPD3 was up-regulated to different levels, and returned to the level of the susceptible parental strain when stable resistance had formed during the course of acquired fluconazole resistance both in vitro and in vivo.  Efflux genes were poorly expressed in mutant strains compared with those of the WT strain.  Conclusions: Our results indicate the important role of the Rpd3/Hda1 family in the development of azole resistance in C. albicans.  Histone deacetylation may govern the expression of genes related to the early stages of adaptation to azole stress, such as efflux pump genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvglqXcJdnsbVg90H21EOLACvtfcHk0lgPKnxj7LHVdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OltbvE&md5=34cf1e334db6d83f40c498cf9218eb8f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv070%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DThe%2520Rpd3%252FHda1%2520family%2520of%2520histone%2520deacetylases%2520regulates%2520azole%2520resistance%2520in%2520Candida%2520albicans%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D1993%26epage%3D2003%26doi%3D10.1093%2Fjac%2Fdkv070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfaller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopapadakou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diekema, D.</span></span> <span> </span><span class="NLM_article-title">Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3797</span>– <span class="NLM_lpage">3804</span>, <span class="refDoi"> DOI: 10.1128/JCM.00618-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FJCM.00618-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=19794038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=3797-3804&author=M.+Pfallerauthor=S.+Messerauthor=N.+Georgopapadakouauthor=L.+Martellauthor=J.+Bestermanauthor=D.+Diekema&title=Activity+of+MGCD290%2C+a+Hos2+histone+deacetylase+inhibitor%2C+in+combination+with+azole+antifungals+against+opportunistic+fungal+pathogens&doi=10.1128%2FJCM.00618-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens</span></div><div class="casAuthors">Pfaller, M. A.; Messer, S. A.; Georgopapadakou, N.; Martell, L. A.; Besterman, J. M.; Diekema, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3797-3804</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the in vitro activity of the Hos2 fungal histone deacetylase (HDAC) inhibitor MGCD290 (MethylGene, Inc.) in combination with azoles against azole-resistant yeasts and molds.  Susceptibility testing was performed by the CLSI M27-A3 and M38-A2 broth microdilution methods.  Testing of the combinations (MGCD290 in combination with fluconazole, posaconazole, or voriconazole) was performed by the checkerboard method.  The fractional inhibitory concns. were detd. and were defined as <0.5 for synergy, ≥0.5 but <4 for indifference, and ≥4 for antagonism.  Ninety-one isolates were tested, as follows: 30 Candida isolates, 10 Aspergillus isolates, 15 isolates of the Zygomycetes order, 10 Cryptococcus neoformans isolates, 8 Rhodotorula isolates, 8 Fusarium isolates, 5 Trichosporon isolates, and 5 Scedosporium isolates.  MGCD290 showed modest activity when it was used alone (MICs, 1 to 8 μg/mL) and was mostly active against azole-resistant yeasts, but the MICs against molds were high (16 to >32 μg/mL).  MGCD290 was synergistic with fluconazole against 55 (60%) of the 91 isolates, with posaconazole against 46 (51%) of the 91 isolates, and with voriconazole against 48 (53%) of the 91 isolates.  Synergy between fluconazole and MGCD290 was obsd. against 26/30 (87%) Candida isolates.  All 23 of the 91 Candida isolates that were not fluconazole susceptible demonstrated a reduced fluconazole MIC that crossed an interpretive breakpoint (e.g., resistant [MIC, ≥64 μg/mL] to susceptible [MIC, ≤8 μg/mL]) when fluconazole was combined with MGCD290 at 0.12 to 4 μg/mL.  The activity of fluconazole plus MGCD290 was also synergistic against 6/10 Aspergillus isolates.  Posaconazole plus MGCD290 demonstrated synergy against 14/15 Zygomycetes (9 Rhizopus isolates and 5 Mucor isolates).  Voriconazole plus MGCD290 demonstrated synergy against six of eight Fusarium isolates.  Thus, MGCD290 demonstrated in vitro synergy with azoles against the majority of clin. isolates tested, including many azole-resistant isolates and genera inherently resistant to azoles (e.g., Mucor and Fusarium).  Further evaluation of fungal HDAC inhibitor-azole combinations is indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLGHRgkGpZwbVg90H21EOLACvtfcHk0liHNp5Dcf5RmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGmsQ%253D%253D&md5=6e526ec447c1f9a383df80b9e1e42a7d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FJCM.00618-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00618-09%26sid%3Dliteratum%253Aachs%26aulast%3DPfaller%26aufirst%3DM.%26aulast%3DMesser%26aufirst%3DS.%26aulast%3DGeorgopapadakou%26aufirst%3DN.%26aulast%3DMartell%26aufirst%3DL.%26aulast%3DBesterman%26aufirst%3DJ.%26aulast%3DDiekema%26aufirst%3DD.%26atitle%3DActivity%2520of%2520MGCD290%252C%2520a%2520Hos2%2520histone%2520deacetylase%2520inhibitor%252C%2520in%2520combination%2520with%2520azole%2520antifungals%2520against%2520opportunistic%2520fungal%2520pathogens%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2009%26volume%3D47%26spage%3D3797%26epage%3D3804%26doi%3D10.1128%2FJCM.00618-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel fungal lanosterol 14alpha-demethylase (CYP51)/histone deacetylase dual inhibitors to treat azole-resistant candidiasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">5341</span>– <span class="NLM_lpage">5359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BB38vgvVKhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=5341-5359&author=G.+Hanauthor=N.+Liuauthor=C.+Liauthor=J.+Tuauthor=Z.+Liauthor=C.+Sheng&title=Discovery+of+novel+fungal+lanosterol+14alpha-demethylase+%28CYP51%29%2Fhistone+deacetylase+dual+inhibitors+to+treat+azole-resistant+candidiasis&doi=10.1021%2Facs.jmedchem.0c00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis</span></div><div class="casAuthors">Han Guiyan; Liu Na; Li Chenglan; Tu Jie; Li Zhuang; Sheng Chunquan; Li Chenglan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5341-5359</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide.  Because of serious antifungal drug resistance, therapeutic efficacy of the current treatment for candidiasis is limited and associated with high mortality.  However, it is highly challenging to develop novel strategies and effective therapeutic agents to combat drug resistance.  Herein, the first generation of lanosterol 14α-demethylase (CYP51)-histone deacetylase (HDAC) dual inhibitors was designed, which exhibited potent antifungal activity against azole-resistant clinical isolates.  In particular, compounds 12h and 15j were highly active both in vitro and in vivo to treat azole-resistant candidiasis.  Antifungal mechanism studies revealed that they acted by blocking ergosterol biosynthesis and HDAC catalytic activity in fungus, suppressing the function of efflux pump, yeast-to-hypha morphological transition, and biofilm formation.  Therefore, CYP51-HDAC dual inhibitors represent a promising strategy to develop novel antifungal agents against azole-resistant candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6ZxFRPxDAcUg6wdEZmT2rfW6udTcc2eY6vBnhJ-FTLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38vgvVKhtg%253D%253D&md5=1e68d74d03f06e077b784cc0bf1b36ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00102%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520fungal%2520lanosterol%252014alpha-demethylase%2520%2528CYP51%2529%252Fhistone%2520deacetylase%2520dual%2520inhibitors%2520to%2520treat%2520azole-resistant%2520candidiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D5341%26epage%3D5359%26doi%3D10.1021%2Facs.jmedchem.0c00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors as a novel strategy for the combinational treatment of leukemia and invasive fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6056</span>– <span class="NLM_lpage">6074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6056-6074&author=Y.+Huangauthor=G.+Dongauthor=H.+Liauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+janus+kinase+2+%28JAK2%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors+as+a+novel+strategy+for+the+combinational+treatment+of+leukemia+and+invasive+fungal+infections&doi=10.1021%2Facs.jmedchem.8b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections</span></div><div class="casAuthors">Huang, Yahui; Dong, Guoqiang; Li, Huanqiu; Liu, Na; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6056-6074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin., leukemia patients often suffer from the limited efficacy of chemotherapy and high risks of infection by invasive fungal pathogens.  Herein, a novel therapeutic strategy was developed in which a small mol. can simultaneously treat leukemia and invasive fungal infections (IFIs).  Novel Janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors were identified to possess potent anti-proliferative activity toward hematol. cell lines and excellent synergistic effects with fluconazole to treat resistant Candida albicans infections.  In particular, compd. I, a highly active and selective JAK2/HDAC6 dual inhibitor, showed excellent in vivo antitumor efficacy in several acute myeloid leukemia (AML) models and synergized with fluconazole for the treatment of resistant C. albicans infections.  This study highlights the therapeutic potential of JAK2/HDAC dual inhibitors in treating AML and IFIs and provides an efficient strategy for multitargeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_ii7EQG1qLVg90H21EOLACvtfcHk0liK06dkpn504w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN&md5=ba7cf74761120f0526ab520196e3dded</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00393%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520janus%2520kinase%25202%2520%2528JAK2%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%2520as%2520a%2520novel%2520strategy%2520for%2520the%2520combinational%2520treatment%2520of%2520leukemia%2520and%2520invasive%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6056%26epage%3D6074%26doi%3D10.1021%2Facs.jmedchem.8b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of carboline derivatives as potent antifungal agents for the treatment of cryptococcal meningitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2376</span>– <span class="NLM_lpage">2389</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisl2mu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2376-2389&author=J.+Tuauthor=Z.+Liauthor=Y.+Jiangauthor=C.+Jiauthor=G.+Hanauthor=Y.+Wangauthor=N.+Liuauthor=C.+Sheng&title=Discovery+of+carboline+derivatives+as+potent+antifungal+agents+for+the+treatment+of+cryptococcal+meningitis&doi=10.1021%2Facs.jmedchem.8b01598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Carboline Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcal Meningitis</span></div><div class="casAuthors">Tu, Jie; Li, Zhuang; Jiang, Yanjuan; Ji, Changjin; Han, Guiyan; Wang, Yan; Liu, Na; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2376-2389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin. treatment of cryptococcal meningitis (CM) remains a significant challenge because of the lack of effective and safe drug therapies.  Developing novel CM therapeutic agents with novel chem. scaffolds and new modes of action is of great importance.  Herein, new β-hexahydrocarboline derivs. are shown to possess potent anticryptococcal activities.  In particular, compd. A4 showed potent in vitro and in vivo anticryptococcal activity with good metabolic stability and blood-brain barrier permeability.  Compd. A4 was orally active and could significantly reduce brain fungal burdens in a murine model of CM.  Moreover, compd. A4 could inhibit several virulence factors of Cryptococcus neoformans and might act by a new mode of action.  Preliminary mechanistic studies revealed that compd. A4 induced DNA double-stranded breaks and cell cycle arrest at the G2 phase by acting on the Cdc25c/CDK1/cyclin B pathway.  Taken together, β-hexahydrocarboline A4 represents a promising lead compd. for the development of next-generation CM therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQe-fb_pBnQLVg90H21EOLACvtfcHk0liK06dkpn504w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisl2mu74%253D&md5=d2fb308a23bcbdf978ac9f7bfd3a86eb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01598%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520carboline%2520derivatives%2520as%2520potent%2520antifungal%2520agents%2520for%2520the%2520treatment%2520of%2520cryptococcal%2520meningitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2376%26epage%3D2389%26doi%3D10.1021%2Facs.jmedchem.8b01598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gryder, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodji, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyelere, A. K.</span></span> <span> </span><span class="NLM_article-title">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.4155%2Ffmc.12.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=22416777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=505-524&author=B.+E.+Gryderauthor=Q.+H.+Sodjiauthor=A.+K.+Oyelere&title=Targeted+cancer+therapy%3A+giving+histone+deacetylase+inhibitors+all+they+need+to+succeed&doi=10.4155%2Ffmc.12.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span></div><div class="casAuthors">Gryder, Berkley E.; Sodji, Quaovi H.; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-524</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of small-mol. therapeutics acting through the regulation of the acetylation states of histone proteins (a form of epigenetic modulation) and other non-histone protein targets.  Over 490 clin. trials have been initiated in the last 10 years, culminating in the approval of two structurally distinct HDACis-SAHA (vorinostat, Zolinza) and FK228 (romidepsin, Istodax).  However, the current HDACis have serious limitations, including ineffectively low concns. in solid tumors and cardiac toxicity, which is hindering their progress in the clinic.  Herein, we review the primary paradigms being pursued to overcome these hindrances, including HDAC isoform selectivity, localized administration, and targeting cap groups to achieve selective tissue and cell type distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwrW1IVCIULVg90H21EOLACvtfcHk0lhDN6cYg1Dqkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D&md5=234080d1b0862680a68062a03afee20c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.3%26sid%3Dliteratum%253Aachs%26aulast%3DGryder%26aufirst%3DB.%2BE.%26aulast%3DSodji%26aufirst%3DQ.%2BH.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DTargeted%2520cancer%2520therapy%253A%2520giving%2520histone%2520deacetylase%2520inhibitors%2520all%2520they%2520need%2520to%2520succeed%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D505%26epage%3D524%26doi%3D10.4155%2Ffmc.12.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, T. C.</span></span> <span> </span><span class="NLM_article-title">Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in <i>Candida albicans</i> isolates from a patient infected with human immunodeficiency virus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1128/AAC.41.7.1482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FAAC.41.7.1482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=9210670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADyaK2sXktlyrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=1482-1487&author=T.+C.+White&title=Increased+mRNA+levels+of+ERG16%2C+CDR%2C+and+MDR1+correlate+with+increases+in+azole+resistance+in+Candida+albicans+isolates+from+a+patient+infected+with+human+immunodeficiency+virus&doi=10.1128%2FAAC.41.7.1482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus</span></div><div class="casAuthors">White, Theodore C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1482-1487</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Resistance to antifungal drugs, specifically azoles such as fluconazole, in the opportunistic yeast Candida albicans has become an increasing problem in human immunodeficiency virus (HIV)-infected individuals.  The mol. mechanisms responsible for this resistance have only recently become apparent and can include alterations in the target enzyme of the azole drugs (lanosterol 14α demethylase [14DM]), or in various efflux pumps from both the ABC transporter and major facilitator gene families.  To det. which of these possible mechanisms was assocd. with the development of drug resistance in a particular case, mRNA levels have been studied in a series of 17 clin. isolates taken from a single HIV-infected patient over 2 yr, during which time the levels of fluconazole resistance of the strain increased over 200-fold.  Using Northern blot anal. of steady-state levels of total RNA from these isolates, we obsd. increased mRNA levels of ERG16 (the 14DM-encoding gene), CDR1 (an ABC transporter), and MDR1 (a major facilitator) in this series.  The timing of the increase in mRNA levels of each of these genes correlated with increases in fluconazole resistance of the isolates.  Increased mRNA levels were not obsd. for three other ABC transporters, two other genes in the ergosterol biosynthetic pathway, or the NADPH-cytochrome P 450 oxidoreductase gene that transfers electrons from NADPH to 14DM.  Increases in mRNA levels of ERG16 and CDR1 correlated with increased cross-resistance to ketoconazole and itraconazole but not to amphotericin B.  A compilation of the genetic alterations identified in this series suggests that resistance develops gradually and is the sum of several different changes, all of which contribute to the final resistant phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcePJcYuq0KrVg90H21EOLACvtfcHk0lhDN6cYg1Dqkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlyrurw%253D&md5=4496d1afe63335deadeb234dae8b8a20</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.41.7.1482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.41.7.1482%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DT.%2BC.%26atitle%3DIncreased%2520mRNA%2520levels%2520of%2520ERG16%252C%2520CDR%252C%2520and%2520MDR1%2520correlate%2520with%2520increases%2520in%2520azole%2520resistance%2520in%2520Candida%2520albicans%2520isolates%2520from%2520a%2520patient%2520infected%2520with%2520human%2520immunodeficiency%2520virus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26spage%3D1482%26epage%3D1487%26doi%3D10.1128%2FAAC.41.7.1482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gow, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Veerdonk, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title"><i>Candida albicans</i> morphogenesis and host defence: discriminating invasion from colonization</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">112</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1038%2Fnrmicro2711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=112&author=N.+A.+Gowauthor=F.+L.+Van+De+Veerdonkauthor=A.+J.+Brownauthor=M.+G.+Netea&title=Candida+albicans+morphogenesis+and+host+defence%3A+discriminating+invasion+from+colonization&doi=10.1038%2Fnrmicro2711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Candida albicans morphogenesis and host defence: discriminating invasion from colonization</span></div><div class="casAuthors">Gow, Neil A. R.; van de Veerdonk, Frank L.; Brown, Alistair J. P.; Netea, Mihai G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Candida albicans is a common fungal pathogen of humans that colonizes the skin and mucosal surfaces of most healthy individuals.  Until recently, little was known about the mechanisms by which mucosal antifungal defenses tolerate colonizing C. albicans but react strongly when hyphae of the same microorganism attempt to invade tissue.  In this Review, we describe the properties of yeast cells and hyphae that are relevant to their interaction with the host, and the immunol. mechanisms that differentially recognize colonizing vs. invading C. albicans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWGRROO3XjrVg90H21EOLACvtfcHk0lhDN6cYg1Dqkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr%252FK&md5=25b8e879677643c2bc01d78f7cf841a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2711%26sid%3Dliteratum%253Aachs%26aulast%3DGow%26aufirst%3DN.%2BA.%26aulast%3DVan%2BDe%2BVeerdonk%26aufirst%3DF.%2BL.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DCandida%2520albicans%2520morphogenesis%2520and%2520host%2520defence%253A%2520discriminating%2520invasion%2520from%2520colonization%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2012%26volume%3D10%26spage%3D112%26doi%3D10.1038%2Fnrmicro2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Midkiff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borochoff-Porte, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. I.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of the <i>Candida albicans</i> budded-to-hyphal transition act through multiple signaling pathways</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e25395</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0025395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1371%2Fjournal.pone.0025395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=21966518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleisLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=J.+Midkiffauthor=N.+Borochoff-Porteauthor=D.+Whiteauthor=D.+I.+Johnson&title=Small+molecule+inhibitors+of+the+Candida+albicans+budded-to-hyphal+transition+act+through+multiple+signaling+pathways&doi=10.1371%2Fjournal.pone.0025395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways</span></div><div class="casAuthors">Midkiff, John; Borochoff-Porte, Nathan; White, Dylan; Johnson, Douglas I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e25395</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The ability of the pathogenic yeast Candida albicans to interconvert between budded and hyphal growth states, herein termed the budded-to-hyphal transition (BHT), is important for C. albicans development and virulence.  The BHT is under the control of multiple cell signaling pathways that respond to external stimuli, including nutrient availability, high temp., and pH.  Previous studies identified 21 small mols. that could inhibit the C. albicans BHT in response to carbon limitation in Spider media.  However, the studies here show that the BHT inhibitors had varying efficacies in other hyphal-inducing media, reflecting their varying abilities to block signaling pathways assocd. with the different media.  Chem. epistasis analyses suggest that most, but not all, of the BHT inhibitors were acting through either the Efg1 or Cph1 signaling pathways.  Notably, the BHT inhibitor clozapine, a FDA-approved drug used to treat atypical schizophrenia by inhibiting G-protein-coupled dopamine receptors in the brain, and several of its functional analogs were shown to act at the level of the Gpr1 G-protein-coupled receptor.  These studies are the first step in detg. the target and mechanism of action of these BHT inhibitors, which may have therapeutic anti-fungal utility in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJiwxHhPivX7Vg90H21EOLACvtfcHk0li70n3CaXx15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleisLjN&md5=4ecfde4d1a30b699489c63c06da2e320</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025395%26sid%3Dliteratum%253Aachs%26aulast%3DMidkiff%26aufirst%3DJ.%26aulast%3DBorochoff-Porte%26aufirst%3DN.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DD.%2BI.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520the%2520Candida%2520albicans%2520budded-to-hyphal%2520transition%2520act%2520through%2520multiple%2520signaling%2520pathways%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0025395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yargosz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. I.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of biofilm formation in laboratory and clinical isolates of <i>Candida albicans</i></span>. <i>J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1099/jmm.0.034124-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1099%2Fjmm.0.034124-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=21903824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=109-114&author=A.+Graldauthor=P.+Yargoszauthor=S.+Caseauthor=K.+Sheaauthor=D.+I.+Johnson&title=Small-molecule+inhibitors+of+biofilm+formation+in+laboratory+and+clinical+isolates+of+Candida+albicans&doi=10.1099%2Fjmm.0.034124-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of biofilm formation in laboratory and clinical isolates of Candida albicans</span></div><div class="casAuthors">Grald, Ariel; Yargosz, Philip; Case, Samantha; Shea, Katelyn; Johnson, Douglas I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-114</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Candida albicans cells have the ability to form biofilms on biotic and abiotic surfaces, such as indwelling medical devices.  C. albicans cells can interconvert between budded and hyphal growth forms, herein termed the budded-to-hyphal transition (BHT), which is important for the formation of mature biofilms.  Previous work identified 23 small org. mols. that could inhibit the BHT but did not affect C. albicans cell viability or budded cell growth.  These BHT inhibitors were proposed to inhibit multiple signalling pathways regulating the BHT, many of which also regulate biofilm formation.  However, only three of the BHT inhibitors, buhytrinA, ETYA and CGP-37157, were capable of inhibiting in vitro biofilm formation of wild-type lab. C. albicans strains.  When clin. C. albicans isolates were examd. for their ability to form biofilms, only 11 of the 28 clin. isolates tested (39%) were capable of forming biofilms.  Although buhytrinA, ETYA and CGP-37157 could inhibit the BHT of all 28 clin. isolates, they were only able to inhibit biofilm formation of a subset of these clin. isolates, with ETYA having 100% efficacy.  These data indicate that the biofilm-forming capability of lab. and clin. isolates of C. albicans, as well as the efficacy of BHT inhibitors against these different isolates, can differ dramatically.  These differences between lab. and clin. isolates should be an important aspect to consider when examg. potentially new antifungal therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI0PuHWl4AubVg90H21EOLACvtfcHk0li70n3CaXx15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yiu7k%253D&md5=0e99283be7528ee0a2c3cde6aec4d231</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1099%2Fjmm.0.034124-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fjmm.0.034124-0%26sid%3Dliteratum%253Aachs%26aulast%3DGrald%26aufirst%3DA.%26aulast%3DYargosz%26aufirst%3DP.%26aulast%3DCase%26aufirst%3DS.%26aulast%3DShea%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BI.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520biofilm%2520formation%2520in%2520laboratory%2520and%2520clinical%2520isolates%2520of%2520Candida%2520albicans%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2012%26volume%3D61%26spage%3D109%26epage%3D114%26doi%3D10.1099%2Fjmm.0.034124-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of <i>Candida albicans</i> filamentation</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e01991</span>, <span class="refDoi"> DOI: 10.1128/mBio.01991-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FmBio.01991-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=29208749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e01991&author=J.+A.+Romoauthor=C.+G.+Pierceauthor=A.+K.+Chaturvediauthor=A.+L.+Lazzellauthor=S.+F.+McHardyauthor=S.+P.+Savilleauthor=J.+L.+Lopez-Ribot&title=Development+of+anti-virulence+approaches+for+candidiasis+via+a+novel+series+of+small-molecule+inhibitors+of+Candida+albicans+filamentation&doi=10.1128%2FmBio.01991-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation</span></div><div class="casAuthors">Romo, Jesus A.; Pierce, Christopher G.; Chaturvedi, Ashok K.; Lazzell, Anna L.; McHardy, Stanton F.; Saville, Stephen P.; Lopez-Ribot, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e01991-17/1-e01991-17/16</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">This leading compd. also demonstrated in vivo activity in clin. relevant murine models of invasive and oral candidiasis.  Overall, our results indicate that compds. within this series represent promising candidates for the development of novel anti-virulence approaches to combat C. albicans infections.  IMPORTANCE Since fungi are eukaryotes, there is a limited no. of fungusspecific targets and, as a result, the antifungal arsenal is exceedingly small.  Furthermore, the efficacy of antifungal treatment is compromised by toxicity and development of resistance.  As a consequence, fungal infections carry high morbidity and mortality rates, and there is an urgent but unmet need for novel antifungal agents.  One appealing strategy for antifungal drug development is to target pathogenetic mechanisms assocd. with infection.  In Candida albicans, one of the most common pathogenic fungi, morphogenetic transitions between yeast cells and filamentous hyphae represent a key virulence factor assocd. with the ability of fungal cells to invade tissues, cause damage, and form biofilms.  Here, we describe and characterize a novel small-mol. compd. capable of inhibiting C. albicans filamentation both in vitro and in vivo; as such, this compd. represents a leading candidate for the development of anti-virulence therapies against candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGPhBx3db77Vg90H21EOLACvtfcHk0li70n3CaXx15Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI&md5=6f14fbe603e993cc98c5364557f39440</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FmBio.01991-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01991-17%26sid%3Dliteratum%253Aachs%26aulast%3DRomo%26aufirst%3DJ.%2BA.%26aulast%3DPierce%26aufirst%3DC.%2BG.%26aulast%3DChaturvedi%26aufirst%3DA.%2BK.%26aulast%3DLazzell%26aufirst%3DA.%2BL.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520of%2520anti-virulence%2520approaches%2520for%2520candidiasis%2520via%2520a%2520novel%2520series%2520of%2520small-molecule%2520inhibitors%2520of%2520Candida%2520albicans%2520filamentation%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26spage%3De01991%26doi%3D10.1128%2FmBio.01991-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlin, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Update on antifungal drug resistance</span>. <i>Curr. Clin. Microbiol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1007/s40588-015-0015-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1007%2Fs40588-015-0015-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=26120512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BC2srotlyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=84-95&author=D.+S.+Perlinauthor=E.+Shorauthor=Y.+Zhao&title=Update+on+antifungal+drug+resistance&doi=10.1007%2Fs40588-015-0015-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Antifungal Drug Resistance</span></div><div class="casAuthors">Perlin David S; Shor Erika; Zhao Yanan</div><div class="citationInfo"><span class="NLM_cas:title">Current clinical microbiology reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">84-95</span>
        ISSN:<span class="NLM_cas:issn">2196-5471</span>.
    </div><div class="casAbstract">Invasive fungal infections remain a major source of global morbidity and mortality, especially among patients with underlying immune suppression.  Successful patient management requires antifungal therapy.  Yet, treatment choices are restricted due to limited classes of antifungal agents and the emergence of antifungal drug resistance.  In some settings, the evolution of multidrug-resistant strains insensitive to several classes of antifungal agents is a major concern.  The resistance mechanisms responsible for acquired resistance are well characterized and include changes in drug target affinity and abundance, and reduction in the intracellular level of drug by biofilms and efflux pumps.  The development of high-level and multidrug resistance occurs through a stepwise evolution of diverse mechanisms.  The genetic factors that influence these mechanisms are emerging and they form a complex symphony of cellular interactions that enable the cell to adapt and/or overcome drug-induced stress.  Drivers of resistance involve a complex blend of host and microbial factors.  Understanding these mechanisms will facilitate development of better diagnostics and therapeutic strategies to overcome and prevent antifungal resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEJ37PEUcnpYYPsCkJIw00fW6udTcc2ebt6vUiMB4Pb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srotlyjsA%253D%253D&md5=ce67cbf7d55c1d1a871f6cfcc2066991</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs40588-015-0015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40588-015-0015-1%26sid%3Dliteratum%253Aachs%26aulast%3DPerlin%26aufirst%3DD.%2BS.%26aulast%3DShor%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DUpdate%2520on%2520antifungal%2520drug%2520resistance%26jtitle%3DCurr.%2520Clin.%2520Microbiol.%2520Rep.%26date%3D2015%26volume%3D2%26spage%3D84%26epage%3D95%26doi%3D10.1007%2Fs40588-015-0015-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Candida biofilms: an update</span>. <i>Eukaryotic Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1128/EC.4.4.633-638.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FEC.4.4.633-638.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=15821123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=633-638&author=G.+Ramageauthor=S.+P.+Savilleauthor=D.+P.+Thomasauthor=J.+L.+Lopez-Ribot&title=Candida+biofilms%3A+an+update&doi=10.1128%2FEC.4.4.633-638.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Candida biofilms: An update</span></div><div class="casAuthors">Ramage, Gordon; Saville, Stephen P.; Thomas, Derek P.; Lopez-Ribot, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Eukaryotic Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">633-638</span>CODEN:
                <span class="NLM_cas:coden">ECUEA2</span>;
        ISSN:<span class="NLM_cas:issn">1535-9778</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review on the formation of Candida albicans biofilms, the role of morphogenetic conversions in this process, quorum sensing in these biofilms, and mol. basis of resistance in Candida biofilms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnNeAtOtxBlbVg90H21EOLACvtfcHk0ljKMyYilzS11g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVGqsLo%253D&md5=a1e605a815358b4f788a2f29d130b9c5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FEC.4.4.633-638.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FEC.4.4.633-638.2005%26sid%3Dliteratum%253Aachs%26aulast%3DRamage%26aufirst%3DG.%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DThomas%26aufirst%3DD.%2BP.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DCandida%2520biofilms%253A%2520an%2520update%26jtitle%3DEukaryotic%2520Cell%26date%3D2005%26volume%3D4%26spage%3D633%26epage%3D638%26doi%3D10.1128%2FEC.4.4.633-638.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of simplified sampangine derivatives with potent antifungal activities against cryptococcal meningitis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1376</span>– <span class="NLM_lpage">1384</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFSnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1376-1384&author=Z.+Liauthor=N.+Liuauthor=J.+Tuauthor=C.+Jiauthor=G.+Hanauthor=C.+Sheng&title=Discovery+of+simplified+sampangine+derivatives+with+potent+antifungal+activities+against+cryptococcal+meningitis&doi=10.1021%2Facsinfecdis.9b00086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Simplified Sampangine Derivatives with Potent Antifungal Activities against Cryptococcal Meningitis</span></div><div class="casAuthors">Li, Zhuang; Liu, Na; Tu, Jie; Ji, Changjin; Han, Guiyan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1376-1384</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cryptococcal meningitis (CM) is assocd. with high morbidity and mortality.  Current antifungal drug therapy for CM is suffered from limited efficacy, significant side effects, emerging drug resistance and unavailability in highly needed countries.  There is an urgent need to develop novel CM therapeutic agents with new mode of action.  On the basis of antifungal natural product sampangine, herein novel simplified isoxazole derivs. were identified to possess excellent inhibitory activity against C. neoformans.  Particularly, compd. 9a was highly active (the min. inhibitory concn. of 80% inhibition, MIC80 = 0.031 g/mL) and significantly inhibited biofilm formation, melanin and urease prodn. of C. neoformans. 9a had good blood-brain barrier (BBB) permeability and effectively reduced the brain fungal burden in a murine model of cryptococcosis.  The antifungal mechanism of compd. 9a was preliminarily investigated by transmission electron microscopy and flow cytometry.  It was able to cause necrocytosis of C. neoformans cells and arrest cell cycle in the G1/S phase.  Isoxazole compd. 9a represents a promising lead compd. for the development of novel CM therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjXA7DwyJALVg90H21EOLACvtfcHk0lhtclu9A_TTdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFSnsr8%253D&md5=8cd4186f57329e3add7bcbef69fcd8ff</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00086%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520simplified%2520sampangine%2520derivatives%2520with%2520potent%2520antifungal%2520activities%2520against%2520cryptococcal%2520meningitis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1376%26epage%3D1384%26doi%3D10.1021%2Facsinfecdis.9b00086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.01.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.bmc.2019.01.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=30711309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFGlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=832-840&author=Z.+Liauthor=N.+Liuauthor=J.+Tuauthor=C.+Jiauthor=G.+Hanauthor=Y.+Wangauthor=C.+Sheng&title=Discovery+of+novel+simplified+isoxazole+derivatives+of+sampangine+as+potent+anti-cryptococcal+agents&doi=10.1016%2Fj.bmc.2019.01.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents</span></div><div class="casAuthors">Li, Zhuang; Liu, Na; Tu, Jie; Ji, Changjin; Han, Guiyan; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">832-840</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cryptococcus neoformans is the leading cause of cryptococcal meningitis, which is assocd. with high mortality due to lack of effective treatment.  Herein a series of tricyclic isoxazole derivs. with excellent anti-cryptococcal activities were identified by structural simplification and scaffold hopping of antifungal natural product sampangine.  Particularly, compd. 8a showed promising features as an anti-cryptococcal lead compd.  It was highly active against C. neoformans (MIC80 = 0.031 μg/mL), which was more potent than fluconazole and voriconazole.  Moreover, compd. 8a showed potent fungicidal activity and had potent inhibitory effects against important virulence factors (i.e. biofilm, melanin and urease) of C. neoformans.  Preliminary antifungal mechanism investigation revealed that compd. 8a induced apoptosis of C. neoformans cells and arrested the cell cycle at the G1/S phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiVD8NPSjWI7Vg90H21EOLACvtfcHk0lhtclu9A_TTdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFGlsrw%253D&md5=54803ec17da3e7749b4a5c233c2d0caf</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.01.029%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520simplified%2520isoxazole%2520derivatives%2520of%2520sampangine%2520as%2520potent%2520anti-cryptococcal%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D832%26epage%3D840%26doi%3D10.1016%2Fj.bmc.2019.01.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1510</span>– <span class="NLM_lpage">1523</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.ejmech.2017.10.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=29126739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1510-1523&author=N.+Liuauthor=H.+Zhongauthor=J.+Tuauthor=Z.+Jiangauthor=Y.+Jiangauthor=Y.+Jiangauthor=Y.+Jiangauthor=J.+Liauthor=W.+Zhangauthor=Y.+Wangauthor=C.+Sheng&title=Discovery+of+simplified+sampangine+derivatives+as+novel+fungal+biofilm+inhibitors&doi=10.1016%2Fj.ejmech.2017.10.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors</span></div><div class="casAuthors">Liu, Na; Zhong, Hua; Tu, Jie; Jiang, Zhigan; Jiang, Yanjuan; Jiang, Yan; Jiang, Yuanying; Li, Jian; Zhang, Wannian; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1510-1523</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Lack of novel antifungal agents and severe drug resistance have led to high incidence and assocd. mortality of invasive fungal infections.  To tackle the challenges, novel antifungal agents with new chemotype, fungicidal activity and anti-resistant potency are highly desirable.  On the basis of our previously identified simplified analog of antifungal natural product sampangine, systemic structure-activity relationships were clarified and two novel derivs. showed promising features as novel antifungal lead compds.  Compds. 22b and 22c showed good fungicidal activity against both fluconazole-sensitive and fluconazole-resistant Candida albicans strains.  Moreover, they were proven to be potent inhibitors of Candida albicans biofilm formation and yeast-to-hypha morphol. transition by down-regulating biofilm-assocd. genes.  In a rat vaginal Candida albicans infection model, compds. 22b and 22c showed excellent therapeutic effects with low toxicity.  The results highlighted the potential of sampangine derivs. to overcome fluconazole-related and biofilm-related drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFASL-br-ge7Vg90H21EOLACvtfcHk0lhzQg-Dsnue8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gurfN&md5=6ddefd6790a57e46c77ed36d9ef2314b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520simplified%2520sampangine%2520derivatives%2520as%2520novel%2520fungal%2520biofilm%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1510%26epage%3D1523%26doi%3D10.1016%2Fj.ejmech.2017.10.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors as a novel strategy for the combinational treatment of leukemia and invasive fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6056</span>– <span class="NLM_lpage">6074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6056-6074&author=Y.+Huangauthor=G.+Dongauthor=H.+Liauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+janus+kinase+2+%28JAK2%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors+as+a+novel+strategy+for+the+combinational+treatment+of+leukemia+and+invasive+fungal+infections&doi=10.1021%2Facs.jmedchem.8b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections</span></div><div class="casAuthors">Huang, Yahui; Dong, Guoqiang; Li, Huanqiu; Liu, Na; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6056-6074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin., leukemia patients often suffer from the limited efficacy of chemotherapy and high risks of infection by invasive fungal pathogens.  Herein, a novel therapeutic strategy was developed in which a small mol. can simultaneously treat leukemia and invasive fungal infections (IFIs).  Novel Janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors were identified to possess potent anti-proliferative activity toward hematol. cell lines and excellent synergistic effects with fluconazole to treat resistant Candida albicans infections.  In particular, compd. I, a highly active and selective JAK2/HDAC6 dual inhibitor, showed excellent in vivo antitumor efficacy in several acute myeloid leukemia (AML) models and synergized with fluconazole for the treatment of resistant C. albicans infections.  This study highlights the therapeutic potential of JAK2/HDAC dual inhibitors in treating AML and IFIs and provides an efficient strategy for multitargeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_ii7EQG1qLVg90H21EOLACvtfcHk0ljGxHy8OtgyYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN&md5=ba7cf74761120f0526ab520196e3dded</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00393%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520janus%2520kinase%25202%2520%2528JAK2%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%2520as%2520a%2520novel%2520strategy%2520for%2520the%2520combinational%2520treatment%2520of%2520leukemia%2520and%2520invasive%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6056%26epage%3D6074%26doi%3D10.1021%2Facs.jmedchem.8b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing of haloperidol: discovery of new benzocyclane derivatives as potent antifungal agents against Cryptococcosis and Candidiasis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVCntrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=768-786&author=C.+Jiauthor=N.+Liuauthor=J.+Tuauthor=Z.+Liauthor=G.+Hanauthor=J.+Liauthor=C.+Sheng&title=Drug+repurposing+of+haloperidol%3A+discovery+of+new+benzocyclane+derivatives+as+potent+antifungal+agents+against+Cryptococcosis+and+Candidiasis&doi=10.1021%2Facsinfecdis.9b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Repurposing of Haloperidol: Discovery of New Benzocyclane Derivatives as Potent Antifungal Agents against Cryptococcosis and Candidiasis</span></div><div class="casAuthors">Ji, Changjin; Liu, Na; Tu, Jie; Li, Zhuang; Han, Guiyan; Li, Jian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">768-786</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the high morbidity and mortality of invasive fungal infections (IFIs), effective and safe antifungal agents are rather limited.  Starting from antifungal lead compd. haloperidol that was identified by drug repurposing, a series of novel benzocyclane derivs. were designed, synthesized, and assayed.  Several compds. showed improved antifungal potency and broader antifungal spectra.  Particularly, compd. B10 showed good inhibitory activities against a variety of fungal pathogens and was proven to be an inhibitor of several virulence factors important for drug resistance.  In the in vivo cryptococcosis and candidiasis models, compd. B10 could effectively reduce the brain fungal burden of Cryptococcus neoformans and synergize with fluconazole to treat resistant Candida albicans infections.  Preliminary antifungal mechanism studies revealed that compd. B10 regained cell membrane damage and down-regulated the overexpression of ERG11 and MDR1 genes when used in combination with fluconazole.  Taken together, haloperidol deriv. B10 represents a promising lead compd. for the development of a new generation of antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqOebtJuo-ULVg90H21EOLACvtfcHk0ljGxHy8OtgyYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVCntrfI&md5=b29fcf3a83254706c510431ee254eb3f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00197%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDrug%2520repurposing%2520of%2520haloperidol%253A%2520discovery%2520of%2520new%2520benzocyclane%2520derivatives%2520as%2520potent%2520antifungal%2520agents%2520against%2520Cryptococcosis%2520and%2520Candidiasis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D768%26epage%3D786%26doi%3D10.1021%2Facsinfecdis.9b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of carboline compounds as novel fungal HDAC inhibitors. The fraction inhibitory concentration index (FICI) is defined as the sum of the ratios that divide the MIC value of each drug used in combination by the value of the drug used alone. Synergism and antagonism were defined by FICIs of ≤0.5 and >4, respectively. An FICI > 0.5 but <4 is considered irrelevant. The subfigure at the bottom right is the antifungal activity in the form of a heat map measured by the checkerboard microdilution assay. The relative growth of fungi (0–1.5) changes from green to black (the greener the color, the stronger the inhibition).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Chemical Synthesis of Carboline Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span><b>Reagents and conditions:</b> (a) K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>OH, yield 64%; (b) NaH, dimethylformamide (DMF), yield 24–85%; (c) trifluoroacetic acid (TFA), CH<sub>2</sub>Cl<sub>2</sub>; and (d) KOH, NH<sub>2</sub>OH·HCl, and CH<sub>3</sub>OH, yield 31–84%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>D12</b> cooperates with FLC to block the emergence of drug resistance and plays a major role in the synergistic process. (A) Compound <b>D12</b> blocks the emergence of FLC resistance in <i>C. albicans</i> (0304103). In total, 1 × 10<sup>4</sup> cells were plated on the Sabouraud Dextrose Agar (SDA) medium containing no drugs (Control), compound <b>D12</b> (8 μg/mL), FLC (32 μg/mL), or the combination. Plates were photographed 48 h after incubation at 35 °C. (B) FLC and compound <b>D12</b> are synergistic against <i>C. albicans</i>. Disks containing compound <b>D12</b> were plated on the plate containing FLC (32 μg/mL). The doses of compound <b>D12</b> on the disks were 32, 8, 2, and 0 μg from the top to the bottom. Experiments could be duplicated biologically. (C) Time growth curves of the <i>C. albicans</i> strain 0304103 under different concentrations of compounds. The initial concentration of <i>C. albicans</i> was 1.5 × 10<sup>6</sup> cells/mL. The number of cells was counted at a specific time point (0, 6, 12, 24, 48 h) and the concentration was calculated. (D) Time kill curves of <i>the C. albicans</i> strain 0304103 when compound <b>D12</b> (32 μg/mL) was used in combination with different concentrations of FLC. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibitory activity of compound <b>D12</b> and TBA against fungal (<i>C. albicans</i> 0304103) and human (HUVEC) total HDACs. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Expression of resistant genes of <i>C. albicans</i>. (A) Difference of <i>ERG11</i> expressed in each group. (B) Difference of <i>MDR1</i> expressed in each group. (C) Difference of <i>CDR1</i> expressed in each group. (D) Difference of <i>CDR2</i> expressed in each group. <i>C. albicans</i> (0304103) solution with initial concentrations of 1 × 10<sup>6</sup> cells/mL was divided into four groups, and, respectively, treated with DMSO (control), FLC (32 μg/mL), <b>D12</b> (32 μg/mL), and FLC + <b>D12</b> (32 + 32 μg/mL). RT-PCR was used to detect differences in the gene expression. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Hypha formation of <i>C. albicans</i> treated with <b>D12</b> and FLC alone or in combination. The initial concentration of <i>C. albicans</i> was 2 × 10<sup>6</sup> cells/mL. The Spider medium was used to induce the hyphae formation. The samples were observed and photographed after 3 h of incubation at 37 °C. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of biofilm formation and disruption of mature biofilms treated with <b>D12</b> and FLC alone or in combination. (A) Inhibition of biofilm formation of <i>C. albicans</i> treated with <b>D12</b> and FLC alone or in combination. (B) Disruption of preformed biofilms of <i>C. albicans</i> treated with <b>D12</b> and FLC alone or in combination. The initial concentration of <i>C. albicans solution</i> was 2 × 10<sup>6</sup> cells/mL. The comparison between the two components was completed by the <i>t</i>-test. *** <i>P</i> < 0.001 compared to the control group. Three independent experiments were performed.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/medium/jm0c01763_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Combination of compound <b>D12</b> and FLC exhibits excellent therapeutic effects in mice candidiasis models. (A) Fungal burden in mice kidneys after treatment with different drugs. The infection model was established using 5 × 10<sup>5</sup> cells of <i>C. albicans</i> (0.04103) and the mice were divided into the control group, FLC group (1 mg/kg), <b>D12</b> group (10 mg/kg), and the combination group (FLC + <b>D12</b>, 1+10 mg/kg). The fungal burden of kidneys was determined after 5 days of treatment. The difference between the groups was compared by the <i>t</i>-test (* <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001, **** <i>p</i> <0.0001). (B) Kidney tissue sections after drug treatment in mouse models of candidiasis. (-) means treated with the vehicle, and the treatments were consistent with the kidney fungal burden experiment. The tissue was observed and photographed with a biological microscope under 40× and 200× fields of view, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-2/acs.jmedchem.0c01763/20210121/images/large/jm0c01763_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01763&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Denning, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bromley, M. J.</span></span> <span> </span><span class="NLM_article-title">Infectious Disease. How to bolster the antifungal pipeline</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1416</span>, <span class="refDoi"> DOI: 10.1126/science.aaa6097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1126%2Fscience.aaa6097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=25814567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFyksbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2015&pages=1414-1416&author=D.+W.+Denningauthor=M.+J.+Bromley&title=Infectious+Disease.+How+to+bolster+the+antifungal+pipeline&doi=10.1126%2Fscience.aaa6097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How to bolster the antifungal pipeline</span></div><div class="casAuthors">Denning, David W.; Bromley, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">6229</span>),
    <span class="NLM_cas:pages">1414-1416</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYf6ts4qXAj7Vg90H21EOLACvtfcHk0liT696HzazWEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFyksbY%253D&md5=ebd5ad0fc0f5e6225a4d9fff63149d6b</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1126%2Fscience.aaa6097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aaa6097%26sid%3Dliteratum%253Aachs%26aulast%3DDenning%26aufirst%3DD.%2BW.%26aulast%3DBromley%26aufirst%3DM.%2BJ.%26atitle%3DInfectious%2520Disease.%2520How%2520to%2520bolster%2520the%2520antifungal%2520pipeline%26jtitle%3DScience%26date%3D2015%26volume%3D347%26spage%3D1414%26epage%3D1416%26doi%3D10.1126%2Fscience.aaa6097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gullo, A.</span></span> <span> </span><span class="NLM_article-title">Invasive fungal infections: the challenge continues</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">73</span>, <span class="refDoi"> DOI: 10.2165/11315530-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.2165%2F11315530-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=19877737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BD1MjmslShtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2009&pages=65-73&author=A.+Gullo&title=Invasive+fungal+infections%3A+the+challenge+continues&doi=10.2165%2F11315530-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive fungal infections: the challenge continues</span></div><div class="casAuthors">Gullo Antonino</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">69 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">65-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Invasive fungal infections (IFIs) are being increasingly recognized as a major threat in critically ill adult and paediatric patients.  They can range widely in severity and can be life threatening in some patients.  Candida and Aspergillus species are the most common causes of IFIs, but other yeasts and filamentous fungi are emerging pathogens.  C. albicans, the most significant pathogenic species, is seen in almost all of the 17% of patients treated in the intensive care unit (ICU) who develop IFIs, and is associated with significant morbidity and mortality.  Non-albicans spp. are becoming more common, particularly in neutropenic patients and those on existing azole therapy.  Early diagnosis is challenging due to delays in, and low sensitivity of, confirmatory blood cultures, and difficulty in discriminating colonization from invasive candidiasis.  Once diagnosed, early initiation of appropriate antifungal therapy is essential for reducing morbidity and mortality.  Amphotericin B deoxycholate and azoles, once standard therapy, have been largely superseded in the ICU by broad-spectrum azoles, liposomal amphotericin B and the newer echinocandin agents with improved efficacy/tolerability profiles.  The echinocandins (caspofungin, micafungin and anidulafungin) exhibit fungicidal activity against Candida spp. and fungistatic activity against Aspergillus spp.  Echinocandins have demonstrated clinical efficacy, broad spectrum of activity and favourable pharmacological properties, and are, therefore, likely to replace fluconazole as the initial antifungal agent of choice among critically ill patients.  Current evidence supports echinocandin empirical therapy for candidaemia or invasive candidiasis in ICU patients with or without neutropenia, and as rescue therapy in patients with life-threatening IFIs caused by strains resistant to other antifungals.  Anidulafungin represents a new advance in the treatment of IFIs and is approved for treatment of candidaemia, intra-abdominal abscesses, peritonitis and oesophageal candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNrRccr0OgNkodMGTatQ7LfW6udTcc2eZx8T6zFZpHxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MjmslShtg%253D%253D&md5=bfa1f73bab6c2adae6a6bf265cf32310</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2165%2F11315530-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11315530-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DGullo%26aufirst%3DA.%26atitle%3DInvasive%2520fungal%2520infections%253A%2520the%2520challenge%2520continues%26jtitle%3DDrugs%26date%3D2009%26volume%3D69%26spage%3D65%26epage%3D73%26doi%3D10.2165%2F11315530-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mylonakis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y. Y.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo activities of pterostilbene against <i>Candida albicans</i> biofilms</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">2344</span>– <span class="NLM_lpage">2355</span>, <span class="refDoi"> DOI: 10.1128/AAC.01583-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FAAC.01583-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=24514088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2cXovVSmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=2344-2355&author=D.+D.+Liauthor=L.+X.+Zhaoauthor=E.+Mylonakisauthor=G.+H.+Huauthor=Y.+Zouauthor=T.+K.+Huangauthor=L.+Yanauthor=Y.+Wangauthor=Y.+Y.+Jiang&title=In+vitro+and+in+vivo+activities+of+pterostilbene+against+Candida+albicans+biofilms&doi=10.1128%2FAAC.01583-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo activities of pterostilbene against Candida albicans biofilms</span></div><div class="casAuthors">Li, De-Dong; Zhao, Lan-Xue; Mylonakis, Eleftherios; Hu, Gan-Hai; Zou, Yong; Huang, Tong-Kun; Yan, Lan; Wang, Yan; Jiang, Yuan-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2344-2355, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Pterostilbene (PTE) is a stilbene-derived phytoalexin that originates from several natural plant sources.  In this study, we evaluated the activity of PTE against Candida albicans biofilms and explored the underlying mechanisms.  In 2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) redn. assays, biofilm biomass measurement, confocal laser scanning microscopy, and SEM, we found that ≤16 μg/mL PTE had a significant effect against C. albicans biofilms in vitro, while it had no fungicidal effect on planktonic C. albicans cells, which suggested a unique antibiofilm effect of PTE.  Then we found that PTE could inhibit biofilm formation and destroy the maintenance of mature biofilms.  At 4 μg/mL, PTE decreased cellular surface hydrophobicity (CSH) and suppressed hyphal formation.  Gene expression microarrays and real-time reverse transcription-PCR showed that exposure of C. albicans to 16 μg/mL PTE altered the expression of genes that function in morphol. transition, ergosterol biosynthesis, oxidoreductase activity, and cell surface and protein unfolding processes (heat shock proteins).  Filamentation-related genes, esp. those regulated by the Ras/cAMP (cAMP) pathway, including ECE1, ALS3, HWP1, HGC1, and RAS1 itself, were downregulated upon PTE treatment, indicating that the antibiofilm effect of PTE was related to the Ras/cAMP pathway.  Then, we found that the addn. of exogenous cAMP reverted the PTE-induced filamentous growth defect.  Finally, with a rat central venous catheter infection model, we confirmed the in vivo activity of PTE against C. albicans biofilms.  Collectively, PTE had strong activities against C. albicans biofilms both in vitro and in vivo, and these activities were assocd. with the Ras/cAMP pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcxr9Baao5_rVg90H21EOLACvtfcHk0liVzFIKmA-gCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXovVSmtLk%253D&md5=b9e37b735cb17649b909b30cc4703713</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FAAC.01583-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01583-13%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%2BD.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DMylonakis%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DG.%2BH.%26aulast%3DZou%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DT.%2BK.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%2BY.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520activities%2520of%2520pterostilbene%2520against%2520Candida%2520albicans%2520biofilms%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D2344%26epage%3D2355%26doi%3D10.1128%2FAAC.01583-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garnaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Champleboux, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maubon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govin, J.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylases and their inhibition in Candida species</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1238</span>, <span class="refDoi"> DOI: 10.3389/fmicb.2016.01238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.3389%2Ffmicb.2016.01238" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=27547205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1238&author=C.+Garnaudauthor=M.+Champlebouxauthor=D.+Maubonauthor=M.+Cornetauthor=J.+Govin&title=Histone+deacetylases+and+their+inhibition+in+Candida+species&doi=10.3389%2Ffmicb.2016.01238"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Histone Deacetylases and Their Inhibition in Candida Species</span></div><div class="casAuthors">Garnaud Cecile; Maubon Daniele; Cornet Muriel; Champleboux Morgane; Govin Jerome</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1238</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Fungi are generally benign members of the human mucosal flora or live as saprophytes in the environment.  However, they can become pathogenic, leading to invasive and life threatening infections in vulnerable patients.  These invasive fungal infections are regarded as a major public health problem on a similar scale to tuberculosis or malaria.  Current treatment for these infections is based on only four available drug classes.  This limited therapeutic arsenal and the emergence of drug-resistant strains are a matter of concern due to the growing number of patients to be treated, and new therapeutic strategies are urgently needed.  Adaptation of fungi to drug pressure involves transcriptional regulation, in which chromatin dynamics and histone modifications play a major role.  Histone deacetylases (HDACs) remove acetyl groups from histones and actively participate in controlling stress responses.  HDAC inhibition has been shown to limit fungal development, virulence, biofilm formation, and dissemination in the infected host, while also improving the efficacy of existing antifungal drugs toward Candida spp.  In this article, we review the functional roles of HDACs and the biological effects of HDAC inhibitors on Candida spp., highlighting the correlations between their pathogenic effects in vitro and in vivo.  We focus on how HDAC inhibitors could be used to treat invasive candidiasis while also reviewing recent developments in their clinical evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqH6RST9Bi-Ebxh97K6Vt6fW6udTcc2eYlIrQfLp8oybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szjtVKisw%253D%253D&md5=73b9e6f664ac8652a3220c7757952ae6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2016.01238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2016.01238%26sid%3Dliteratum%253Aachs%26aulast%3DGarnaud%26aufirst%3DC.%26aulast%3DChampleboux%26aufirst%3DM.%26aulast%3DMaubon%26aufirst%3DD.%26aulast%3DCornet%26aufirst%3DM.%26aulast%3DGovin%26aufirst%3DJ.%26atitle%3DHistone%2520deacetylases%2520and%2520their%2520inhibition%2520in%2520Candida%2520species%26jtitle%3DFront.%2520Microbiol.%26date%3D2016%26volume%3D7%26spage%3D1238%26doi%3D10.3389%2Ffmicb.2016.01238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ostrosky-Zeichner, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadevall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galgiani, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Odds, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, J. H.</span></span> <span> </span><span class="NLM_article-title">An insight into the antifungal pipeline: selected new molecules and beyond</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">719</span>, <span class="refDoi"> DOI: 10.1038/nrd3074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1038%2Fnrd3074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=20725094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCmurvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=719&author=L.+Ostrosky-Zeichnerauthor=A.+Casadevallauthor=J.+N.+Galgianiauthor=F.+C.+Oddsauthor=J.+H.+Rex&title=An+insight+into+the+antifungal+pipeline%3A+selected+new+molecules+and+beyond&doi=10.1038%2Fnrd3074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">An insight into the antifungal pipeline: selected new molecules and beyond</span></div><div class="casAuthors">Ostrosky-Zeichner, Luis; Casadevall, Arturo; Galgiani, John N.; Odds, Frank C.; Rex, John H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">719-727</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Invasive fungal infections are increasing in incidence and are assocd. with substantial mortality.  Improved diagnostics and the availability of new antifungals have revolutionized the field of medical mycol. in the past decades.  This Review focuses on recent developments in the antifungal pipeline, concg. on promising candidates such as new azoles, polyenes and echinocandins, as well as agents such as nikkomycin Z and the sordarins.  Developments in vaccines and antibody-based immunotherapy are also discussed.  Few therapeutic products are currently in active development, and progression of therapeutic agents with fungus-specific mechanisms of action is of key importance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-y4lzJruauLVg90H21EOLACvtfcHk0liwEfxhMvUP0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCmurvK&md5=d7ccb58b653d567179e53437061df80e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd3074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3074%26sid%3Dliteratum%253Aachs%26aulast%3DOstrosky-Zeichner%26aufirst%3DL.%26aulast%3DCasadevall%26aufirst%3DA.%26aulast%3DGalgiani%26aufirst%3DJ.%2BN.%26aulast%3DOdds%26aufirst%3DF.%2BC.%26aulast%3DRex%26aufirst%3DJ.%2BH.%26atitle%3DAn%2520insight%2520into%2520the%2520antifungal%2520pipeline%253A%2520selected%2520new%2520molecules%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D719%26doi%3D10.1038%2Fnrd3074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nicola, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albuquerque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paes, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kioshima, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadio, A. K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocca, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felipe, M. S.</span></span> <span> </span><span class="NLM_article-title">Antifungal drugs: new insights in research & development</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">21</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2018.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.pharmthera.2018.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=30347212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2019&pages=21-38&author=A.+M.+Nicolaauthor=P.+Albuquerqueauthor=H.+C.+Paesauthor=L.+Fernandesauthor=F.+F.+Costaauthor=E.+S.+Kioshimaauthor=A.+K.+R.+Abadioauthor=A.+L.+Boccaauthor=M.+S.+Felipe&title=Antifungal+drugs%3A+new+insights+in+research+%26+development&doi=10.1016%2Fj.pharmthera.2018.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Antifungal drugs: New insights in research & development</span></div><div class="casAuthors">Nicola, Andre Moraes; Albuquerque, Patricia; Paes, Hugo Costa; Fernandes, Larissa; Costa, Fabricio F.; Kioshima, Erika Seki; Abadio, Ana Karina Rodrigues; Bocca, Anamelia Lorenzetti; Felipe, Maria Sueli</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">195</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">21-38</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The need for better antifungal therapy is commonly accepted in view of the high mortality rates assocd. with systemic infections, the low no. of available antifungal classes, their assocd. toxicity and the increasing no. of infections caused by strains with natural or acquired resistance.  The urgency to expand the range of therapeutic options for the treatment of fungal infections has led researchers in recent decades to seek alternative antifungal targets when compared to the conventional ones currently used.  Although new potential targets are reported, translating the discoveries from bench to bedside is a long process and most of these drugs fail to reach the patients.  In this review, we discuss the development of antifungal drugs focusing on the approach of drug repurposing and the search for novel drugs for classical targets, the most recently described gene targets for drug development, the possibilities of immunotherapy using antibodies, cytokines, therapeutic vaccines and antimicrobial peptides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOHI9vLKZwzbVg90H21EOLACvtfcHk0li-It_3rLpWug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVWisrzJ&md5=c4dc91ed5580dcd7b09e2b03b5680382</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2018.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2018.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DNicola%26aufirst%3DA.%2BM.%26aulast%3DAlbuquerque%26aufirst%3DP.%26aulast%3DPaes%26aufirst%3DH.%2BC.%26aulast%3DFernandes%26aufirst%3DL.%26aulast%3DCosta%26aufirst%3DF.%2BF.%26aulast%3DKioshima%26aufirst%3DE.%2BS.%26aulast%3DAbadio%26aufirst%3DA.%2BK.%2BR.%26aulast%3DBocca%26aufirst%3DA.%2BL.%26aulast%3DFelipe%26aufirst%3DM.%2BS.%26atitle%3DAntifungal%2520drugs%253A%2520new%2520insights%2520in%2520research%2520%2526%2520development%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D195%26spage%3D21%26epage%3D38%26doi%3D10.1016%2Fj.pharmthera.2018.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, R.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, B.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, R.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, P.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.-Y.</span></span> <span> </span><span class="NLM_article-title">Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant <i>Candida albicans</i>: endogenous ROS augmentation</span>. <i>J. Proteome Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">5296</span>– <span class="NLM_lpage">5304</span>, <span class="refDoi"> DOI: 10.1021/pr9005074</span> </span><div class="citationLinks">[<a href="/doi/10.1021/pr9005074" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFOqtb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=5296-5304&author=Y.+Xuauthor=Y.+Wangauthor=L.+Yanauthor=R.-M.+Liangauthor=B.-D.+Daiauthor=R.-J.+Tangauthor=P.-H.+Gaoauthor=Y.-Y.+Jiang&title=Proteomic+analysis+reveals+a+synergistic+mechanism+of+fluconazole+and+berberine+against+fluconazole-resistant+Candida+albicans%3A+endogenous+ROS+augmentation&doi=10.1021%2Fpr9005074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: Endogenous ROS augmentation</span></div><div class="casAuthors">Xu, Yi; Wang, Yan; Yan, Lan; Liang, Rong-Mei; Dai, Bao-Di; Tang, Ren-Jie; Gao, Ping-Hui; Jiang, Yuan-Ying</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Proteome Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">5296-5304</span>CODEN:
                <span class="NLM_cas:coden">JPROBS</span>;
        ISSN:<span class="NLM_cas:issn">1535-3893</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A previous study showed that concomitant use of berberine (BBR) and fluconazole (FLC) provided a synergistic action against FLC-resistant Candida albicans (C. albicans) clin. strains in vitro.  To clarify the mechanism underlying this action, the authors performed a comparative proteomic study in untreated control cells and cells treated with FLC and/or BBR in 2 clin. strains of C. albicans resistant to FLC.  Their analyses identified 16 differentially expressed proteins, most of which were related to energy metab. (e.g., Gap1, Adh1, and Aco1).  Functional analyses revealed that FLC + BBR treatment increased mitochondrial membrane potential, decreased intracellular ATP level, inhibited ATP synthase activity, and increased generation of endogenous reactive oxygen species (ROS) in FLC-resistant strains.  In addn., checkerboard microdilution assay showed that addn. of antioxidant ascorbic acid or reduced glutathione reduced the synergistic antifungal activity of FLC + BBR significantly.  These results suggest that mitochondrial aerobic respiration shift and endogenous ROS augmentation contribute to the synergistic action of FLC + BBR against FLC-resistant C. albicans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe-555LzTQqLVg90H21EOLACvtfcHk0li-It_3rLpWug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFOqtb%252FE&md5=2240cc574a99bf927aa200b6dac3af7c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fpr9005074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fpr9005074%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DLiang%26aufirst%3DR.-M.%26aulast%3DDai%26aufirst%3DB.-D.%26aulast%3DTang%26aufirst%3DR.-J.%26aulast%3DGao%26aufirst%3DP.-H.%26aulast%3DJiang%26aufirst%3DY.-Y.%26atitle%3DProteomic%2520analysis%2520reveals%2520a%2520synergistic%2520mechanism%2520of%2520fluconazole%2520and%2520berberine%2520against%2520fluconazole-resistant%2520Candida%2520albicans%253A%2520endogenous%2520ROS%2520augmentation%26jtitle%3DJ.%2520Proteome%2520Res.%26date%3D2009%26volume%3D8%26spage%3D5296%26epage%3D5304%26doi%3D10.1021%2Fpr9005074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, D.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Invasive candidiasis in intensive care units in China: a multicentre prospective observational study</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>68</i></span>,  <span class="NLM_fpage">1660</span>– <span class="NLM_lpage">1668</span>, <span class="refDoi"> DOI: 10.1093/jac/dkt083</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1093%2Fjac%2Fdkt083" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=23543609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFCitbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2013&pages=1660-1668&author=F.+Guoauthor=Y.+Yangauthor=Y.+Kangauthor=B.+Zangauthor=W.+Cuiauthor=B.+Qinauthor=Y.+Qinauthor=Q.+Fangauthor=T.+Qinauthor=D.+Jiang&title=Invasive+candidiasis+in+intensive+care+units+in+China%3A+a+multicentre+prospective+observational+study&doi=10.1093%2Fjac%2Fdkt083"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Invasive candidiasis in intensive care units in China: a multicentre prospective observational study</span></div><div class="casAuthors">Guo, Fengmei; Yang, Yi; Kang, Yan; Zang, Bin; Cui, Wei; Qin, Bingyu; Qin, Yingzhi; Fang, Qiang; Qin, Tiehe; Jiang, Dongpo; Li, Weiqin; Gu, Qin; Zhao, Hongsheng; Liu, Dawei; Guan, Xiangdong; Li, Jianguo; Ma, Xiaochun; Yu, Kaijiang; Chan, Dechang; Yan, Jing; Tang, Yaoqing; Liu, Wei; Li, Ruoyu; Qiu, Haibo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1660-1668</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives To describe the epidemiol., microbiol. and management of invasive Candida infection (ICI) in intensive care units (ICUs) in China.  Methods A multicentre, prospective, observational study in 67 hospital ICUs across China.  Patients were ≥18 years old with clin. signs of infection and at least one of the following diagnostic criteria: (i) histopathol., cytopathol. or microscopic confirmation of yeast cells from a normally sterile site; (ii) at least one peripheral blood culture pos. for Candida; and (iii) pos. Candida culture from a normally sterile site.  The China-SCAN study is registered with ClinicalTrials.gov (NCT T01253954).  Results ICI incidence was 0.32% (306 patients/96 060 ICU admissions) and median time between ICU admission and diagnosis was 10.0 days.  Candida albicans was the most prevalent single isolate (41.8% of patients), although non-albicans species accounted for the majority of infections.  Diagnostic confirmation was based solely on at least one pos. blood culture in 290 (94.8%) cases.  Treatment was initiated after diagnostic confirmation in 166/268 (61.9%) patients.  Triazoles (62.7%) and echinocandins (34.2%) were the most commonly used antifungal agents; first-line therapy was typically fluconazole (37.7%).  The median duration of antifungal therapy was 14 days.  The mortality rate was 36.6% (112/306); the median time between diagnosis and death was 14.5 days.  Mortality was higher in older individuals, those with solid tumors, those with recent invasive mech. ventilation and those with a higher sequential organ failure assessment score at diagnostic confirmation.  Susceptibility to first-line antifungals was assocd. with lower mortality than dose-dependent susceptibility or complete resistance (P = 0.008).  Conclusions More infections were caused by non-albicans than Candida albicans strains.  The majority of patients were treated only after diagnostic confirmation, rather than empirically.  First-line antifungal susceptibility was assocd. with lower mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcDrKNy2pe8rVg90H21EOLACvtfcHk0lgFmcCM_gIp0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFCitbs%253D&md5=ee8da03375b5824d56745dc48a7d4869</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkt083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkt083%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DKang%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DQin%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DD.%26atitle%3DInvasive%2520candidiasis%2520in%2520intensive%2520care%2520units%2520in%2520China%253A%2520a%2520multicentre%2520prospective%2520observational%2520study%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2013%26volume%3D68%26spage%3D1660%26epage%3D1668%26doi%3D10.1093%2Fjac%2Fdkt083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Spitzer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, G. D.</span></span> <span> </span><span class="NLM_article-title">Combinatorial strategies for combating invasive fungal infections</span>. <i>Virulence</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">185</span>, <span class="refDoi"> DOI: 10.1080/21505594.2016.1196300</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1080%2F21505594.2016.1196300" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=27268286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGls7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=169-185&author=M.+Spitzerauthor=N.+Robbinsauthor=G.+D.+Wright&title=Combinatorial+strategies+for+combating+invasive+fungal+infections&doi=10.1080%2F21505594.2016.1196300"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial strategies for combating invasive fungal infections</span></div><div class="casAuthors">Spitzer, Michaela; Robbins, Nicole; Wright, Gerard D.</div><div class="citationInfo"><span class="NLM_cas:title">Virulence</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">169-185</span>CODEN:
                <span class="NLM_cas:coden">VIRUCS</span>;
        ISSN:<span class="NLM_cas:issn">2150-5608</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis, Inc.</span>)
        </div><div class="casAbstract">Invasive fungal infections are an important cause of human mortality and morbidity, particularly for immunocompromised populations.  However, there remains a paucity of antifungal drug treatments available to combat these fungal pathogens.  Further, antifungal compds. are plagued with problems such as host toxicity, fungistatic activity, and the emergence of drug resistance in pathogen populations.  A promising therapeutic strategy to increase drug effectiveness and mitigate the emergence of drug resistance is through the use of combination drug therapy.  In this review we describe the current arsenal of antifungals in medicine and elaborate on the benefits of combination therapy to expand our current antifungal drug repertoire.  We examine those antifungal combinations that have shown potential against fungal pathogens and discuss strategies being employed to discover novel combination therapeutics, in particular combining antifungal agents with non-antifungal bioactive compds.  The findings summarized in this review highlight the promise of combinatorial strategies in combating invasive mycosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvt4bQOjaNnrVg90H21EOLACvtfcHk0lgFmcCM_gIp0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGls7nJ&md5=4318a442233ec8cb8a59d319e84b35b1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1080%2F21505594.2016.1196300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F21505594.2016.1196300%26sid%3Dliteratum%253Aachs%26aulast%3DSpitzer%26aufirst%3DM.%26aulast%3DRobbins%26aufirst%3DN.%26aulast%3DWright%26aufirst%3DG.%2BD.%26atitle%3DCombinatorial%2520strategies%2520for%2520combating%2520invasive%2520fungal%2520infections%26jtitle%3DVirulence%26date%3D2017%26volume%3D8%26spage%3D169%26epage%3D185%26doi%3D10.1080%2F21505594.2016.1196300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowen, L. E.</span></span> <span> </span><span class="NLM_article-title">Using combination therapy to thwart drug resistance</span>. <i>Future Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1719</span>– <span class="NLM_lpage">1726</span>, <span class="refDoi"> DOI: 10.2217/fmb.15.68</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.2217%2Ffmb.15.68" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=26597425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVyktbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=1719-1726&author=J.+A.+Hillauthor=L.+E.+Cowen&title=Using+combination+therapy+to+thwart+drug+resistance&doi=10.2217%2Ffmb.15.68"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Using combination therapy to thwart drug resistance</span></div><div class="casAuthors">Hill, Jessica A.; Cowen, Leah E.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1719-1726</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Drug combination therapy is a promising strategy to extend the lifespan of our antimicrobials.  Drug combinations used in treatment must be carefully selected to minimize the evolution of resistance, either by carefully detg. drug pairs that hinder the acquisition of resistance mechanisms, or by screening for combinations that inhibit growth and show reduced vulnerability to resistance.  Modeling of interactions between drugs has provided intriguing insights into strategies for combination therapy deployment.  Ultimately, more rigorous clin. trials need to be performed to evaluate the lab. and modeling results and advance treatment options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY_0ohVLhTJbVg90H21EOLACvtfcHk0lgQSJ0BlGtHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVyktbzI&md5=a6834b1376682c02b4b631e4619d21d3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2217%2Ffmb.15.68&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb.15.68%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BA.%26aulast%3DCowen%26aufirst%3DL.%2BE.%26atitle%3DUsing%2520combination%2520therapy%2520to%2520thwart%2520drug%2520resistance%26jtitle%3DFuture%2520Microbiol.%26date%3D2015%26volume%3D10%26spage%3D1719%26epage%3D1726%26doi%3D10.2217%2Ffmb.15.68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlin, D. S.</span></span> <span> </span><span class="NLM_article-title">Coping with stress and the emergence of multidrug resistance in fungi</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">e1004668</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1371%2Fjournal.ppat.1004668" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=25790300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmtlSksbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&author=E.+Shorauthor=D.+S.+Perlin&title=Coping+with+stress+and+the+emergence+of+multidrug+resistance+in+fungi&doi=10.1371%2Fjournal.ppat.1004668"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Coping with stress and the emergence of multidrug resistance in fungi</span></div><div class="casAuthors">Shor, Erika; Perlin, David S.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1004668/1-e1004668/7</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">A review.  Frequent and prolonged exposures of fungal cells to antifungal drugs activate fungal stress responses, which both support the short-term cellular adaptation to the drugs and promote genetic instability to facilitate the emergence of stable drug resistant mutants refractory to therapy, including multidrug-resistant strains.  We focus on drug resistance in Candida species because of its clin. significance, esp. with the development of emerging multidrug resistance, and because mechanisms of drug resistance and stress-assocd. genetic instability are best studied in Candida.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomq9_8wt-FP7Vg90H21EOLACvtfcHk0lgQSJ0BlGtHVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmtlSksbk%253D&md5=13b2e0d6924a806b7796261606dd7580</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004668%26sid%3Dliteratum%253Aachs%26aulast%3DShor%26aufirst%3DE.%26aulast%3DPerlin%26aufirst%3DD.%2BS.%26atitle%3DCoping%2520with%2520stress%2520and%2520the%2520emergence%2520of%2520multidrug%2520resistance%2520in%2520fungi%26jtitle%3DPLoS%2520Pathog.%26date%3D2015%26volume%3D11%26doi%3D10.1371%2Fjournal.ppat.1004668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, W. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edlind, T. D.</span></span> <span> </span><span class="NLM_article-title">Histone deacetylase inhibitors enhance <i>Candida albicans</i> sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3532</span>– <span class="NLM_lpage">3539</span>, <span class="refDoi"> DOI: 10.1128/AAC.46.11.3532-3539.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FAAC.46.11.3532-3539.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=12384361" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=3532-3539&author=W.+L.+Smithauthor=T.+D.+Edlind&title=Histone+deacetylase+inhibitors+enhance+Candida+albicans+sensitivity+to+azoles+and+related+antifungals%3A+correlation+with+reduction+in+CDR+and+ERG+upregulation&doi=10.1128%2FAAC.46.11.3532-3539.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation</span></div><div class="casAuthors">Smith, W. Lamar; Edlind, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3532-3539</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Histone acetylation and deacetylation play important roles in eukaryotic gene regulation.  Several histone deacetylase (HDA) inhibitors have been characterized, including trichostatin A (TSA), apicidin, and sodium butyrate.  We tested their effects on Candida albicans in vitro growth, heat sensitivity, and germ tube formation; minimal effects were obsd.  However, there was a dramatic effect of TSA on C. albicans sensitivity to the azoles fluconazole, itraconazole, and miconazole.  Similar effects were obsd. with other HDA inhibitors and with the antifungals terbinafine and fenpropimorph, which target, as do azoles, enzymes in the ergosterol biosynthetic pathway.  In contrast, HDA inhibitors had minimal effect on the activities of amphotericin B, flucytosine, and echinocandin, which have unrelated targets.  Specifically, addn. of 3 μg of TSA/mL lowered the itraconazole MIC for five susceptible C. albicans isolates an av. of 2.7-fold at 24 h, but this increased to > 200-fold at 48 h.  Thus, the primary effect of TSA was a redn. in azole trailing.  TSA also enhanced itraconazole activity against Candida parapsilosis and Candida tropicalis but had no effect with four less related yeast species.  To examine the mol. basis for these effects, we studied expression of ERG genes (encoding azole and terbinafine targets) and CDR/MDR1 genes (encoding multidrug transporters) in C. albicans cells treated with fluconazole or terbinafine with or without TSA.  Both antifungals induced to various levels the expression of ERG1, ERG11, CDR1, and CDR2; addn. of TSA reduced this upregulation 50 to 100%.  This most likely explains the inhibition of azole and terbinafine trailing by TSA and, more generally, provides evidence that trailing is mediated by upregulation of target enzymes and multidrug transporters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4DpmS0neAOrVg90H21EOLACvtfcHk0lh0vy7EbatRaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xot1yktbc%253D&md5=8a372cf4fcb9077cf8b92c21b37792bf</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FAAC.46.11.3532-3539.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.46.11.3532-3539.2002%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DW.%2BL.%26aulast%3DEdlind%26aufirst%3DT.%2BD.%26atitle%3DHistone%2520deacetylase%2520inhibitors%2520enhance%2520Candida%2520albicans%2520sensitivity%2520to%2520azoles%2520and%2520related%2520antifungals%253A%2520correlation%2520with%2520reduction%2520in%2520CDR%2520and%2520ERG%2520upregulation%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2002%26volume%3D46%26spage%3D3532%26epage%3D3539%26doi%3D10.1128%2FAAC.46.11.3532-3539.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotili, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brosch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passariello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palamara, A. T.</span></span> <span> </span><span class="NLM_article-title">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in <i>Candida albicans</i></span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1225</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.12.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.bmcl.2006.12.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=17196388" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1221-1225&author=A.+Maiauthor=D.+Rotiliauthor=S.+Massaauthor=G.+Broschauthor=G.+Simonettiauthor=C.+Passarielloauthor=A.+T.+Palamara&title=Discovery+of+uracil-based+histone+deacetylase+inhibitors+able+to+reduce+acquired+antifungal+resistance+and+trailing+growth+in+Candida+albicans&doi=10.1016%2Fj.bmcl.2006.12.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans</span></div><div class="casAuthors">Mai, Antonello; Rotili, Dante; Massa, Silvio; Brosch, Gerald; Simonetti, Giovanna; Passariello, Claudio; Palamara, Anna Teresa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1221-1225</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Among fungal pathogens such as Candida albicans, acquired drug resistance has not been assocd. with plasmids or other transferable elements, but it is thought to involve primarily mutations and genetic or epigenetic phenomena.  This the authors to test some histone deacetylase inhibitors (HDACi) from their library, in combination with fluconazole, against C. albicans strains in vitro.  Among the tested compds., the two chloro-contg. uracil-hydroxamates 1c and 1d showed a strong redn. of the MIC values on Candida strains that show the trailing growth effect.  In this assay, 1c,d were more potent than SAHA, a well-known HDAC inhibitor, in reducing the Candida growth.  Compds. 1c,d as well as SAHA were able to inhibit the fluconazole-induced resistance induction in Candida cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgG2dBVCiTN7Vg90H21EOLACvtfcHk0lh0vy7EbatRaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvVyjsL8%253D&md5=459aca01b82b284070f9bfe6229aca3b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.12.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.12.028%26sid%3Dliteratum%253Aachs%26aulast%3DMai%26aufirst%3DA.%26aulast%3DRotili%26aufirst%3DD.%26aulast%3DMassa%26aufirst%3DS.%26aulast%3DBrosch%26aufirst%3DG.%26aulast%3DSimonetti%26aufirst%3DG.%26aulast%3DPassariello%26aufirst%3DC.%26aulast%3DPalamara%26aufirst%3DA.%2BT.%26atitle%3DDiscovery%2520of%2520uracil-based%2520histone%2520deacetylase%2520inhibitors%2520able%2520to%2520reduce%2520acquired%2520antifungal%2520resistance%2520and%2520trailing%2520growth%2520in%2520Candida%2520albicans%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1221%26epage%3D1225%26doi%3D10.1016%2Fj.bmcl.2006.12.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in <i>Candida albicans</i></span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1993</span>– <span class="NLM_lpage">2003</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1093%2Fjac%2Fdkv070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=25825380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OltbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2015&pages=1993-2003&author=X.+Liauthor=Q.+Caiauthor=H.+Meiauthor=X.+Zhouauthor=Y.+Shenauthor=D.+Liauthor=W.+Liu&title=The+Rpd3%2FHda1+family+of+histone+deacetylases+regulates+azole+resistance+in+Candida+albicans&doi=10.1093%2Fjac%2Fdkv070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans</span></div><div class="casAuthors">Li, Xiaofang; Cai, Qing; Mei, Huan; Zhou, Xiaowei; Shen, Yongnian; Li, Dongmei; Liu, Weida</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1993-2003</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Objectives: The histone deacetylase (HDAC) has recently been linked to the morphogenesis and virulence of yeast.  However, the effects of HDAC on antifungal susceptibility are not well understood.  We sought to characterize the action of histone deacetylation on azole resistance in Candida albicans and its possible mechanism of action.  Methods: A total of 40 C. albicans strains were studied.  Azole susceptibility with or without trichostatin A (TSA) was detd. according to the CLSI microdilution method.  The null mutants of HDA1 and RPD3 (genes targeted by TSA) were also investigated using drop-plate assays and a rapid acquisition of adaptation to the azole test.  Transcriptional levels of HDAC genes and efflux genes were quantified using RT-PCR for both the basal and fluconazole-induced conditions.  Results: The inhibition of HDACs by TSA (0.25 mg/L) markedly reduced the trailing growth and the growth of most C. albicans strains.  Trailing growth for C. albicans strains was decreased from 2-fold to 256-fold at 48 h.  The deletion of HDA1 or RPD3 increased the susceptibility to azoles compared with the WT strain.  The expression of HDA1 and RPD3 was up-regulated to different levels, and returned to the level of the susceptible parental strain when stable resistance had formed during the course of acquired fluconazole resistance both in vitro and in vivo.  Efflux genes were poorly expressed in mutant strains compared with those of the WT strain.  Conclusions: Our results indicate the important role of the Rpd3/Hda1 family in the development of azole resistance in C. albicans.  Histone deacetylation may govern the expression of genes related to the early stages of adaptation to azole stress, such as efflux pump genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvglqXcJdnsbVg90H21EOLACvtfcHk0ljWLlTcR9H_DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OltbvE&md5=34cf1e334db6d83f40c498cf9218eb8f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv070%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DThe%2520Rpd3%252FHda1%2520family%2520of%2520histone%2520deacetylases%2520regulates%2520azole%2520resistance%2520in%2520Candida%2520albicans%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2015%26volume%3D70%26spage%3D1993%26epage%3D2003%26doi%3D10.1093%2Fjac%2Fdkv070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pfaller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Georgopapadakou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besterman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diekema, D.</span></span> <span> </span><span class="NLM_article-title">Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">3797</span>– <span class="NLM_lpage">3804</span>, <span class="refDoi"> DOI: 10.1128/JCM.00618-09</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FJCM.00618-09" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=19794038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2009&pages=3797-3804&author=M.+Pfallerauthor=S.+Messerauthor=N.+Georgopapadakouauthor=L.+Martellauthor=J.+Bestermanauthor=D.+Diekema&title=Activity+of+MGCD290%2C+a+Hos2+histone+deacetylase+inhibitor%2C+in+combination+with+azole+antifungals+against+opportunistic+fungal+pathogens&doi=10.1128%2FJCM.00618-09"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens</span></div><div class="casAuthors">Pfaller, M. A.; Messer, S. A.; Georgopapadakou, N.; Martell, L. A.; Besterman, J. M.; Diekema, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Microbiology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3797-3804</span>CODEN:
                <span class="NLM_cas:coden">JCMIDW</span>;
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report on the in vitro activity of the Hos2 fungal histone deacetylase (HDAC) inhibitor MGCD290 (MethylGene, Inc.) in combination with azoles against azole-resistant yeasts and molds.  Susceptibility testing was performed by the CLSI M27-A3 and M38-A2 broth microdilution methods.  Testing of the combinations (MGCD290 in combination with fluconazole, posaconazole, or voriconazole) was performed by the checkerboard method.  The fractional inhibitory concns. were detd. and were defined as <0.5 for synergy, ≥0.5 but <4 for indifference, and ≥4 for antagonism.  Ninety-one isolates were tested, as follows: 30 Candida isolates, 10 Aspergillus isolates, 15 isolates of the Zygomycetes order, 10 Cryptococcus neoformans isolates, 8 Rhodotorula isolates, 8 Fusarium isolates, 5 Trichosporon isolates, and 5 Scedosporium isolates.  MGCD290 showed modest activity when it was used alone (MICs, 1 to 8 μg/mL) and was mostly active against azole-resistant yeasts, but the MICs against molds were high (16 to >32 μg/mL).  MGCD290 was synergistic with fluconazole against 55 (60%) of the 91 isolates, with posaconazole against 46 (51%) of the 91 isolates, and with voriconazole against 48 (53%) of the 91 isolates.  Synergy between fluconazole and MGCD290 was obsd. against 26/30 (87%) Candida isolates.  All 23 of the 91 Candida isolates that were not fluconazole susceptible demonstrated a reduced fluconazole MIC that crossed an interpretive breakpoint (e.g., resistant [MIC, ≥64 μg/mL] to susceptible [MIC, ≤8 μg/mL]) when fluconazole was combined with MGCD290 at 0.12 to 4 μg/mL.  The activity of fluconazole plus MGCD290 was also synergistic against 6/10 Aspergillus isolates.  Posaconazole plus MGCD290 demonstrated synergy against 14/15 Zygomycetes (9 Rhizopus isolates and 5 Mucor isolates).  Voriconazole plus MGCD290 demonstrated synergy against six of eight Fusarium isolates.  Thus, MGCD290 demonstrated in vitro synergy with azoles against the majority of clin. isolates tested, including many azole-resistant isolates and genera inherently resistant to azoles (e.g., Mucor and Fusarium).  Further evaluation of fungal HDAC inhibitor-azole combinations is indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLGHRgkGpZwbVg90H21EOLACvtfcHk0ljWLlTcR9H_DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGmsQ%253D%253D&md5=6e526ec447c1f9a383df80b9e1e42a7d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FJCM.00618-09&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.00618-09%26sid%3Dliteratum%253Aachs%26aulast%3DPfaller%26aufirst%3DM.%26aulast%3DMesser%26aufirst%3DS.%26aulast%3DGeorgopapadakou%26aufirst%3DN.%26aulast%3DMartell%26aufirst%3DL.%26aulast%3DBesterman%26aufirst%3DJ.%26aulast%3DDiekema%26aufirst%3DD.%26atitle%3DActivity%2520of%2520MGCD290%252C%2520a%2520Hos2%2520histone%2520deacetylase%2520inhibitor%252C%2520in%2520combination%2520with%2520azole%2520antifungals%2520against%2520opportunistic%2520fungal%2520pathogens%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2009%26volume%3D47%26spage%3D3797%26epage%3D3804%26doi%3D10.1128%2FJCM.00618-09" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel fungal lanosterol 14alpha-demethylase (CYP51)/histone deacetylase dual inhibitors to treat azole-resistant candidiasis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">5341</span>– <span class="NLM_lpage">5359</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00102</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00102" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BB38vgvVKhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=5341-5359&author=G.+Hanauthor=N.+Liuauthor=C.+Liauthor=J.+Tuauthor=Z.+Liauthor=C.+Sheng&title=Discovery+of+novel+fungal+lanosterol+14alpha-demethylase+%28CYP51%29%2Fhistone+deacetylase+dual+inhibitors+to+treat+azole-resistant+candidiasis&doi=10.1021%2Facs.jmedchem.0c00102"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Fungal Lanosterol 14α-Demethylase (CYP51)/Histone Deacetylase Dual Inhibitors to Treat Azole-Resistant Candidiasis</span></div><div class="casAuthors">Han Guiyan; Liu Na; Li Chenglan; Tu Jie; Li Zhuang; Sheng Chunquan; Li Chenglan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5341-5359</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Invasive fungal infections (particularly candidiasis) are emerging as severe infectious diseases worldwide.  Because of serious antifungal drug resistance, therapeutic efficacy of the current treatment for candidiasis is limited and associated with high mortality.  However, it is highly challenging to develop novel strategies and effective therapeutic agents to combat drug resistance.  Herein, the first generation of lanosterol 14α-demethylase (CYP51)-histone deacetylase (HDAC) dual inhibitors was designed, which exhibited potent antifungal activity against azole-resistant clinical isolates.  In particular, compounds 12h and 15j were highly active both in vitro and in vivo to treat azole-resistant candidiasis.  Antifungal mechanism studies revealed that they acted by blocking ergosterol biosynthesis and HDAC catalytic activity in fungus, suppressing the function of efflux pump, yeast-to-hypha morphological transition, and biofilm formation.  Therefore, CYP51-HDAC dual inhibitors represent a promising strategy to develop novel antifungal agents against azole-resistant candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6ZxFRPxDAcUg6wdEZmT2rfW6udTcc2eZfd6M_D8-ePLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38vgvVKhtg%253D%253D&md5=1e68d74d03f06e077b784cc0bf1b36ca</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00102%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520fungal%2520lanosterol%252014alpha-demethylase%2520%2528CYP51%2529%252Fhistone%2520deacetylase%2520dual%2520inhibitors%2520to%2520treat%2520azole-resistant%2520candidiasis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D5341%26epage%3D5359%26doi%3D10.1021%2Facs.jmedchem.0c00102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors as a novel strategy for the combinational treatment of leukemia and invasive fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6056</span>– <span class="NLM_lpage">6074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6056-6074&author=Y.+Huangauthor=G.+Dongauthor=H.+Liauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+janus+kinase+2+%28JAK2%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors+as+a+novel+strategy+for+the+combinational+treatment+of+leukemia+and+invasive+fungal+infections&doi=10.1021%2Facs.jmedchem.8b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections</span></div><div class="casAuthors">Huang, Yahui; Dong, Guoqiang; Li, Huanqiu; Liu, Na; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6056-6074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin., leukemia patients often suffer from the limited efficacy of chemotherapy and high risks of infection by invasive fungal pathogens.  Herein, a novel therapeutic strategy was developed in which a small mol. can simultaneously treat leukemia and invasive fungal infections (IFIs).  Novel Janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors were identified to possess potent anti-proliferative activity toward hematol. cell lines and excellent synergistic effects with fluconazole to treat resistant Candida albicans infections.  In particular, compd. I, a highly active and selective JAK2/HDAC6 dual inhibitor, showed excellent in vivo antitumor efficacy in several acute myeloid leukemia (AML) models and synergized with fluconazole for the treatment of resistant C. albicans infections.  This study highlights the therapeutic potential of JAK2/HDAC dual inhibitors in treating AML and IFIs and provides an efficient strategy for multitargeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_ii7EQG1qLVg90H21EOLACvtfcHk0ljLQLo_qjhGKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN&md5=ba7cf74761120f0526ab520196e3dded</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00393%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520janus%2520kinase%25202%2520%2528JAK2%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%2520as%2520a%2520novel%2520strategy%2520for%2520the%2520combinational%2520treatment%2520of%2520leukemia%2520and%2520invasive%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6056%26epage%3D6074%26doi%3D10.1021%2Facs.jmedchem.8b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of carboline derivatives as potent antifungal agents for the treatment of cryptococcal meningitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2376</span>– <span class="NLM_lpage">2389</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisl2mu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2376-2389&author=J.+Tuauthor=Z.+Liauthor=Y.+Jiangauthor=C.+Jiauthor=G.+Hanauthor=Y.+Wangauthor=N.+Liuauthor=C.+Sheng&title=Discovery+of+carboline+derivatives+as+potent+antifungal+agents+for+the+treatment+of+cryptococcal+meningitis&doi=10.1021%2Facs.jmedchem.8b01598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Carboline Derivatives as Potent Antifungal Agents for the Treatment of Cryptococcal Meningitis</span></div><div class="casAuthors">Tu, Jie; Li, Zhuang; Jiang, Yanjuan; Ji, Changjin; Han, Guiyan; Wang, Yan; Liu, Na; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2376-2389</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin. treatment of cryptococcal meningitis (CM) remains a significant challenge because of the lack of effective and safe drug therapies.  Developing novel CM therapeutic agents with novel chem. scaffolds and new modes of action is of great importance.  Herein, new β-hexahydrocarboline derivs. are shown to possess potent anticryptococcal activities.  In particular, compd. A4 showed potent in vitro and in vivo anticryptococcal activity with good metabolic stability and blood-brain barrier permeability.  Compd. A4 was orally active and could significantly reduce brain fungal burdens in a murine model of CM.  Moreover, compd. A4 could inhibit several virulence factors of Cryptococcus neoformans and might act by a new mode of action.  Preliminary mechanistic studies revealed that compd. A4 induced DNA double-stranded breaks and cell cycle arrest at the G2 phase by acting on the Cdc25c/CDK1/cyclin B pathway.  Taken together, β-hexahydrocarboline A4 represents a promising lead compd. for the development of next-generation CM therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQe-fb_pBnQLVg90H21EOLACvtfcHk0ljLQLo_qjhGKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisl2mu74%253D&md5=d2fb308a23bcbdf978ac9f7bfd3a86eb</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01598%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520carboline%2520derivatives%2520as%2520potent%2520antifungal%2520agents%2520for%2520the%2520treatment%2520of%2520cryptococcal%2520meningitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2376%26epage%3D2389%26doi%3D10.1021%2Facs.jmedchem.8b01598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gryder, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodji, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyelere, A. K.</span></span> <span> </span><span class="NLM_article-title">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">505</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.4155/fmc.12.3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.4155%2Ffmc.12.3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=22416777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=505-524&author=B.+E.+Gryderauthor=Q.+H.+Sodjiauthor=A.+K.+Oyelere&title=Targeted+cancer+therapy%3A+giving+histone+deacetylase+inhibitors+all+they+need+to+succeed&doi=10.4155%2Ffmc.12.3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed</span></div><div class="casAuthors">Gryder, Berkley E.; Sodji, Quaovi H.; Oyelere, Adegboyega K.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">505-524</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Histone deacetylase inhibitors (HDACis) have now emerged as a powerful new class of small-mol. therapeutics acting through the regulation of the acetylation states of histone proteins (a form of epigenetic modulation) and other non-histone protein targets.  Over 490 clin. trials have been initiated in the last 10 years, culminating in the approval of two structurally distinct HDACis-SAHA (vorinostat, Zolinza) and FK228 (romidepsin, Istodax).  However, the current HDACis have serious limitations, including ineffectively low concns. in solid tumors and cardiac toxicity, which is hindering their progress in the clinic.  Herein, we review the primary paradigms being pursued to overcome these hindrances, including HDAC isoform selectivity, localized administration, and targeting cap groups to achieve selective tissue and cell type distribution.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWwrW1IVCIULVg90H21EOLACvtfcHk0li525KR-pfWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVajsL8%253D&md5=234080d1b0862680a68062a03afee20c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4155%2Ffmc.12.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.12.3%26sid%3Dliteratum%253Aachs%26aulast%3DGryder%26aufirst%3DB.%2BE.%26aulast%3DSodji%26aufirst%3DQ.%2BH.%26aulast%3DOyelere%26aufirst%3DA.%2BK.%26atitle%3DTargeted%2520cancer%2520therapy%253A%2520giving%2520histone%2520deacetylase%2520inhibitors%2520all%2520they%2520need%2520to%2520succeed%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2012%26volume%3D4%26spage%3D505%26epage%3D524%26doi%3D10.4155%2Ffmc.12.3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, T. C.</span></span> <span> </span><span class="NLM_article-title">Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in <i>Candida albicans</i> isolates from a patient infected with human immunodeficiency virus</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">1482</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1128/AAC.41.7.1482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FAAC.41.7.1482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=9210670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADyaK2sXktlyrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1997&pages=1482-1487&author=T.+C.+White&title=Increased+mRNA+levels+of+ERG16%2C+CDR%2C+and+MDR1+correlate+with+increases+in+azole+resistance+in+Candida+albicans+isolates+from+a+patient+infected+with+human+immunodeficiency+virus&doi=10.1128%2FAAC.41.7.1482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus</span></div><div class="casAuthors">White, Theodore C.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1482-1487</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Resistance to antifungal drugs, specifically azoles such as fluconazole, in the opportunistic yeast Candida albicans has become an increasing problem in human immunodeficiency virus (HIV)-infected individuals.  The mol. mechanisms responsible for this resistance have only recently become apparent and can include alterations in the target enzyme of the azole drugs (lanosterol 14α demethylase [14DM]), or in various efflux pumps from both the ABC transporter and major facilitator gene families.  To det. which of these possible mechanisms was assocd. with the development of drug resistance in a particular case, mRNA levels have been studied in a series of 17 clin. isolates taken from a single HIV-infected patient over 2 yr, during which time the levels of fluconazole resistance of the strain increased over 200-fold.  Using Northern blot anal. of steady-state levels of total RNA from these isolates, we obsd. increased mRNA levels of ERG16 (the 14DM-encoding gene), CDR1 (an ABC transporter), and MDR1 (a major facilitator) in this series.  The timing of the increase in mRNA levels of each of these genes correlated with increases in fluconazole resistance of the isolates.  Increased mRNA levels were not obsd. for three other ABC transporters, two other genes in the ergosterol biosynthetic pathway, or the NADPH-cytochrome P 450 oxidoreductase gene that transfers electrons from NADPH to 14DM.  Increases in mRNA levels of ERG16 and CDR1 correlated with increased cross-resistance to ketoconazole and itraconazole but not to amphotericin B.  A compilation of the genetic alterations identified in this series suggests that resistance develops gradually and is the sum of several different changes, all of which contribute to the final resistant phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcePJcYuq0KrVg90H21EOLACvtfcHk0li525KR-pfWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlyrurw%253D&md5=4496d1afe63335deadeb234dae8b8a20</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1128%2FAAC.41.7.1482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.41.7.1482%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DT.%2BC.%26atitle%3DIncreased%2520mRNA%2520levels%2520of%2520ERG16%252C%2520CDR%252C%2520and%2520MDR1%2520correlate%2520with%2520increases%2520in%2520azole%2520resistance%2520in%2520Candida%2520albicans%2520isolates%2520from%2520a%2520patient%2520infected%2520with%2520human%2520immunodeficiency%2520virus%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1997%26volume%3D41%26spage%3D1482%26epage%3D1487%26doi%3D10.1128%2FAAC.41.7.1482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gow, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Veerdonk, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netea, M. G.</span></span> <span> </span><span class="NLM_article-title"><i>Candida albicans</i> morphogenesis and host defence: discriminating invasion from colonization</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">112</span>, <span class="refDoi"> DOI: 10.1038/nrmicro2711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1038%2Fnrmicro2711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=112&author=N.+A.+Gowauthor=F.+L.+Van+De+Veerdonkauthor=A.+J.+Brownauthor=M.+G.+Netea&title=Candida+albicans+morphogenesis+and+host+defence%3A+discriminating+invasion+from+colonization&doi=10.1038%2Fnrmicro2711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Candida albicans morphogenesis and host defence: discriminating invasion from colonization</span></div><div class="casAuthors">Gow, Neil A. R.; van de Veerdonk, Frank L.; Brown, Alistair J. P.; Netea, Mihai G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">112-122</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Candida albicans is a common fungal pathogen of humans that colonizes the skin and mucosal surfaces of most healthy individuals.  Until recently, little was known about the mechanisms by which mucosal antifungal defenses tolerate colonizing C. albicans but react strongly when hyphae of the same microorganism attempt to invade tissue.  In this Review, we describe the properties of yeast cells and hyphae that are relevant to their interaction with the host, and the immunol. mechanisms that differentially recognize colonizing vs. invading C. albicans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodWGRROO3XjrVg90H21EOLACvtfcHk0li525KR-pfWlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1aitr%252FK&md5=25b8e879677643c2bc01d78f7cf841a6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro2711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro2711%26sid%3Dliteratum%253Aachs%26aulast%3DGow%26aufirst%3DN.%2BA.%26aulast%3DVan%2BDe%2BVeerdonk%26aufirst%3DF.%2BL.%26aulast%3DBrown%26aufirst%3DA.%2BJ.%26aulast%3DNetea%26aufirst%3DM.%2BG.%26atitle%3DCandida%2520albicans%2520morphogenesis%2520and%2520host%2520defence%253A%2520discriminating%2520invasion%2520from%2520colonization%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2012%26volume%3D10%26spage%3D112%26doi%3D10.1038%2Fnrmicro2711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Midkiff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borochoff-Porte, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. I.</span></span> <span> </span><span class="NLM_article-title">Small molecule inhibitors of the <i>Candida albicans</i> budded-to-hyphal transition act through multiple signaling pathways</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e25395</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0025395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1371%2Fjournal.pone.0025395" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=21966518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtleisLjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=J.+Midkiffauthor=N.+Borochoff-Porteauthor=D.+Whiteauthor=D.+I.+Johnson&title=Small+molecule+inhibitors+of+the+Candida+albicans+budded-to-hyphal+transition+act+through+multiple+signaling+pathways&doi=10.1371%2Fjournal.pone.0025395"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways</span></div><div class="casAuthors">Midkiff, John; Borochoff-Porte, Nathan; White, Dylan; Johnson, Douglas I.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e25395</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The ability of the pathogenic yeast Candida albicans to interconvert between budded and hyphal growth states, herein termed the budded-to-hyphal transition (BHT), is important for C. albicans development and virulence.  The BHT is under the control of multiple cell signaling pathways that respond to external stimuli, including nutrient availability, high temp., and pH.  Previous studies identified 21 small mols. that could inhibit the C. albicans BHT in response to carbon limitation in Spider media.  However, the studies here show that the BHT inhibitors had varying efficacies in other hyphal-inducing media, reflecting their varying abilities to block signaling pathways assocd. with the different media.  Chem. epistasis analyses suggest that most, but not all, of the BHT inhibitors were acting through either the Efg1 or Cph1 signaling pathways.  Notably, the BHT inhibitor clozapine, a FDA-approved drug used to treat atypical schizophrenia by inhibiting G-protein-coupled dopamine receptors in the brain, and several of its functional analogs were shown to act at the level of the Gpr1 G-protein-coupled receptor.  These studies are the first step in detg. the target and mechanism of action of these BHT inhibitors, which may have therapeutic anti-fungal utility in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJiwxHhPivX7Vg90H21EOLACvtfcHk0ljPqjNHtgfSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtleisLjN&md5=4ecfde4d1a30b699489c63c06da2e320</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0025395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0025395%26sid%3Dliteratum%253Aachs%26aulast%3DMidkiff%26aufirst%3DJ.%26aulast%3DBorochoff-Porte%26aufirst%3DN.%26aulast%3DWhite%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DD.%2BI.%26atitle%3DSmall%2520molecule%2520inhibitors%2520of%2520the%2520Candida%2520albicans%2520budded-to-hyphal%2520transition%2520act%2520through%2520multiple%2520signaling%2520pathways%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0025395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yargosz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Case, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. I.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibitors of biofilm formation in laboratory and clinical isolates of <i>Candida albicans</i></span>. <i>J. Med. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">114</span>, <span class="refDoi"> DOI: 10.1099/jmm.0.034124-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1099%2Fjmm.0.034124-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=21903824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC38Xit1yiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=109-114&author=A.+Graldauthor=P.+Yargoszauthor=S.+Caseauthor=K.+Sheaauthor=D.+I.+Johnson&title=Small-molecule+inhibitors+of+biofilm+formation+in+laboratory+and+clinical+isolates+of+Candida+albicans&doi=10.1099%2Fjmm.0.034124-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibitors of biofilm formation in laboratory and clinical isolates of Candida albicans</span></div><div class="casAuthors">Grald, Ariel; Yargosz, Philip; Case, Samantha; Shea, Katelyn; Johnson, Douglas I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medical Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">109-114</span>CODEN:
                <span class="NLM_cas:coden">JMMIAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-2615</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">Candida albicans cells have the ability to form biofilms on biotic and abiotic surfaces, such as indwelling medical devices.  C. albicans cells can interconvert between budded and hyphal growth forms, herein termed the budded-to-hyphal transition (BHT), which is important for the formation of mature biofilms.  Previous work identified 23 small org. mols. that could inhibit the BHT but did not affect C. albicans cell viability or budded cell growth.  These BHT inhibitors were proposed to inhibit multiple signalling pathways regulating the BHT, many of which also regulate biofilm formation.  However, only three of the BHT inhibitors, buhytrinA, ETYA and CGP-37157, were capable of inhibiting in vitro biofilm formation of wild-type lab. C. albicans strains.  When clin. C. albicans isolates were examd. for their ability to form biofilms, only 11 of the 28 clin. isolates tested (39%) were capable of forming biofilms.  Although buhytrinA, ETYA and CGP-37157 could inhibit the BHT of all 28 clin. isolates, they were only able to inhibit biofilm formation of a subset of these clin. isolates, with ETYA having 100% efficacy.  These data indicate that the biofilm-forming capability of lab. and clin. isolates of C. albicans, as well as the efficacy of BHT inhibitors against these different isolates, can differ dramatically.  These differences between lab. and clin. isolates should be an important aspect to consider when examg. potentially new antifungal therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrI0PuHWl4AubVg90H21EOLACvtfcHk0ljPqjNHtgfSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xit1yiu7k%253D&md5=0e99283be7528ee0a2c3cde6aec4d231</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1099%2Fjmm.0.034124-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fjmm.0.034124-0%26sid%3Dliteratum%253Aachs%26aulast%3DGrald%26aufirst%3DA.%26aulast%3DYargosz%26aufirst%3DP.%26aulast%3DCase%26aufirst%3DS.%26aulast%3DShea%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DD.%2BI.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520biofilm%2520formation%2520in%2520laboratory%2520and%2520clinical%2520isolates%2520of%2520Candida%2520albicans%26jtitle%3DJ.%2520Med.%2520Microbiol.%26date%3D2012%26volume%3D61%26spage%3D109%26epage%3D114%26doi%3D10.1099%2Fjmm.0.034124-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Romo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaturvedi, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzell, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHardy, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of <i>Candida albicans</i> filamentation</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e01991</span>, <span class="refDoi"> DOI: 10.1128/mBio.01991-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FmBio.01991-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=29208749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=e01991&author=J.+A.+Romoauthor=C.+G.+Pierceauthor=A.+K.+Chaturvediauthor=A.+L.+Lazzellauthor=S.+F.+McHardyauthor=S.+P.+Savilleauthor=J.+L.+Lopez-Ribot&title=Development+of+anti-virulence+approaches+for+candidiasis+via+a+novel+series+of+small-molecule+inhibitors+of+Candida+albicans+filamentation&doi=10.1128%2FmBio.01991-17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Development of anti-virulence approaches for candidiasis via a novel series of small-molecule inhibitors of Candida albicans filamentation</span></div><div class="casAuthors">Romo, Jesus A.; Pierce, Christopher G.; Chaturvedi, Ashok K.; Lazzell, Anna L.; McHardy, Stanton F.; Saville, Stephen P.; Lopez-Ribot, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e01991-17/1-e01991-17/16</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">This leading compd. also demonstrated in vivo activity in clin. relevant murine models of invasive and oral candidiasis.  Overall, our results indicate that compds. within this series represent promising candidates for the development of novel anti-virulence approaches to combat C. albicans infections.  IMPORTANCE Since fungi are eukaryotes, there is a limited no. of fungusspecific targets and, as a result, the antifungal arsenal is exceedingly small.  Furthermore, the efficacy of antifungal treatment is compromised by toxicity and development of resistance.  As a consequence, fungal infections carry high morbidity and mortality rates, and there is an urgent but unmet need for novel antifungal agents.  One appealing strategy for antifungal drug development is to target pathogenetic mechanisms assocd. with infection.  In Candida albicans, one of the most common pathogenic fungi, morphogenetic transitions between yeast cells and filamentous hyphae represent a key virulence factor assocd. with the ability of fungal cells to invade tissues, cause damage, and form biofilms.  Here, we describe and characterize a novel small-mol. compd. capable of inhibiting C. albicans filamentation both in vitro and in vivo; as such, this compd. represents a leading candidate for the development of anti-virulence therapies against candidiasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGPhBx3db77Vg90H21EOLACvtfcHk0ljPqjNHtgfSog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKmtLjI&md5=6f14fbe603e993cc98c5364557f39440</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FmBio.01991-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.01991-17%26sid%3Dliteratum%253Aachs%26aulast%3DRomo%26aufirst%3DJ.%2BA.%26aulast%3DPierce%26aufirst%3DC.%2BG.%26aulast%3DChaturvedi%26aufirst%3DA.%2BK.%26aulast%3DLazzell%26aufirst%3DA.%2BL.%26aulast%3DMcHardy%26aufirst%3DS.%2BF.%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DDevelopment%2520of%2520anti-virulence%2520approaches%2520for%2520candidiasis%2520via%2520a%2520novel%2520series%2520of%2520small-molecule%2520inhibitors%2520of%2520Candida%2520albicans%2520filamentation%26jtitle%3DmBio%26date%3D2017%26volume%3D8%26spage%3De01991%26doi%3D10.1128%2FmBio.01991-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perlin, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span> <span> </span><span class="NLM_article-title">Update on antifungal drug resistance</span>. <i>Curr. Clin. Microbiol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1007/s40588-015-0015-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1007%2Fs40588-015-0015-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=26120512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A280%3ADC%252BC2srotlyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2015&pages=84-95&author=D.+S.+Perlinauthor=E.+Shorauthor=Y.+Zhao&title=Update+on+antifungal+drug+resistance&doi=10.1007%2Fs40588-015-0015-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Update on Antifungal Drug Resistance</span></div><div class="casAuthors">Perlin David S; Shor Erika; Zhao Yanan</div><div class="citationInfo"><span class="NLM_cas:title">Current clinical microbiology reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">84-95</span>
        ISSN:<span class="NLM_cas:issn">2196-5471</span>.
    </div><div class="casAbstract">Invasive fungal infections remain a major source of global morbidity and mortality, especially among patients with underlying immune suppression.  Successful patient management requires antifungal therapy.  Yet, treatment choices are restricted due to limited classes of antifungal agents and the emergence of antifungal drug resistance.  In some settings, the evolution of multidrug-resistant strains insensitive to several classes of antifungal agents is a major concern.  The resistance mechanisms responsible for acquired resistance are well characterized and include changes in drug target affinity and abundance, and reduction in the intracellular level of drug by biofilms and efflux pumps.  The development of high-level and multidrug resistance occurs through a stepwise evolution of diverse mechanisms.  The genetic factors that influence these mechanisms are emerging and they form a complex symphony of cellular interactions that enable the cell to adapt and/or overcome drug-induced stress.  Drivers of resistance involve a complex blend of host and microbial factors.  Understanding these mechanisms will facilitate development of better diagnostics and therapeutic strategies to overcome and prevent antifungal resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEJ37PEUcnpYYPsCkJIw00fW6udTcc2ebvtMaix_Winbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srotlyjsA%253D%253D&md5=ce67cbf7d55c1d1a871f6cfcc2066991</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs40588-015-0015-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40588-015-0015-1%26sid%3Dliteratum%253Aachs%26aulast%3DPerlin%26aufirst%3DD.%2BS.%26aulast%3DShor%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DUpdate%2520on%2520antifungal%2520drug%2520resistance%26jtitle%3DCurr.%2520Clin.%2520Microbiol.%2520Rep.%26date%3D2015%26volume%3D2%26spage%3D84%26epage%3D95%26doi%3D10.1007%2Fs40588-015-0015-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramage, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saville, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Ribot, J. L.</span></span> <span> </span><span class="NLM_article-title">Candida biofilms: an update</span>. <i>Eukaryotic Cell</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">638</span>, <span class="refDoi"> DOI: 10.1128/EC.4.4.633-638.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1128%2FEC.4.4.633-638.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=15821123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjvVGqsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=633-638&author=G.+Ramageauthor=S.+P.+Savilleauthor=D.+P.+Thomasauthor=J.+L.+Lopez-Ribot&title=Candida+biofilms%3A+an+update&doi=10.1128%2FEC.4.4.633-638.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Candida biofilms: An update</span></div><div class="casAuthors">Ramage, Gordon; Saville, Stephen P.; Thomas, Derek P.; Lopez-Ribot, Jose L.</div><div class="citationInfo"><span class="NLM_cas:title">Eukaryotic Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">633-638</span>CODEN:
                <span class="NLM_cas:coden">ECUEA2</span>;
        ISSN:<span class="NLM_cas:issn">1535-9778</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">A review on the formation of Candida albicans biofilms, the role of morphogenetic conversions in this process, quorum sensing in these biofilms, and mol. basis of resistance in Candida biofilms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnNeAtOtxBlbVg90H21EOLACvtfcHk0ljSPsr8zzVa1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjvVGqsLo%253D&md5=a1e605a815358b4f788a2f29d130b9c5</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FEC.4.4.633-638.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FEC.4.4.633-638.2005%26sid%3Dliteratum%253Aachs%26aulast%3DRamage%26aufirst%3DG.%26aulast%3DSaville%26aufirst%3DS.%2BP.%26aulast%3DThomas%26aufirst%3DD.%2BP.%26aulast%3DLopez-Ribot%26aufirst%3DJ.%2BL.%26atitle%3DCandida%2520biofilms%253A%2520an%2520update%26jtitle%3DEukaryotic%2520Cell%26date%3D2005%26volume%3D4%26spage%3D633%26epage%3D638%26doi%3D10.1128%2FEC.4.4.633-638.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of simplified sampangine derivatives with potent antifungal activities against cryptococcal meningitis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1376</span>– <span class="NLM_lpage">1384</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00086</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00086" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXptFSnsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1376-1384&author=Z.+Liauthor=N.+Liuauthor=J.+Tuauthor=C.+Jiauthor=G.+Hanauthor=C.+Sheng&title=Discovery+of+simplified+sampangine+derivatives+with+potent+antifungal+activities+against+cryptococcal+meningitis&doi=10.1021%2Facsinfecdis.9b00086"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Simplified Sampangine Derivatives with Potent Antifungal Activities against Cryptococcal Meningitis</span></div><div class="casAuthors">Li, Zhuang; Liu, Na; Tu, Jie; Ji, Changjin; Han, Guiyan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1376-1384</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cryptococcal meningitis (CM) is assocd. with high morbidity and mortality.  Current antifungal drug therapy for CM is suffered from limited efficacy, significant side effects, emerging drug resistance and unavailability in highly needed countries.  There is an urgent need to develop novel CM therapeutic agents with new mode of action.  On the basis of antifungal natural product sampangine, herein novel simplified isoxazole derivs. were identified to possess excellent inhibitory activity against C. neoformans.  Particularly, compd. 9a was highly active (the min. inhibitory concn. of 80% inhibition, MIC80 = 0.031 g/mL) and significantly inhibited biofilm formation, melanin and urease prodn. of C. neoformans. 9a had good blood-brain barrier (BBB) permeability and effectively reduced the brain fungal burden in a murine model of cryptococcosis.  The antifungal mechanism of compd. 9a was preliminarily investigated by transmission electron microscopy and flow cytometry.  It was able to cause necrocytosis of C. neoformans cells and arrest cell cycle in the G1/S phase.  Isoxazole compd. 9a represents a promising lead compd. for the development of novel CM therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgjXA7DwyJALVg90H21EOLACvtfcHk0ljSPsr8zzVa1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXptFSnsr8%253D&md5=8cd4186f57329e3add7bcbef69fcd8ff</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00086%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520simplified%2520sampangine%2520derivatives%2520with%2520potent%2520antifungal%2520activities%2520against%2520cryptococcal%2520meningitis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1376%26epage%3D1384%26doi%3D10.1021%2Facsinfecdis.9b00086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">840</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2019.01.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.bmc.2019.01.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=30711309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFGlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2019&pages=832-840&author=Z.+Liauthor=N.+Liuauthor=J.+Tuauthor=C.+Jiauthor=G.+Hanauthor=Y.+Wangauthor=C.+Sheng&title=Discovery+of+novel+simplified+isoxazole+derivatives+of+sampangine+as+potent+anti-cryptococcal+agents&doi=10.1016%2Fj.bmc.2019.01.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of novel simplified isoxazole derivatives of sampangine as potent anti-cryptococcal agents</span></div><div class="casAuthors">Li, Zhuang; Liu, Na; Tu, Jie; Ji, Changjin; Han, Guiyan; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">832-840</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cryptococcus neoformans is the leading cause of cryptococcal meningitis, which is assocd. with high mortality due to lack of effective treatment.  Herein a series of tricyclic isoxazole derivs. with excellent anti-cryptococcal activities were identified by structural simplification and scaffold hopping of antifungal natural product sampangine.  Particularly, compd. 8a showed promising features as an anti-cryptococcal lead compd.  It was highly active against C. neoformans (MIC80 = 0.031 μg/mL), which was more potent than fluconazole and voriconazole.  Moreover, compd. 8a showed potent fungicidal activity and had potent inhibitory effects against important virulence factors (i.e. biofilm, melanin and urease) of C. neoformans.  Preliminary antifungal mechanism investigation revealed that compd. 8a induced apoptosis of C. neoformans cells and arrested the cell cycle at the G1/S phase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiVD8NPSjWI7Vg90H21EOLACvtfcHk0ljSPsr8zzVa1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFGlsrw%253D&md5=54803ec17da3e7749b4a5c233c2d0caf</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2019.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2019.01.029%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DC.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520simplified%2520isoxazole%2520derivatives%2520of%2520sampangine%2520as%2520potent%2520anti-cryptococcal%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2019%26volume%3D27%26spage%3D832%26epage%3D840%26doi%3D10.1016%2Fj.bmc.2019.01.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">1510</span>– <span class="NLM_lpage">1523</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.10.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=10.1016%2Fj.ejmech.2017.10.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=29126739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsl2gurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2018&pages=1510-1523&author=N.+Liuauthor=H.+Zhongauthor=J.+Tuauthor=Z.+Jiangauthor=Y.+Jiangauthor=Y.+Jiangauthor=Y.+Jiangauthor=J.+Liauthor=W.+Zhangauthor=Y.+Wangauthor=C.+Sheng&title=Discovery+of+simplified+sampangine+derivatives+as+novel+fungal+biofilm+inhibitors&doi=10.1016%2Fj.ejmech.2017.10.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of simplified sampangine derivatives as novel fungal biofilm inhibitors</span></div><div class="casAuthors">Liu, Na; Zhong, Hua; Tu, Jie; Jiang, Zhigan; Jiang, Yanjuan; Jiang, Yan; Jiang, Yuanying; Li, Jian; Zhang, Wannian; Wang, Yan; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1510-1523</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Lack of novel antifungal agents and severe drug resistance have led to high incidence and assocd. mortality of invasive fungal infections.  To tackle the challenges, novel antifungal agents with new chemotype, fungicidal activity and anti-resistant potency are highly desirable.  On the basis of our previously identified simplified analog of antifungal natural product sampangine, systemic structure-activity relationships were clarified and two novel derivs. showed promising features as novel antifungal lead compds.  Compds. 22b and 22c showed good fungicidal activity against both fluconazole-sensitive and fluconazole-resistant Candida albicans strains.  Moreover, they were proven to be potent inhibitors of Candida albicans biofilm formation and yeast-to-hypha morphol. transition by down-regulating biofilm-assocd. genes.  In a rat vaginal Candida albicans infection model, compds. 22b and 22c showed excellent therapeutic effects with low toxicity.  The results highlighted the potential of sampangine derivs. to overcome fluconazole-related and biofilm-related drug resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFASL-br-ge7Vg90H21EOLACvtfcHk0ljHm4aAd3zhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsl2gurfN&md5=6ddefd6790a57e46c77ed36d9ef2314b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.10.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.10.043%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhong%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520simplified%2520sampangine%2520derivatives%2520as%2520novel%2520fungal%2520biofilm%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D143%26spage%3D1510%26epage%3D1523%26doi%3D10.1016%2Fj.ejmech.2017.10.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors as a novel strategy for the combinational treatment of leukemia and invasive fungal infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6056</span>– <span class="NLM_lpage">6074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6056-6074&author=Y.+Huangauthor=G.+Dongauthor=H.+Liauthor=N.+Liuauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+janus+kinase+2+%28JAK2%29+and+histone+deacetylase+%28HDAC%29+dual+inhibitors+as+a+novel+strategy+for+the+combinational+treatment+of+leukemia+and+invasive+fungal+infections&doi=10.1021%2Facs.jmedchem.8b00393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Janus Kinase 2 (JAK2) and Histone Deacetylase (HDAC) Dual Inhibitors as a Novel Strategy for the Combinational Treatment of Leukemia and Invasive Fungal Infections</span></div><div class="casAuthors">Huang, Yahui; Dong, Guoqiang; Li, Huanqiu; Liu, Na; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6056-6074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Clin., leukemia patients often suffer from the limited efficacy of chemotherapy and high risks of infection by invasive fungal pathogens.  Herein, a novel therapeutic strategy was developed in which a small mol. can simultaneously treat leukemia and invasive fungal infections (IFIs).  Novel Janus kinase 2 (JAK2) and histone deacetylase (HDAC) dual inhibitors were identified to possess potent anti-proliferative activity toward hematol. cell lines and excellent synergistic effects with fluconazole to treat resistant Candida albicans infections.  In particular, compd. I, a highly active and selective JAK2/HDAC6 dual inhibitor, showed excellent in vivo antitumor efficacy in several acute myeloid leukemia (AML) models and synergized with fluconazole for the treatment of resistant C. albicans infections.  This study highlights the therapeutic potential of JAK2/HDAC dual inhibitors in treating AML and IFIs and provides an efficient strategy for multitargeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3_ii7EQG1qLVg90H21EOLACvtfcHk0ljHm4aAd3zhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Snu7rN&md5=ba7cf74761120f0526ab520196e3dded</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00393%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520janus%2520kinase%25202%2520%2528JAK2%2529%2520and%2520histone%2520deacetylase%2520%2528HDAC%2529%2520dual%2520inhibitors%2520as%2520a%2520novel%2520strategy%2520for%2520the%2520combinational%2520treatment%2520of%2520leukemia%2520and%2520invasive%2520fungal%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6056%26epage%3D6074%26doi%3D10.1021%2Facs.jmedchem.8b00393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Drug repurposing of haloperidol: discovery of new benzocyclane derivatives as potent antifungal agents against Cryptococcosis and Candidiasis</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">768</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.9b00197</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00197" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVCntrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=768-786&author=C.+Jiauthor=N.+Liuauthor=J.+Tuauthor=Z.+Liauthor=G.+Hanauthor=J.+Liauthor=C.+Sheng&title=Drug+repurposing+of+haloperidol%3A+discovery+of+new+benzocyclane+derivatives+as+potent+antifungal+agents+against+Cryptococcosis+and+Candidiasis&doi=10.1021%2Facsinfecdis.9b00197"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Drug Repurposing of Haloperidol: Discovery of New Benzocyclane Derivatives as Potent Antifungal Agents against Cryptococcosis and Candidiasis</span></div><div class="casAuthors">Ji, Changjin; Liu, Na; Tu, Jie; Li, Zhuang; Han, Guiyan; Li, Jian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">768-786</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Despite the high morbidity and mortality of invasive fungal infections (IFIs), effective and safe antifungal agents are rather limited.  Starting from antifungal lead compd. haloperidol that was identified by drug repurposing, a series of novel benzocyclane derivs. were designed, synthesized, and assayed.  Several compds. showed improved antifungal potency and broader antifungal spectra.  Particularly, compd. B10 showed good inhibitory activities against a variety of fungal pathogens and was proven to be an inhibitor of several virulence factors important for drug resistance.  In the in vivo cryptococcosis and candidiasis models, compd. B10 could effectively reduce the brain fungal burden of Cryptococcus neoformans and synergize with fluconazole to treat resistant Candida albicans infections.  Preliminary antifungal mechanism studies revealed that compd. B10 regained cell membrane damage and down-regulated the overexpression of ERG11 and MDR1 genes when used in combination with fluconazole.  Taken together, haloperidol deriv. B10 represents a promising lead compd. for the development of a new generation of antifungal agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqOebtJuo-ULVg90H21EOLACvtfcHk0ljHm4aAd3zhNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVCntrfI&md5=b29fcf3a83254706c510431ee254eb3f</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00197&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00197%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DTu%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHan%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDrug%2520repurposing%2520of%2520haloperidol%253A%2520discovery%2520of%2520new%2520benzocyclane%2520derivatives%2520as%2520potent%2520antifungal%2520agents%2520against%2520Cryptococcosis%2520and%2520Candidiasis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D768%26epage%3D786%26doi%3D10.1021%2Facsinfecdis.9b00197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01763">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48737"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01763?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01763</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings of the target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_001.csv">CSV</a>);</p></li><li><p class="inline">synergism of TBA in combination with different first-line azole drugs; synergism of compounds <b>D1–12</b> in combination with azoles (VRC and ITC) against <i>C. albicans</i> (0304103); synergism of compound <b>D12</b> in combination with azoles (VRC and ITC) against various clinically isolated <i>C. albicans</i>, <i>C. krusei</i>, <i>C. auris</i>, <i>C. glabrata</i>, <i>C. tropicalis</i>, and <i>C. neoformans</i>; cytotoxicity of compound <b>D12</b> and SAHA alone or in combination with FLC; sequence of primers; the relative growth of various clinically isolated strains (<a class="ref showTableEvent internalNav" href="#tbl2">Table <a class="ref showTableEvent internalNav" href="#tbl2">2</a></a>) presented by the form of heat maps; protocols of the cytotoxicity assay; structural characterization; spectral data of target compounds; and HPLC spectra (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_001.csv">jm0c01763_si_001.csv (0.78 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01763/suppl_file/jm0c01763_si_002.pdf">jm0c01763_si_002.pdf (3.31 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01763&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01763%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-2%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01763" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66797f1ca8bd1955","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
